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Summary 
 
The unique ability of the adaptive immune system to mount effective responses 
against a wide variety of environmental threats depends on the generation of a 
functionally diverse and self-tolerant pool of T lymphocytes. The T cell 
developmental program takes place within specialized cellular niches of the thymus 
formed by thymic epithelial cells (TECs). The thymic epithelium is classically divided 
into two main lineages, the cortical (c) and medullary (m) TECs, with both 
subpopulations having well-defined roles in coordinating distinct phases of T cell 
differentiation and repertoire selection. The function of the thymus decreases with 
age, a physiological process that is associated with structural, cellular and functional 
alterations in the cTEC and mTEC niches. Despite the important advances in our 
understanding about distinct aspects of TEC biology, the mechanisms governing the 
homeostasis of TECs in the adult thymus remain poorly defined. 
In this thesis, by generating novel conditional loss-of-function mouse models, we 
studied the cellular and molecular pathways involved in the maintenance and 
regeneration of TEC microenvironments and their function. In Chapter II, we provide 
evidence that position p53 as a novel molecular determinant of TEC function 
throughout life. We report that specific loss of p53 in TECs primarily disrupts the 
integrity of the medullary niche, by altering RANK-driven mTEC differentiation and 
the transcriptional profile of mTECs. Furthermore, we show that p53 is critical to 
maintain regular thymopoiesis and the functional capacity of mTECs to induce self-
tolerance during life. In Chapter III, we study the temporal and spatial requirements 
for Interleukin-7 (IL-7), a cytokine with chief roles in pre- and intra-thymic stages of 
thymopoiesis, in the regeneration of the thymus promoted by sex steroid ablation 
(SSA). We document that SSA enhances thymic activity in young but not aged 
germline IL-7 knockout mice, an outcome that correlated with a defective expansion 
of the hematopoietic niche in the bone marrow of the later. Moreover, conditional 
deletion of IL-7 in TECs show that 1) thymic renewal after SSA proceeds 
independently of TEC-derived IL-7 and 2) the increase in thymic function following 
SSA is functionally linked to the BM compartment. 
Collectively, the results within this thesis provide new insights on novel molecular 
processes that govern the homeostasis and recovery of the TEC microenvironments 
Summary 
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during normal and altered physiological settings. This knowledge is of fundamental 
importance in the design of tailor-made therapeutic strategies aimed at repairing and 
improving thymic functioning in different medical conditions linked to poor or 
misguided T cell responses. 
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Resumo 
 
A capacidade única do sistema imune adaptativo de estabelecer respostas 
efetivas contra uma grande variedade de ameaças ambientais depende da geração 
de um grupo de linfócitos T funcionalmente diverso e auto-tolerante. O programa de 
desenvolvimento das células T ocorre em nichos celulares especializados do timo 
formados por células epiteliais do timo (TECs). O epitélio tímico é tipicamente 
dividido em duas linhagens principais, as TEC corticais (c) e medulares (m), ambas 
com funções bem definidas na coordenação de distintas fases da diferenciação das 
células T e seleção do repertório. A função do timo diminui com a idade, um 
processo fisiológico associado a alterações estruturais, celulares e funcionais dos 
nichos das cTEC e mTEC. Apesar dos importantes avanços relacionados com 
aspetos distintos da biologia das TEC, os mecanismos que regem a homeostasia 
das TEC no timo adulto permanecem mal definidos. 
Nesta tese, através da geração de novos modelos de ratinho com perdas 
condicionais de função, estudamos as vias celulares e moleculares envolvidas na 
manutenção e regeneração dos microambientes das TEC, assim como na sua 
função. No capítulo II, fornecemos evidências que posicionam p53 como um novo 
determinante molecular da função das TEC ao longo da vida. Nós descrevemos 
que a perda especifica de p53 nas TEC altera principalmente a integridade do nicho 
medular, alterando a diferenciação das mTEC que dependem de RANK e o perfil 
transcricional das mTEC. Além disso, demonstramos que p53 é fundamental para 
manter a timopoiese regular e a capacidade funcional das mTEC para induzir auto-
tolerância durante a vida. No capítulo III, estudamos os requisitos temporais e 
espaciais da interleucina-7 (IL-7), uma citoquina com um papel fundamental em 
estádios pré- e intra-tímicos da timopoiese, na regeneração do timo promovido pela 
remoção das hormonais sexuais (SSA). Nós documentamos que a SSA melhora a 
atividade tímica em ratinhos jovens, mas não envelhecidos, deficientes para IL-7, 
um efeito que se correlaciona com uma expansão defeituosa do nicho 
hematopoiético da medula óssea dos mesmos. Para além disso, a deleção 
condicional de IL-7 nas TECs mostra que 1) a regeneração do timo após a SSA 
ocorre independentemente de IL-7 produzida especificamente pelas TEC e 2) o 
aumento da função tímica após a SSA encontra-se funcionalmente à medula óssea. 
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Em suma, os resultados descritos nesta tese fornecem informações sobre novos 
processos moleculares envolvidos na homeostasia e recuperação dos 
microambientes das TEC durante situações fisiológicas normais ou alteradas. Este 
conhecimento é de extrema importância para o desenvolvimento de novas 
estratégias terapêuticas destinadas a reparar e melhorar o funcionamento tímico 
em diferentes condições médicas ligadas a respostas de células T pobres ou 
comprometidas.  
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A Brief Overview of the Immune System 
 
During millions of years, organisms have coped with a physical and hostile 
environment populated by a wide variety of pathogens and toxic substances. In 
response to these challenges, a multiplicity of defence mechanisms centred on the 
discrimination between “self versus non-self” have emerged and progressively 
became more sophisticated amongst species in order to ensure their survival (1). 
This defence machinery evolved in (jawed) vertebrates to form a complex and 
dynamic network, called immune system, which includes a myriad of different cell 
types, receptors and molecular mediators prone to respond towards foreign antigens 
while avoiding harm the host-tissues (2). 
Depending on the specificity of the immune response and the timing of 
activation, the immune system can be subdivided into two main compartments – 
innate and adaptive (3). The innate immunity, an ancient system common to all 
metazoan species, represents the very first line of immune protection by providing a 
rapid and broad inflammatory response. The innate mechanisms of defence are 
diverse and range from the non-specific anatomical barriers and molecular 
mediators (such as complement and defensins) to the selective recognition of highly 
conserved structural components of microbes and virus through a group of germ-
line encoded pattern recognition receptors (PPRs) (4). However, since the number 
of PRRs became insufficient to recognize the enormous variability and molecular 
heterogeneity of pathogen-associated molecular structures, the development of new 
strategies of innate immune evasion by microorganisms became more recurrent. 
This event created an enormous selective pressure on the organisms, eventually 
contributing to the emergence of a more advanced mechanism of protection, called 
adaptive immunity (5). The adaptive immune system is mainly centred on antigen-
specific receptors that are expressed by T and B lymphocytes. An interesting feature 
of the adaptive immunity is the ability to form immunological memory, characterized 
by the formation of long-lived cells that persist in a quiescent state and rapidly 
respond upon re-exposure to the same antigen. In contrast with the germline-
encoded PRRs, antigen-specific receptors are generated through the somatic 
rearrangement of different variable (V), diversity (D) and joining (J) immunoglobulin 
(Ig) gene segments. The random nature of this recombination process allows the 
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formation of a vast repertoire of different T cell receptors (TCRs) and B cell 
receptors (BCRs), each with unique specificities for a limitless variety of foreign 
antigen (6). Still, the existence of such diversity is simultaneously dangerous to the 
host due to the formation of specific TCRs and BCRs against self-antigens. Thus, 
the maintenance of an immunological self-tolerant state is ensured by the 
coordinated action of central and peripheral mechanisms that eliminate or regulate 
self-reactive lymphocytes (7, 8). Nevertheless, while fundamentally different in many 
aspects of their biology and function, innate and adaptive immune responses are 
intimately linked, relying on each other in order to build an effective defence 
network. 
The different cell lineages that compose the immune system are originated from 
a highly organized process termed hematopoiesis (9). The establishment of the 
hematopoietic system begins early during embryogenesis with the first cells arising 
in the yolk sac. This event represents the most primitive wave of hematopoiesis and 
mainly involves the production of erythrocytes whose function is to aid tissue 
oxygenation during embryo development (10, 11). Nonetheless, the primitive 
hematopoietic wave only exists transiently and is rapidly replaced by a definitive 
wave of hematopoiesis characterized by the emergence of self-renewing 
hematopoietic stem cells (HSCs). HSCs, which provide a long-term source of all 
immune lineages, are first detected in the aorta-gonad-mesonephros (AGM) region 
of the embryo (9, 11). From this anatomical place HSCs colonize the fetal liver, 
where they undergo active expansion, and ultimately migrate to the bone marrow 
(BM) during the late phase of embryogenesis, where hematopoiesis is established 
throughout life (9, 11). Within the BM, distinct stromal cells populations form 
specialized niches (endosteal, vascular and reticular) that are responsible for HSCs 
maintenance and differentiation through the provision of key regulatory signals (12). 
Through intermediate lineage-restricted progenitors, HSCs can give rise to two main 
immune branches:  lymphoid and myeloid. The lymphoid lineage includes T, B and 
natural killer (NK) cells, while the myeloid is comprised by monocyte/macrophages, 
granulocytes and megakaryocytes (13). Interestingly, although dendritic cells (DCs) 
are also of hematopoietic origin, their lineage affiliation remains unclear since they 
can differentiate from both lymphoid and myeloid committed progenitors (13). 
Remarkably, while most of the abovementioned hematopoietic cells differentiate 
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within the BM, the generation of a diverse and self-restricted repertoire of T 
lymphocytes require unique microenvironments exclusively found in the thymus. 
 
Thymus: The Cradle of T Cell Immunity 
 
Originally described by Galen of Pergamum (130-200 AD), the thymus has 
remained an enigmatic organ for centuries, surrounded by many queries regarding 
to its physiology and clinical relevance (14). The importance of the thymus was only 
documented in 1961 by Jacques Miller’s studies on virus induced-leukaemia in 
neonatal thymectomyzed mice. His observations settled an intense dispute, ending 
with the recognition of the thymus as a non-redundant lymphoid organ of the 
immune system with a chief role in the development of T lymphocytes (15). 
Evolutionary, the appearance of a prototypical thymic structure, as we know it 
nowadays, coincides with the introduction of the VDJ recombination system in 
lymphocyte development in Gnathostomata (jawed vertebrates). Since the 
stochastic mechanism of VDJ recombination amplifies exponentially the chance of 
developing self-reactivity, it is postulated that the thymus evolved as a physical 
separated organ with the ability to provide a sophisticated quality-control mechanism 
for tolerance induction (16, 17). The existence of a thymus is a common trait of all 
jawed vertebrates, although in jawless such as the lamprey larvae, a thymus-like 
structure (termed thymoid) has been identified (18). The origin of the thymus from 
specialized pockets of the foregut endodermal tube, termed pharyngeal pouches, is 
a conserved feature among different thymus-bearing vertebrates (17, 19). Still, the 
anatomical location and number of thymic lobes per animal can strikingly diverge 
between species. For instance, sharks exhibit five thymus pair, with each lobe 
arising from the second to six pharyngeal pouches, while many mammals only have 
a bilobated thymus that emanates from the third or fourth pharyngeal pouch (17). 
Nevertheless, irrespectively of these differences, the unique function of the thymus 
in supporting the development of a diverse and self-tolerant T lymphocyte 
population is a common characteristic across all jawed vertebrates. 
In mammals, the thymus is a bilobated structure that is situated in the superior 
anterior mediastinum, above the heart. Each lobe is anatomically organized in two 
distinct compartments, an outer cortex and inner medulla, a characteristic that is 
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well conserved across thymus-bearing species (Figure 1A) (19). The ability of this 
organ to support T cell development, or thymopoiesis, relies on an organized three-
dimensional network of thymic stromal cells that provides the essential molecular 
cues required for differentiation of T cell precursors, also known as thymocytes, from 
BM-derived hematopoietic progenitors (20). Thymic epithelial cells (TECs) are the 
major constituent of the thymic stroma and are categorized into cortical (cTECs) and 
medullary (mTECs) subtypes, according to their spatial location, morphology and 
functional proprieties (21). The composition and cellularity of the thymic epithelium is 
considerably variable over time, with TECs representing less than 1% of the total 
thymic cellularity during adulthood (22). Other important elements of the thymic 
stroma include endothelium, mesenchyme and cells with a hematopoietic origin, 
such as dendritic cells, macrophages and B cells (Figure 1B) (23). Together, they 
are responsible to support key events of thymopoiesis, including migration, survival, 
proliferation, commitment and selection of developing thymocytes.  
 
Despite the importance of the thymus in maintaining a self-tolerant and 
pathogen-reactive peripheral T cell compartment through the continual production of 
naive T lymphocytes, its function is not constant and slowly wanes with aging (24). 
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This phenomenon is known as thymic involution (disclosed later in this thesis) and 
represents one of the hallmarks of the ageing immune system in all thymic-bearing 
species (25). It is mainly characterized by a progressive disruption of the normal 
cortical and medullary thymic architecture, alongside with alterations on the cellular 
composition of the thymic stroma (26). As a result, the capacity of the thymus to 
support thymopoiesis becomes gradually compromised, leading to a reduction in the 
number of thymocytes and T cell output, thereby contributing for a reduced 
immunosurveillance. Although aged-related thymic involution does not represent a 
life threatening event, it can indirectly contribute for an increased susceptibility to 
infectious diseases, neoplastic and autoimmune disorders during elderly (27, 28). 
 
Regulation of T Cell Development by the Thymic Stromal 
Microenvironments 
 
Unlike the majority of the hematopoietic lineages, the generation of a diverse 
pool of self-tolerant and non-self reactive T cells occurs inside the unique niches of 
the thymus. Two main lineages of T cells are produced in the thymus and can 
distinguished based on the distinct expression of αβ or γδ TCR complexes, with the 
development of αβ T cells standing as the predominant pathway (20). While γδ T 
cell differentiation remains elusive, the differentiation of prototypical αβ CD4+ and 
CD8+ T cells is more general understood and will be detailed below. The 
differentiation of T lymphocytes is a highly orchestrated process that involves a 
series of developmental checkpoints that function to select cells bearing major 
histocompatibility complex (MHC)-restricted TCR while limiting the production of 
cells bearing non-functional or autoreactive TCRs. As consequence of such rigorous 
events, only 1-3% of thymocytes are able to survive and migrate into the peripheral 
lymphoid organs (29). As the thymus does not contain self-renewal progenitors, the 
long-term maintenance of thymopoiesis is assured by the recruitment of 
hematopoietic-derived precursors that are present in the fetal liver and BM at 
different phases of embryonic and postnatal life (30). Yet, thymic colonization is not 
a continuous event, but rather a temporally regulated phenomenon that occurs in 
discrete waves, depending on the availability of dedicated thymic-seeding progenitor 
niches (31, 32). 
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The precise nature of the thymic seeding progenitors (TSPs) still remains 
questionable. Efforts to uncover their identity have been hampered by the fact that 
several phenotypically distinct BM-derived progenitors possess T cell lineage 
potential (33). A more complex scenario emerged with the discovery that early 
thymic progenitor (ETPs) in the thymus possess multiple lineage potential (both 
myeloid and lymphoid), rather than a T cell lineage restriction, and are molecularly 
related to distinct BM-derived progenitors (34). The initial wave of thymic 
colonization occurs very early during mouse embryogenesis (embryonic day 12) 
(35) and is mediated by a chemotactic gradient established through the intrathymic 
production of three main chemokines, CCL21, CCL25 and CXCL12 (36–38). As this 
recruitment occurs prior to the vascularization of the thymic rudiment, TSPs home 
into the thymus by transversing through the surrounding mesenchymal capsule (39, 
40). Nonetheless, in the post-natal thymus, once the vasculature is well established, 
T cell progenitors enter across blood vessels located nearby the cortico-medullary 
junction (CMJ) (41). At this stage, in addition to the cooperative action of chemokine 
signals (36), thymic colonization is also facilitated by the expression of adhesion 
molecules on the thymic endothelium, such as P-selectin (42, 43). 
Upon arrival into the thymus, thymocyte progenitors undergo T lineage 
specification through a series of distinct developmental checkpoints (Figure 2). At 
this stage, as these cells lack the expression of the CD4 and CD8 co-receptor, they 
are referred as double-negative (DN) thymocytes. By monitoring the expression 
profile of the surface markers CD44 and CD25, DN thymocytes can be further 
divided into four phenotypically distinct sub-stages of maturation, from DN1 to DN4. 
During their developmental progression, DN thymocytes are relocated outwards 
from the CMJ to the sub-capsular region of the cortex. Different chemokine 
receptors, such as CXCR4, CCR9 and CCR7, are important for the outer movement 
of DN thymocyte in response to respective CXCL12, CCL25 and CCL21 gradients 
(20, 44). Furthermore, the directional migration of DN cells across the thymic cortex 
is further facilitated by integrin-mediated cell-cell interactions. Adhesion molecules, 
such as α4β integrins expressed by DN thymocytes and vascular cell adhesion 
molecule-1 (VCAM-1) expressed by cTECs have been implicated in this process 
(45). 
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The most immature population of thymocytes, known as DN1 (CD44+CD25-) 
cells, persists in very restricted regions of the CMJ during the first 10 days of their 
intrathymic residence (46). Transition into the DN2 (CD44+CD25+) stage is marked 
by the irreversible commitment of thymocytes towards the T cell lineage. This event 
involves the repression of alternative gene expression programs typical of other 
hematopoietic lineages and is promoted by the Notch-signalling pathway, via Dll4-
Notch1 interaction (47, 48). At this stage, the recombination activating gene (RAG) 
enzymes -1 and -2 promote the VDJ rearrangement of the γ-, δ-, and β- TCR locus 
(49, 50). Moreover, progression to the DN2 stage coincides with thymocyte 
migration towards the outer cortex and is characterized by their active proliferation 
(41). The expansion and survival of these cells relies on the provision of stromal 
derived cytokines, in particular, stem cell factor (SCF or kit ligand) and interleukin 7 
(IL-7) (30). The productive rearrangement, assembly and signalling through the γδ 
TCR allow the differentiation of a minor DN3 thymocyte fraction towards γδ T cell 
lineage (51). By the other hand, thymocytes that succeed in generating a productive 
in-frame Tcrβ rearrangement begin to assemble at its surface a pre-TCR complex, 
which is composed by a β-chain and an invariant pre-TCRα chain associated with 
CD3 signalling molecules (52). The assembling of a functional pre-TCR complex is 
assured by a critical checkpoint known as β-selection (53). During this process, 
signalling through the pre-TCR, along with Notch1 and CXCL12-derived signals 
(54–56), rescue DN3 (CD44-CD25+) thymocytes from apoptosis, stimulate 
proliferation, cease the TCRβ locus recombination (allelic exclusion) and promote 
cell differentiation towards the DN4 (CD44-CD25-) stage (20). Following β-selection, 
thymocytes initiate the rearrangement of the TCRα locus and invert their migration 
towards the medulla while progress through a transient state as immature CD8 
single positive (ISP8) cells (20). Transition to the double positive stage is 
characterized by the upregulation of CD4 and CD8 co-receptors and the expression 
of a fully assembled αβ TCR. The CD4+CD8+ DP population encompasses the 
majority of developing thymocytes (~80%) and represent the unselected repertoire 
of T cells (29, 57). 
Still in the cortex, DP thymocytes are subsequently screened for the capacity of 
their newly generated αβ TCR repertoire to recognize endogenous peptides in the 
context of self-major histocompatibility complex (MHC) molecules expressed by 
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cTECs (58, 59). It is considered that the specificity and binding strength of the TCR 
with peptide-MHC complexes (pMHC) dictates the fate of DP thymocytes. If these 
interactions occur within a threshold of low affinity, DP thymocytes receive signals 
for survival and differentiate into the single positive (SP) stage, in a process known 
as positive selection. This crucial checkpoint assures the selection of cells that bear 
potentially useful and self-MHC restricted TCR. On the other hand, high affinity 
interactions between TCR-pMHC lead to the apoptotic deletion of self-reactive 
thymocytes. Nonetheless, as most of the DP thymocytes express αβ TCR that are 
incapable of interact properly with self-MHC molecules, they undergo “death by 
neglect” through a programmed cell death process (29). Consequently, only 3-5% of 
developing thymocytes are able to progress beyond this developmental checkpoint 
at the DP stage (60).  
 
The lineage-specific differentiation of DP thymocytes into the CD4 or CD8 SP 
stage is mostly determined by the specificity and restriction of the TCR to MHC 
molecules. DP thymocytes whose TCR recognize MHC class II (MHC-II) within the 
limits of moderate affinity differentiate into CD4+ SP cells, while cells that express 
TCR recognizing MHC class I (MHC-I) commit into the CD8+ SP lineage. As this 
decision making process is not completely understood, different models have been 
proposed over the years. The most recent one, known as “kinetic signalling”, implies 
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that is the duration of the TCR-pMHC interaction rather than signal strength that 
dictates CD4/CD8 lineage choice (61). According to this model, TCR-signalled DP 
thymocytes start by terminating Cd8 gene expression and progress through an 
intermediate stage characterized by a CD4+CD8low phenotype (62, 63). At this point, 
lineage decision starts to take place depending on whether TCR signalling ceases 
or persists. During MHC-II restricted selection, persistent TCR signals foster 
CD4+CD8low thymocyte differentiation towards the CD4+ lineage (64). Contrariwise, 
the progressive reduction on CD8 cell surface levels contributes for the disruption of 
the MHC-I restricted TCR interaction. Ablation of TCR signalling enables 
intermediate thymocytes to become responsive to IL-7-derived signals, which 
supports “coreceptor reversal” and commitment to the CD8 differentiation lineage 
(64, 65). Several transcription factors have been identified as key modulators of 
CD4/CD8 lineage choice. Th-POK (T-helper inducing POZ/Kruppel-like factor), 
whose expression is upregulated in intermediate thymocytes by persistent TCR 
signalling, is defined as a master regulator of CD4 T cell differentiation and acts in 
part by repressing the expression of CD8 lineage genes (66, 67). On the other hand, 
RUNX3 (runt-related transcription factor 3) is critical for CD8 T cell lineage 
commitment. Its expression occurs following TCR signal cessation in response to IL-
7 derived signals (65) and acts by promoting the silencing of the Cd4 gene 
expression and block of Th-POK expression (68, 69). The regulatory negative loop 
involving Th-POK and RUNX3, where they reciprocally prevent each other’s 
expression, is crucial to reinforce lineage choice (70). Additional factors, such as 
TOX (thymus high mobility group box protein) and GATA3 (GATA-binding protein) 
also appear to be important in thymocyte differentiation, particularly in CD4 lineage 
choice (71–73). 
Following positive selection, thymocytes begin to migrate from the cortex into the 
medulla. This relocation event occurs as result of several changes in integrin and 
chemokine receptor expression profile in post-positively selected cells (44). TCR-
signalled DP thymocytes start by upregulating their expression levels of CCR7 and 
migrate towards to the medulla in response to a chemotactic gradient established by 
the CCR7-ligands (CCL19/CCL21) (74, 75), mainly produced by mTECs (76, 77). 
Additionally, other studies have also revealed the contribution of plexinD1 and 
CCR4 in governing the optimal cortical-medullary transition of post-selected 
Chapter I | Introduction 
Page | 12 
thymocytes (78, 79). In the medulla, SP thymocytes are scanned for the presence of 
high-affinity TCR to self-antigens within their positively selected TCR repertoire. For 
that sole purpose, mTECs express distinct clusters of tissue-restricted antigens 
(TRAs) through the entire medullary region. This unique characteristic, known as 
promiscuous gene expression (pGE), allows the premature exposure of SP 
thymocytes to protein-derived antigens which are otherwise limited to specific 
tissues within the body (80). mTEC-dependent pGE program is partially under the 
control of the transcription factor autoimmune regulator (Aire) and the newly 
identified FEZ family zinc finger 2 (Fezf2) (81, 82). Direct presentation of mTEC-
derived TRA or cross-presentation by thymic dendritic cells is responsible to shape 
a self-tolerant T cell repertoire (83, 84), by promoting the clonal deletion of SP 
thymocytes bearing potentially autoreactive TCRs. This process is named negative 
selection, and together with positive selection, corresponds to two critical 
checkpoints that fine-tune T cell repertoire. Alternatively, a fraction of self-reactive 
CD4+ SP cells are rescued from clonal deletion and undergo differentiation into a 
specialized regulatory subset of T cells (85), characterized by the expression of the 
transcription factor Foxp3 (86). T regulatory cells (Tregs) are central to the 
maintenance of immune homeostasis, namely in the prevention of spontaneous 
autoimmunity (87). Thus, both Treg differentiation and negative selection represent 
two distinct, but interconnected, events in the establishment of central tolerance. 
Thymocytes that continue through the selection process display a medullary 
residency of approximately 4-5 days (88). During this period, they undergo receptor 
tuning and terminal maturation steps, transitioning from a semi-mature 
CD69hiCD24hiCD62LlowQa2low to a mature CD69lowCD24lowCD62LhighQa2high 
phenotype (89), before acquiring the functional competences to join the peripheral 
naïve T cell pool. Interestingly, the functional role of the medullary niche extends 
beyond negative selection and Treg generation as it was also shown to nurture the 
differentiation of unique non-conventional T cell lineages, including the fetal-derived 
Vγ5+ γδ thymocytes and invariant natural killer T (iNKT) cells (90, 91). 
The egress of T cells from the thymus is under the tight control of the 
sphingosine-1-phosphate receptor 1 (S1P1), a G-protein coupled receptor (GPCR) 
expressed on SP thymocytes (92, 93). Increased surface expression of S1P1 is only 
observed on mature SP cells following TCR signalling termination due to the 
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increased transcriptional activity of Krϋppel-like factor 2 (Klf2) (94). As result, fully 
mature SP thymocytes are able to sense the chemotactic gradient established by 
the physiological ligand of S1P1, the sphingosine-1-phosphate (S1P), whose 
concentration is higher in circulation than within most tissues (44). This bioactive 
sphingolipid is mainly produced by pericytes, a neurocrestal derived population 
positioned nearby the CMJ (95), where it functions as an egress signal and is 
maintained at very low levels in other thymic regions owing to the action of dendritic 
cell-specific S1P lyases (96) or TEC/endothelial-derived lipid phosphate 
phosphatase 3 (LPP3) enzyme (97). Additionally, the CCR7/CCL19 and 
CXCR4/CXCL12 axis have been shown to contribute for fetal thymocyte egress (98, 
99), although they appear to be dispensable in the adult thymus. Hence, evidence 
might suggest the existence of a developmental switch between CCR7/CXCR4-
dependent and S1P1-mediated emigration throughout development. 
 
The Basics of Thymic Organogenesis 
 
The establishment of functionally competent thymic epithelial microenvironments 
is a critical prerequisite for the development of a diverse and self-tolerant peripheral 
T cell compartment (21). Thymic organogenesis is a well-orchestrated process 
involving the synchronised crosstalk of cells from all three embryonic germ layers 
(endoderm-derived epithelium, ectoderm-derived neural crest (NC) mesenchyme, 
mesoderm-derived hematopoietic cells) under the influence of distinct molecular 
programmes (100). The murine thymus development can be temporally divided in 
two main phases (Figure 3) (101). The early organogenesis phase (from embryonic 
day (E) 9.5-12.5) comprises a series of morphogenetic events such as positioning, 
initiation and outgrowth of the thymic anlage, as well as detachment and initiation of 
the migration of the thymus to its final anatomical position (100). This stage is also 
characterized by the initial differentiation and proliferation of the thymic epithelium in 
a thymocyte-independent manner (102, 103). By the other hand, the late phase of 
thymic organogenesis (from E13-birth) essentially relies on signals derived from 
developing thymocytes to further support the maturation of the thymic epithelium 
into distinct cortical and medullary microenvironments (104, 105). 
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The early ontogeny of the murine thymus is intimately connected with the 
formation of the parathyroid gland, with both organs emerging as a shared structure 
from the third pharyngeal pouches (3PP) of the foregut endodermal tube around 
E11 of gestation (106). The patterning of specific parathyroid and thymic domains 
within the common primordium occurs prior to formation of the organ rudiments and 
is critically dependent on two lineage determinants, Glial cells missing homolog 2 
(Gcm2) and Forkhead box N1 (Foxn1), respectively. The transcription factor Gcm2, 
a key regulator of parathyroid differentiation, is first expressed in the anterior-dorsal 
region of the 3PP epithelium as early as E9.5 (107, 108). By contrast, the 
expression of Foxn1, a chief transcription factor involved in the cell-autonomous 
differentiation of TECs, is only detected from E10.5 onwards at the posterior-ventral 
side of the pouch (107, 109). Following the establishment of two molecularly distinct 
organ domains, the common parathyroid-thymus primordia proliferates and 
detaches from the lateral surfaces of the pharynx around E11.75, in a process that 
is mediated by apoptotic cell death (110). At E12.5, the thymus and parathyroid 
gland separate from each other and begin to migrate towards their final anatomical 
locations at the mediastinum anterior-ventral to the heart (thymus) and adjacent to 
the thyroid (parathyroid) (100). Intriguingly, a small fraction of mice and humans has 
been shown to possess an accessory thymus that is located in the cervical region of 
the neck (111–113). The murine cervical thymus resembles the thoracic counterpart 
in many molecular and functional aspects, as it exhibits a normal cortex and medulla 
organization with the capability to support T cell differentiation (112, 113). Yet, 
organogenesis of the cervical thymus does not happen in parallel with the thoracic 
structure, as the onset of Foxn1 expression in the cervical anlage only occurs 
around E15 of gestation (114). Recent data propose two discrete developmental 
pathways for TECs within the cervical thymi: One possibility is that TECs arise from 
uncommitted endodermal cells that lag behind during the physical segregation of the 
parathyroid-thymus domains. Alternatively, they might develop from the 
transdifferentiation of parathyroid-fated cells (115). 
During embryogenesis, a population of neural-crest-derived mesenchymal cells 
(NCCs) migrate to the third pharyngeal arch and progressively delimits the thymic 
epithelial anlage (116). NCCs, which contribute to the formation of the thymic 
mesenchymal capsule and surrounding vasculature (117, 118), also act as key 
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regulators of many aspects of thymus development and morphogenesis. The 
surrounding NCC-derived mesenchymal cells influence the proliferation and 
homeostasis of the thymic epithelium along embryogenesis through the provision of 
fibroblast growth factors (FGF) -7 and -10 (119), as well as retinoic acid (RA) and 
insulin-like growth factor (IGF) -1 and -2 (120, 121). Studies performing NCC-
specific ablation established its functional importance in regulating the correct 
patterning of the third pharyngeal pouch endoderm into thymus-parathyroid domains 
(122), although the molecular mechanisms involved still remain unclear. 
Additionally, signals provided by NCCs have been implicated in the separation of the 
thymus from the pharynx and its subsequent migration to the thoracic cavity (123, 
124). A role for NCC-derived mesenchyme in supporting the maturation of 
thymocyte precursors beyond the DN1 stage has all been proposed in experiments 
using reaggregate thymic organ cultures (RTOC) (125, 126). Although it remains 
unclear how mesenchymal cells influence T cell development, a possible 
mechanism might implicate components of the extracellular matrix (ECM) that 
present and concentrate essential soluble growth factors, such as cytokines (127).  
 
In the recent years, much progress has been made in uncovering the complex 
molecular network that controls the establishment and early patterning of the thymic 
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primordium. A number of transcription factors, including homeobox A3 (Hoxa3), 
eyes absent 1 homologue (Eya1), paired box gene 1 (Pax1), Pax9, sine oculis-
related homeobox 1 homologue (Six1), Six4 and T-box protein 1 (Tbx1) have been 
associated with this regulatory network (128–134). Mutations in any of these genes 
lead to thymus aplasia or hypoplasia, or a complete failure of the thymic anlage to 
migrate towards its final anatomical location. Nonetheless, as these transcription 
factors are both expressed by the pharyngeal pouches and NCC-derived 
mesenchyme, their loss of function causes pleiotropic defects which makes 
challenging to attribute a direct role of these genes in thymus development (100). 
Hence, in order to understand their precise contribution during thymic ontogeny, 
experimental systems employing TEC-specific and temporal controlled gene 
deletions may be required. 
Among the hierarchy of transcription factors involved in thymic organogenesis, 
Foxn1 is the most significant one as it remains the only gene described to be 
indispensable for TEC development (135). Foxn1 is a member of the forkhead box 
transcription factor and contains a winged-helix/forkhead DNA-binding domain and a 
transcriptional activation domain (136). Mice that lack the Foxn1 gene are referred 
as nude and they are athymic, since the thymic anlage is unable to differentiate in a 
functional TEC compartment and become colonized with lymphocyte precursors 
(137, 138). A small, alymphoid cystic thymic rudiment persists into adulthood which 
results in the lack of functional T cells and severe immunodeficiency (135). 
Interestingly, thymic organogenesis stills proceeds normally in nude mice until E11 
with the formation of the common thymus-parathyroid primordium, suggesting that 
Foxn1 is not involved in the initial thymic/parathyroid fate specification (137). The 
transcription factor Foxn1 is found in all jawed vertebrates and is believed to 
appeared during evolution as result of the duplication of the Foxn4 gene (139). 
Although with a nearly identical protein structure, a notable feature of Foxn1 is the 
presence of distinct DNA binding domains when compare to its ancient paralog 
Foxn4 (139). Appearance of this gene might have allowed the expansion of the 
ancient genetic network regulating thymopoiesis, which forced the primordial thymus 
to become more specialized in coordinating exclusively T cell development rather 
than being a bipotent lymphopoietic organ supporting both T and B cell 
differentiation (140). In this regard, apart of being essential for the differentiation and 
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identity of the thymic epithelium, Foxn1 is has been shown to be a crucial 
transcriptional regulator of downstream targets that are important to support T cell 
development. Among these are genes that contribute for antigen processing and 
presentation, lymphocyte migration and T-cell lineage commitment (e.g. - β5t, 
CCL25 and Dll4) (141). At present, the mechanism that induces and maintains 
Foxn1 expression in TECs is far from being understood. Some evidence suggests 
that Bone morphogenetic protein (Bmp) and Wingless-related MMTV integration 
(Wnt) signals might regulate Foxn1 expression (142–144), even though the role of 
the Wnt family remains to be verified in vivo. Additionally, recent data also 
demonstrated that retinoblastoma (Rb) family of proteins are able to transcriptionally 
regulate Foxn1 expression (145). Understand the mechanisms that regulate Foxn1 
is of pivotal importance, as it will permit the development of novel strategies to 
manipulate the thymopoietic capacity of the thymus under different physiological 
settings. 
 
Thymic epithelial cells: Establishing the foundations of 
T cell development 
 
In recent years, TECs have been extensively studied with the purpose of gaining 
a better understanding about the precursor-progeny relationship and the cellular and 
molecular mechanisms behind the establishment of functionally competent TEC 
microenvironments. 
The partitioning of TECs into specialized subpopulations of cTECs and mTECs, 
relies on a highly dynamic differentiation process from epithelial precursors that is 
initiated early during fetal development and proceeds throughout post-natal life 
(146). In the past, there were some conflicting interpretations about the precise 
origin of the thymic epithelium. Several studies proposed a “dual germ layer origin” 
model were the cortical and medullary microenvironments result from the folding of 
an ectodermal layer around the endoderm (147, 148). However, the prevailing view 
supports that the thymic epithelium originates solely from progenitors with an 
exclusive endodermal origin (110). Yet, such studies did not clarify whether these 
two functionally distinct TEC lineages stem from a common bipotent progenitor or, 
alternatively, from lineage-committed progenitors. The existence of common 
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bipotent TEC progenitors (TECp) was first suggested by the identification of a minor 
TEC population co-expressing both cortical and medullary markers (149, 150). 
These putative TEC progenitors, identified by the co-expression of Keratin (K) 5 and 
8, were located in the vicinity of the cortico-medullary junction in the adult thymus 
(150). Although was postulated their involvement in the maintenance of the K5+ 
mTEC and K8+ cTEC compartment, there was no direct evidence supporting the 
idea that such population were bipotent TECp. Years later, the existence of bipotent 
TECp and lineage relationship between the two main TEC subsets was finally 
addressed in two complementary reports that took advantage of lineage-tracing 
systems (151, 152). First, single yellow fluorescent protein (YFP)-labelled E12.5 
TECs were shown to contribute for both cTEC and mTEC lineage when 
microinjected in a host thymus microenvironment. Interestingly, contribution to a 
single cTEC or mTEC lineage was markedly absent, indicating that most, if not all, 
E12 TECs might own bipotent activity (151). In the second study, using a gain-of-
function strategy where a conditional mutant allele of Foxn1 was reverted to wild-
type function in individual TECs of nude mice, it was shown that bipotent TECp can 
persist in the postnatal thymus and contribute for the generation of functional thymic 
niches (152). Furthermore, additional studies indicate that the size of the Foxn1-
positive TEC progenitor pool is critical to determine the overall thymopoietic capacity 
of the thymus (153). These observations support the notion that whereas bipotent 
progenitors arise during thymic organogenesis independently of Foxn1, its presence 
is critical to initiate the core transcriptional program involved in TECp differentiation 
and progression into cortical and medullary TEC lineages (Figure 4A).  
Despite the described major advances, the robust isolation and phenotypic 
characterization of TEC precursors has been difficult to attain due to the paucity of 
cell specific markers. Initial studies suggested MTS24, a monoclonal antibody that 
recognize the orphan protein placenta-expressed transcript-1 (Plet-1) (154), as a 
putative marker to identify embryonic TEC progenitors (155, 156). Plet1+ TECs were 
shown to possess the capacity to generate a fully functional competent and 
organized thymic microenvironment, compartmentalized into cortex and medulla, 
whereas the Plet1- subset was unable to establish such TEC niches and functional 
thymus. Plet1-expressing TECs are first detected as early as E12 and progressively 
becomes rare with age, as in the postnatal thymus its expression is limited to small 
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subpopulations located in the thymic medulla and cortico-medullary junction (155, 
156). Nonetheless, in the subsequent years, reassessment of TEC progenitor 
potential using MTS24 revealed that its expression was not restricted to a progenitor 
population as E14 MTS24- TECs also had the potential to generate a functional 
thymus (157). Additionally, E18 MTS24+ cells displayed little capacity to build a 
competent thymic graft when transplanted into the kidney capsule of nude mice, 
thereby arguing against the usage of such marker to exclusively identify TEC 
bipotent progenitors (157). More recently, several reports described the existence of 
a transitional stage where embryonic TEC progenitors might be characterized by the 
expression of cTEC-associated traits, including CD205, β5t and IL7YFP (158–160). 
These observations paved the way to establish the “serial progression” model of 
embryonic TEC development, in which bipotent progenitors transit through a phase 
where they express a cTEC footprint prior to the emergence of mTECs (Figure 4B) 
(161). Supporting the notion that TEC progenitors might nestle within the thymic 
cortex, different studies demonstrated the ability of distinct postnatal and adult cTEC 
subsets to form colonies with self-renewal capacity in vitro, and to generate both 
cTEC and mTEC lineages in RTOCs (162, 163). Despite the remarkable progress in 
the characterization of TEC precursors, there is still a lack of consensus regarding 
their molecular and phenotypic characteristics in the embryonic and adult thymus. 
Additionally, distinct TEC precursors are all defined at the population level, as they 
cannot be yet recognized as single cell. Future studies involving genome-wide 
analysis at a single cell level would be crucial to better define the nature and specific 
molecular signature of TEPs in the embryonic/postnatal/adult thymus. 
 A B cTEP 
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Specialization of the thymic microenvironment – Development and 
function of cTECs 
 
The development of cTECs constitutes a primitive hallmark event in the 
establishment of a functionally competent microenvironment, essential for attraction, 
lineage specification and subsequent selection of T cell precursors. Cells from the 
cTEC lineage can be defined by the phenotypically expression of specific surface 
markers such as K8 and K18, Ly-51 (also known as BP1/CD249), CD205 (also 
known as DEC-205) and the atypical chemokine receptor 4 (ACKR4, also known as 
CCRL1). Furthermore, functional molecules such as Dll4, high levels of IL-7 and β5t 
may be also used to aid in the identification and characterization of cTECs (164). 
Apart of these, the cortical epithelium also shares some classical markers with cells 
from the mTEC lineage, including the epithelial cell adhesion molecule (EpCAM), 
MHC-II and CD40. Interestingly, the expression levels of some of these markers 
revealed the existence of a certain heterogeneity within the cTEC compartment, with 
discrete subsets being defined according to the broad expression of MHC-II, CD40, 
Dll4 and IL-7 (22, 160, 165, 166). 
 In contrast to our knowledge regarding mTEC development (covered later in this 
thesis), the intermediate steps in cTEC differentiation downstream of bipotent 
progenitors and the mechanism underlying their homeostasis are still poorly 
comprehended. Initial studies focusing on the precursor-product relationship of the 
cTEC lineage revealed that TECs exhibiting a cortical phenotype (K8-positive) are 
already detected prior to the colonization of the thymic rudiment by lymphocyte 
progenitors at E11.5 (103). Interestingly, the emergence of this population is not 
compromised in mice with a profound arrest in early T cell development (Rag2-/-Il2rg-
/-; CD3εTge26 and Ikaros-/-) (103), supporting the notion that the initial stages of 
cTEC differentiation can proceed in a thymocyte-independent fashion. Still, during 
late stages of ontogeny and in the absence of thymocyte-derived signals, the 
cortical microenvironment displays a disturbed architecture with little organization 
and accumulation of TECs co-expressing K5 and K8 (103, 150). Interestingly, the 
presence of DN3 thymocytes in Rag-/- mice is sufficient to promote the formation of a 
threedimensional reticular cTEC network (104), demonstrating the existence of a DN 
stage-specific requirement for maturation of the cortical epithelium. However, the 
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lack of appropriate markers to better define the developmental maturation of the 
cortical niche has hindered the identification of potential cTEC-restricted progenitors. 
More recently, the differential expression of the CD205, CD40 and MHCII molecules 
permitted the identification of presumable lineage-committed cTEC progenitors and 
established new sequential stages of cTEC development (165). Cells with a 
CD205+CD40- phenotype are proposed to represent a population of cTEC 
progenitors that lies in between bipotent progenitors and mature cTECs. In support 
of this hypothesis, intermediate cTEC progenitors are enriched in proliferating cells 
and express lower levels of cTEC-specific transcripts such as β5t and cathepsin L, 
when compared with more mature cortical cells (CD205+CD40+MHC-IIhigh) (165). 
Foxn1 expression but not thymocyte-derived signals were required for the initial 
appearance of intermediate cTEC progenitors as early as E12. Yet, the 
developmental maturation of cTECs, defined by the acquisition of MHC-II and CD40, 
did not occur in a cell-autonomous manner and was essentially dependent on the 
presence of DN1-3 thymocytes (165). Along with these observations, our laboratory 
demonstrated that the progressive acquisition of CCRL1 marked a differentiation 
stage in cTECs, which also relies on lymphoepithelial interactions with early DN 
stages, as its expression is partially blocked in Rag2-/-Il2rg-/- mice (167). Still, the 
precise nature of signals provided by DN thymocytes to cTECs remains to be 
determined, and further studies to better characterize new developmental 
checkpoints of the cortical epithelium are warranted.  
cTECs play a critical role in orchestrating multiple processes during early stages 
of thymopoiesis, including homing of T cell progenitors into the thymus through the 
production of several chemokines (CCL25 and CXCL12), T cell lineage specification 
via the notch ligand Dll4, and thymocyte precursor expansion via secretion of IL-7 
and kit ligand (also known as stem cell factor) (Figure 5) (21). The ability of cTECs 
to support positive selection of developing thymocytes relies on their distinctive 
protein degradation machinery and antigen-processing capacity (168). These 
features ensure that the array of self-peptides presented by cTECs during selection 
are distinct and not redundant from those displayed by mTECs and thymic DCs. 
Generation of a broad repertoire of MHC-II-associated peptides have been shown to 
be dependent on the presence of the thymus-specific serine protease (TSSP) and 
the lysosomal protease cathepsin L, as deficiency in any of these proteases results 
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in impaired positive selection of CD4+ SP cells (169, 170). Furthermore, positive 
selection of some MHC-II-restricted transgenic TCRs was shown to be 
compromised upon ablation of genes involved in macroauthophagy in the thymic 
epithelium (171), suggesting a role for this pathway in shaping the composition of 
MHC-II ligandome on cTECs (Figure 5). The cytoplasmatic production of MHC-I-
associated peptides is critically dependent on a specialized form of proteasome, 
termed the thymoproteasome. A unique characteristic of this complex is the 
incorporation of a cTEC-restricted proteolytic β5t subunit (encoded by the gene 
Psmb11) (Figure 5), which confers an altered proteolytic activity that is distinct from 
other proteasomes containing other β5 subunits (172). Consequently, the β5t-
containing thymoproteasome is capable of generating a unique set of low affinity 
peptides for MHC-I presentation. Mice lacking β5t exhibit a severe impairment in 
positive selection of CD8+ SP cells, whereas the CD4+ T cell compartment remains 
unaffected (172). Moreover, the few CD8+ T cells that are produced in Psmb11-/- 
mice are functionally compromised and present an altered αβTCR repertoire (173). 
Interestingly, a recent study also provides evidence that thymoproteasome-
dependent positive selection can impact on the antigen responsiveness of mature 
CD8+ T cells in the periphery (174). Hence, through the expression of a unique set 
of intracellular proteolytic enzymes, cTECs are able to produce a distinct array of 
selecting self-peptides that are pivotal for the production of a functional and diverse 
T cell repertoire.  
Chapter I | Introduction 
Page | 23  
Setting up the perimeter for tolerance induction – Cellular and 
functional features of mTECs 
 
1) Associated phenotypic markers and precursor-product relations 
 
Epithelial cells from the thymic medulla can be phenotypically identified by the 
surface expression of molecules such as K5 and K14 as well as by the binding of 
antibodies to unknown mTEC-expressing molecules, which includes ERTR5 and 
mouse thymic stroma 10 (MTS10). Additionally, the lectin Ulex Europeus Agglutinin 
1 (UEA-1) also demonstrates selective reactivity with the vast majority of cells from 
the mTEC lineage. Further phenotypic identification of discrete mTEC 
subpopulations can be accomplished using an additional panel of molecules 
encompassing CD40, CD80, MHC-II, Aire, Fezf2 and Involucrin (21, 146). 
Gaining a better understanding about the core network lying behind the 
establishment and function of the mTEC microenvironment should aid in the 
development of new therapeutic strategies to control autoimmune-related disorders. 
For that reason, the characterization of the mTEC-committed progenitors as well as 
the cues involved in lineage-specification and differentiation of the medullary 
epithelium have been under intense investigation in recent years. The first evidence 
of mTEC-restricted progenitors came from the observation that the development of 
distinct clonal islets of medullary epithelium arise from single progenitor cells (175). 
Subsequent studies identified a mTEC-restricted progenitor population based on the 
expression of the tight junction components Claudin-3 and -4 (Cld3,4), with 
Cld3,4high cells being capable to exclusively give rise to mTECs, particularly to a 
mature Aire-expressing subpopulation, when mixed in RTOC and grafted into nude 
mice (176). Remarkably, embryonic Cld3,4high TECs implanted in a mTEC-defective 
thymic microenvironment were capable of re-establish and sustain the generation of 
a functional medullary epithelium throughout life (177). A further degree of 
heterogeneity within the mTEC-committed progenitors was revealed with the 
identification of a fraction of Cld3,4high TECs expressing stage-specific embryonic 
antigen (SSEA-1) (177), a marker commonly associated with embryonic stem cells 
(178). This subset was shown to be highly enriched in cells with self-renewable 
clonogenic capacity that also have the ability to specifically generate mature mTECs 
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in vivo (177). These findings render the classification of these cells as mTEC stem 
cells. SSEA1+Cld3,4high TECs are rare in the adult thymus, suggesting that the pool 
of unipotent mTEC-committed progenitors might become exhausted throughout life. 
Indeed, adult SSEA1+Cld3,4high TECs demonstrated a markedly reduced 
competence in generating mature mTEC subsets, when compared with the 
embryonic counterparts (177). More recently, different studies have demonstrated 
the existence of some heterogeneity within the pool of mTEC precursors based on 
additional phenotypic traits. mTEC-committed progenitors expressing the receptor 
activator of NF-κB (RANK), a key regulator of mTEC differentiation, were described 
as possible downstream progeny of SSEA1+Cld3,4high mTEC stem cells, although a 
direct lineage relationship between both subsets remains undefined. RANK+ mTEC 
progenitors are detected within the SSEA1-Cld3,4high subset of the E14 thymus and 
preferentially give rise to cells of the mTEC lineage (179). Moreover, podoplanin 
(PDPN)-expressing TECs located at the cortical-medullary junction (jTECs) were 
classified as mTEC-committed precursors due to their involvement in the generation 
of nearly half of the adult mTEC compartment (76). While SSEA1+Cld3,4high and 
PDPN+ jTECs were described to derive from embryonic and postnatal cells with a 
past history of β5t expression (180, 181), the exact precursors of the RANK+SSEA1-
Cld3,4high population remains unknown. Hence, further studies are required to better 
define the precursor-product relationship among different mTEC-committed 
progenitors and also their spatiotemporal contribution for the maintenance of distinct 
mTEC lineages along life. 
The generation of a functional medullary microenvironment is essential for 
induction of self-tolerance. mTEC development entails several subsequent stages of 
maturation, with each of them being defined by the expression levels of specific 
molecular markers. Early analysis of the mTEC compartment in relation to MHC-II 
and CD80 expression levels enabled the definition of two main populations, 
immature/mTEClow (MHC-IIlowCD80low) and mature/mTEChigh (MHC-IIhighCD80high) 
subtypes (22). A direct progenitor-progeny relationship was also demonstrated 
among both subsets (182–184), suggesting that the mTEClow niche harbour the 
progenitors that contribute for the establishment of the mature medullary epithelium. 
Over the years, different observations revealed some further degree of 
heterogeneity within both mTEC sublineages. Although commonly defined as 
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immature, the mTEClow population has been shown to contain a significant 
proportion of cells bearing functionally mature features. Among these are included 
CCL21-expressing cells (77), as well as involucrin-expressing terminally 
differentiated mTECs (185), a developmental stage that subsist beyond post-Aire 
expression (186). Likewise, distinct subpopulations within the mTEChigh 
compartment were also recognized based on the differential expression profile of 
Aire, Fezf2 and osteoprotegerin (OPG) (82, 187, 188). 
 
2) Thymic crosstalk governs mTEC differentiation 
 
The highly dynamic nature of the thymic medulla, where mTEChigh cells exhibit a 
rapid turnover time of 2-3 weeks (182, 183), is suggestive of the need for continual 
renewal of the mature mTEC compartment via immature precursors. Still, the 
differentiation of mTEC-restricted progenitors and acquisition of mature properties 
does not happen in a cell-autonomous manner but rather is influenced by 
thymocyte-derived signal, a symbiotic process named “TEC-Thymocyte crosstalk” 
(105, 189). Initial analysis of mice lacking signal components of both canonical and 
non-canonical nuclear factor kappa B (NF-κB) pathway paved the way for better 
comprehending the molecular mechanisms behind mTEC development. Disruption 
of downstream NF-κB-associated effectors molecules, such as NF-κB inducing 
kinase (NIK), Tumour necrosis factor receptor-associated factor 6 (TRAF6) and 
reticuloendotheliosis viral oncogene related B (RelB), resulted in an abnormal mTEC 
architecture, impaired differentiation of Aire-expressing mTECs and consequent 
organ-specific autoimmunity (190–192). Subsequent studies identified multiple 
members of the tumour necrosis factor receptor (TNFR) superfamily as the 
upstream key activators of NF-κB signalling during mTEC development. Among 
these, the lymphotoxin β receptor (LTβR), receptor activator of NF-κB (RANK) and 
CD40 are the best studied. The first TNFR member reported to play a pivotal role in 
mTEC differentiation and function was LTβR. Mice that lack LTβR have 
disorganized medullary architecture and a substantial overall reduction in mTEC 
cellularity, alongside with abnormalities in thymocyte egress and autoimmune 
manifestations (193). Moreover, LTβR-mediated signals in mTECs were shown to 
contribute for a diverse array of cellular and molecular processes. Apart of 
controlling the expression of Aire-independent TRAs, the LTβR pathway also 
Chapter I | Introduction 
Page | 26 
influences the thymic DC pool implicated in negative selection, the expression of 
chemokines (CCL19 and CCL21) by mTEClow cells and the terminal differentiation of 
post-Aire mTECs (77, 185, 194–196). In contrast to LTβR, both RANK and CD40 
have been shown to play vital roles in foster the development of the Aire-expressing 
mTECs (184, 197, 198). In particular, RANK signalling pathway was classified as 
key regulator of mTEC development, advocating for the existence of a hierarchy 
among the different TNFR members. Contrary to the lack of CD40, RANK-deficient 
mice exhibit a severe phenotype characterized by a marked reduction in mTEC 
cellularity, particularly Aire-expressing cells, and an impaired central tolerance due 
to a defective promiscuous gene expression program (184, 197). Interestingly, this 
phenotype is further exacerbated in CD40/RANK double deficient mice supporting a 
cooperative role for both receptors in the optimal differentiation of the medullary 
epithelium (197). During the last years, several studies have investigated the 
intrathymic cellular sources that provide CD40 and RANK ligands (CD40L and 
RANKL) at distinct stages of thymus development. Different hematopoietic 
populations appear to express RANKL, the physiological ligand of RANK, within 
discrete developmental windows. Whereas in the fetal period, CD4+CD3- lymphoid 
tissue inducer (LTi) cells and invariant Vγ5+ thymocytes nurture mTEC emergence 
as the major sources of RANKL (90, 184), the expression of this ligand across the 
post-natal life is circumscribed to positively selected CD4+ thymocytes and CD1d-
restricted iNKT cells (91, 198). On the other hand, CD40L is exclusively provided by 
CD4+ SP thymocytes (198, 199), reinforcing the notion that the CD40 pathway 
contributes for the establishment of a functional thymic medulla during post-natal 
life. Interestingly, interaction with CD4+ thymocytes carrying auto-reactive TCRs was 
shown to be critical in fostering the optimal expansion and architectural organization 
of the medullary compartment (200, 201), possibly as result of an efficient delivery of 
RANKL and CD40L signals. Regardless of their individual contributions, the genesis 
of mTECs seems to rely on the sequential and coordinated interplay among the 
different TNFR members. A synergistic interaction between LTβR and RANK was 
shown to take place at early stages of fetal development, during which LTβR signals 
enhances RANK expression on mTEC precursors (202). In turn, RANK-mediated 
signalling is able to promote the rapid upregulation of CD40 levels in mTECs, prior 
to the acquisition of mature traits (e.g.: Aire, CD80 and TRA expression) (199). 
Despite the unequivocal importance of LTβR, RANK and CD40, a recent report 
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described a novel role of histone deacetylase 3 (HDAC3) in initiating a mTEC-
specific transcriptional program, which is required for mTEC lineage specification 
and development (203). Interestingly, Hdac3 operates independently of the NF-κB 
signalling pathway, which advocates for the existence of several layers of 
complexity involving mTEC lineage specification and differentiation. 
 
3) The multifarious functions of the thymic medulla 
 
While undergoing through different phases of maturation, the medullary 
epithelium attains the functional competence to support the late stages of T cell 
development. Apart of producing multiple chemokines (e.g.: CCL21, CCL19 or 
XCL1) or sustaining the differentiation of specific populations of nonconventional T 
cell lineages, the most critical function of mTECs is to guarantee the establishment 
of central tolerance, both via negative selection and cell-fate diversion towards the 
Treg lineage (Figure 6) (21). Owing to their exceptional capacity to promiscuously 
express most of the protein-coding genes, mTECs operate as a library of ubiquitous 
and tissue-restricted self-antigens, continuously presenting them to screen for 
potential auto-reactivities within the αβ TCR repertoire of SP thymocytes (80). 
Although pGE is a remarkable feature of mTECs, the highest degree of this 
property, both in respect to number and diversity of expressed TRA, is observed 
within the mature medullary epithelium (204, 205). Recent data described that TRA 
expression in the medullary epithelium follows a mosaic pattern, with every 
individual mTEC progressing through different stages defined by expression of 
particular TRA-encoding gene clusters (206, 207). Although each TRA is expressed 
in only 1-3% of mTECs at a given point (208, 209), this process allows a robust 
coverage of the αβ TCR repertoire by ensuring maximal TRA representation at a 
population level. The mechanisms underlying the promiscuous expression of TRA 
have been partially revealed, with the transcription regulators Aire and Fezf2 
emerging as the main molecular determinants of this phenomenon (81, 82). Aire, the 
mutated gene in the rare autoimmune polyglandular syndrome type 1 (APS-1) 
disorder (210, 211), is described to govern the expression of a large portion of TRAs 
(approximately 40%) in mature mTECs (205, 212). The mechanism of action by 
which Aire controls pGE is intriguing, as this regulator does not function as a classic 
transcription factor that bind to a promoter element and initiate transcription (213). 
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Instead, it was described that Aire recognizes genes that possess silenced 
chromatin stages (214). This process involves the selective recognition of 
hypomethylated histone H3 lysine 4 (H3K4), a mark associated with poorly 
transcribed genes, by the first plan homeodomain (PHD1) of Aire (215, 216). At the 
same time, this binding stabilizes Aire and initiates the recruitment of numerous 
transcriptional regulators involved in chromatin structure and DNA damage 
response, transcriptional elongation, RNA processing and nuclear export (217). This 
leads to the formation of a multimeric protein complex that unleashes the stalled 
RNA polymerase II, thereby enabling the transcription of Aire-dependent TRA genes 
(213, 218). Our knowledge regarding the mechanisms involved in the transcriptional 
regulation of this unusual factor is still incomplete. However, recent data identified a 
highly conversed noncoding sequence 1 (CNS1) upstream of the Aire coding region, 
containing two NF-κB responsive elements that are critical for RANK-mediated 
induction of Aire (219, 220). Thus, these results appreciate the direct impact of 
RANK signalling in Aire transcription, a role that goes beyond of its contribution for 
the developmental maturation of mTECs. Apart of its well-described influence in 
TRA induction, there are also a number of studies indicating alternative functions of 
Aire, namely in chemokine expression and mTEC maturation (186, 221–223). Also, 
expression of Aire during a perinatal age-window was reported as critical for the 
generation of a pool of natural-derived Tregs with unique characteristics (224, 225). 
More recently, the transcriptional regulator Fezf2 was reported to contribute for the 
selective induction of Aire-independent pGE in mTECs. Although absence of Fezf2 
expression results in organ-specific autoimmunity (82), the spectrum of inflammatory 
lesions was different from those observed in Aire-deficient mice, suggesting that 
both factors work independently but synergistically in controlling TRA expression. 
Indeed, while some TRA genes (12.3%) are reciprocally regulated by both Aire and 
Fezf2, most Fezf2-dependent genes (21.1%) are still expressed in the absence of 
Aire (82). Fezf2 is detectable within both mTEClow and mTEChigh subsets and it was 
described to be exclusively induced downstream of the LTβR pathway (82). In 
contrast with this observation, recent data established that specific deletion of LTβR 
in TECs failed to interfere with Fezf2 levels and TRA expression. Instead, it 
proposed the involvement of the RANK-signalling pathway as the major regulator of 
Fezf2 expression and function in tolerance induction (195). Nevertheless, as Fez2 
and Aire only govern 60% of TRA genes (82), future studies are necessary to 
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uncover new tolerogenic transcriptional regulators of pGE in the medullary 
epithelium.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Thymic degeneration and regeneration 
 
One of the hallmarks of the ageing vertebrate immune system is the progressive 
deterioration of the thymic function, an evolutionary conserved physiological process 
termed “Thymic involution” (25). Aged-related involution of the thymus occurs much 
earlier than other acknowledged features of aging, although with different onsets 
across species. For instance, whereas atrophy of the murine thymus was shown to 
commence around the time of sexual maturity (22, 226), aged-related involution in 
human thymus is already detected from the first year of life (227). Nevertheless, in 
both mice and human, the major features of thymic atrophy include perturbations in 
the stromal epithelial microenvironment, characterized by a dramatic reduction in 
total TEC cellularity, loss of the normal cortex and medulla compartmentalization, 
appearance of areas devoid of epithelium and the expansion of adipose tissue and 
fibroblasts in perivascular spaces (Figure 7) (22, 27, 228–232). Albeit the aged 
thymus still presents some residual capacity to support T cell development (233), its 
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regression is intimately linked with abnormalities, both at a quantitative and 
qualitative level, in the peripheral T cell compartment. These changes comprise a 
noticeable reduction in the frequency of functional naïve T cells with a skewing 
towards an increased memory T cell pool, a constriction of the TCR repertoire and 
impaired immune responses to new antigens (Figure 7) (24). Under normal 
circumstances, thymic involution is of minimal consequences to a healthy individual, 
but the diminished competence of the immune system during elderly has been 
implicated with an augmented incidence of diseases, such as autoimmunity, cancer 
or opportunistic infections (27, 28). 
 
Despite being recognized as a natural biological cause for more than one century 
(234), the precise mechanism(s) responsible for the atrophy of the thymus remains 
poorly understood. The significant impact of aging on the HSC compartment led to 
the notion that a primary cause of thymic involution would be related with a reduced 
intrinsic capacity of the aged T cell progenitors to home the thymus (24). Yet, 
different studies provided evidence that transferring young HSCs or ETPs into old 
mice did not reverse thymic involution (235, 236). Furthermore, the functional 
capacity of aged ETP to settle the thymus was shown not to be considerably 
different from their young counterparts (229). Although aged-dependent alterations 
in the BM might contribute to exacerbate the degeneration of the thymus over time 
(237), there is no clear indication that positions downstream changes in the HSC 
niche as the primary cause of thymic atrophy. Over the years, several studies 
revealed multiple layers of complexity regarding the cellular and molecular 
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mediators of thymic involution. Nevertheless, thymic atrophy is currently recognized 
to unfold due to intrinsic and extrinsic age-dependent alterations of the thymic 
stroma, in particular in TECs (28). During the course of involution, TECs were 
shown to downregulate expression of several genes that are crucial in controlling 
the epithelial niche activity and maintenance (238). Specifically, the expression of 
the key regulator Foxn1 was observed to diminish with age, concomitantly with the 
progressive expansion of Foxn1-negative cells within both cortical and medullary 
thymic epithelium (114, 239, 240). Interestingly, evidence suggests that cortex-
specific downregulation of Foxn1 may be the main driver of thymic involution as 
result of an impaired expression of genes involved in cTEC-dependent T cell 
differentiation (240). Moreover, attenuation of Foxn1 levels in the perinatal thymus 
leads to a premature atrophy (241), whereas inducible upregulation of Foxn1 in a 
fully involuted thymus was able to revert organ aged-associated defects, as shown 
by the improvement of thymic architecture, thymopoietic capacity and TEC 
molecular profile close to those of the young thymus (242). Hence, these 
observations suggest that both the onset and progression of thymic involution may 
be linked to a decline in Foxn1 expression, although the existence of other factors 
cannot be formally excluded. 
The intrathymic microenvironment is characterized by a complex network of 
paracrine, autocrine and endocrine signals involving a number of soluble mediators 
(243), which may act as secondary agents in exacerbating the age-related decline of 
the thymus. For example, many thymic cytokines and hormones are differentially 
expressed with age. Different studies revealed a pro-inflammatory signature in the 
microenvironment of aged thymus, which result of an increased expression of 
cytokines Il1a, Il1b, Il6, Il12b, Il18, and Tnf (238, 244). Some of these cytokines 
were shown to have suppressive effect on the thymic function. In line with this, IL-1 
and IL-6 administration to mice resulted in thymic involution (244, 245). On the other 
hand, mice lacking the Nlrp3 inflammasome were protected against age-related 
thymic deterioration, due to the inability to produce active IL-1 (246). Among the 
different hormonal factors proposed to stimulate thymic involution are the sex 
steroids (247). The rapid declined in thymic function during puberty has been 
associated with a raise in sex hormone levels, which are known to exert profound 
inhibitory effects on immune functions (248, 249). This concept is consistent with 
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observations that both thymocytes and TECs express sex steroid receptor and that 
the exogenous administration of sexual hormones caused a collapse in thymic 
function (250–255). More recently, genome-wide transcriptome analysis revealed 
that androgen signalling in TECs represses the expression of several genes 
involved in their maintenance and function, including Foxn1 (256). Furthermore, 
evidence demonstrates that androgen-mediated thymic atrophy is mainly caused by 
a direct influence on TECs, despite the expression of the androgen receptor by 
thymocytes (252). The clear influence of sex steroids in the homeostasis of the 
thymus led to the consideration that intervening in this pathway could represent a 
mean of reversing thymic atrophy. Indeed, blockade sex steroid production, either 
surgically or via luteinising hormone releasing hormone (LHRH) analogues, 
stimulates thymic rejuvenation in old mice (257–259). These alterations include the 
rebuilding of the TEC microenvironment, both at phenotypic, numerical and 
functional level, and a boost in the thymopoietic capacity of the aged thymus to the 
levels observed in their young counterpart (22, 257, 258, 260). Interestingly, studies 
revealed similar beneficial effects of sex steroid ablation (SSA) in the BM, such as 
reverting deficits in the hematopoietic and stromal niche. These changes comprise 
an expansion in HSCs, CLPs and B cells as well as an elevated production of 
stromal-derived factors (261, 262). Also, SSA has a beneficial effect in accelerating 
thymic recovery in clinical setting related with bone marrow transplantation and 
cytoablative therapies (263–267). Whereas the influence of SSA for thymic regrowth 
has been described from more than one century ago (268), the exact molecular 
mechanism underlying these regenerative effects still remains elusive, even though 
some recent studies suggested the participation of IL-7, CCL25 and Dll4 (260, 266, 
269). Understand these mechanisms would be of importance, as transient ablation 
of sex steroids could represent an attractive immune regenerative strategy in 
diverse clinical contexts. 
Despite the substantial advances in our understanding about many aspects of 
TEC biology, we still lack knowledge regarding the mechanisms that govern the 
homeostasis of the thymic epithelium throughout life. In the next chapters of this 
thesis, I will summarize the findings of our work that together provide insights on 
novel molecular processes that regulate the maintenance and function of the TEC 
niche during normal and altered physiological settings.   
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Aims 
 
In this thesis, we aimed at investigating the cellular and molecular basis that 
governs the maintenance, function and regeneration of TEC compartments. In 
Chapter II, we investigated the contribution of the transcription factor p53 to the 
homeostasis of the thymic epithelium. In Chapter III, we studied the temporal and 
spatial requirements for Interleukin-7 (IL-7) in the regeneration of the thymus 
promoted by sex steroid ablation (SSA). To address these questions, we generated 
novel conditional loss-of-function mouse models, which were characterized by 
taking advantage of multicolour flow cytometry analysis, thymic organotypic cultures, 
next-generation sequencing technology and in vitro and in vivo functional assays. 
Uncovering the rules that determine the establishment and function of distinct 
TEC microenvironments remains as one of the most important challenges in the 
field of thymus research. Ultimately, knowledge in this area will contribute to a better 
comprehension about the mechanisms that govern T cell generation and tolerance 
induction. 
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Abstract 
 
Thymic epithelial cells (TECs) provide crucial microenvironments for T-cell 
development and tolerance induction. As the regular function of the thymus declines 
with age, it is of fundamental and clinical relevance to decipher new determinants 
that control TEC homeostasis in vivo. Beyond its recognized tumour suppressive 
function, p53 controls several immunoregulatory pathways. To study the cell-
autonomous role of p53 in thymic epithelium functioning, we developed and 
analysed mice with conditional inactivation of Trp53 in TECs (p53cKO). We report 
that loss of p53 primarily disrupts the integrity of medullary TEC (mTEC) niche, a 
defect that spreads to the adult cortical TEC (cTEC) compartment. Mechanistically, 
we found that p53 controls specific and broad programs of mTEC differentiation. 
Apart from restraining the expression and responsiveness of RANK, which is central 
for mTEC differentiation, deficiency of p53 in TECs altered multiple functional 
modules of the mTEC transcriptome, including tissue-restricted antigen expression. 
As a result, p53cKO mice presented premature defects in mTEC-dependent 
regulatory T cell differentiation and thymocyte maturation, which progressed to a 
failure in regular and regenerative thymopoiesis and peripheral T-cell homeostasis 
in the adulthood. Lastly, peripheral signs of altered immunological tolerance unfold 
in mutant mice and in immunodeficient mice that received p53cKO-derived 
thymocytes. Our findings position p53 as a novel molecular determinant of thymic 
epithelium function throughout life.  
 
Introduction 
 
Within the thymus, thymic epithelial cells (TECs) orchestrate the development of 
functionally diverse and self-tolerant T cells (1). Importantly, impaired TEC functions 
arise with aging, cytoablative regimens and infection, which compromise T-cell 
responses to pathogens and vaccination in the elderly and patients undergoing bone 
marrow transplantations (BMT) or chemotherapy. Equally, failures in TEC-mediated 
tolerance induction lead to autoimmunity (2). Hence, the identification of novel 
regulators of TEC homeostasis is crucial to comprehend the foundations of immunity 
and to intervene medically in disorders linked to a dysfunctional thymus. 
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Cortical (c) and medullary (m) TECs define two functionally distinct 
microenvironments, which differentiate from bipotent TEC progenitors (1). While 
cTECs drive T-cell lineage specification and positive selection, mTECs promote the 
maturation of positively selected thymocytes, regulatory T cell differentiation and 
elimination of autoreactive T cells (1). Important to mTEC function is their ability to 
express tissue-restricted antigens (TRA) (2), which depends in part on Auto-immune 
regulator (Aire) and Fezf2 (3, 4). Past studies elucidated the role of members of TNF 
receptor superfamily (TNFRSF) receptor activator of NF-кB (RANK), lymphotoxin β 
receptor (LtβR) and CD40 in the maturation of mTECs (1). Still, the molecular 
determinants that control the function of these key inducers of mTECs remain 
unknown. Other uncertainties concern the signalling pathways that maintain the 
multilayered function of TECs in vivo.  
The tumour suppressor protein p53 is a recognized regulator of cell-cycle arrest 
and apoptosis. Yet, recent studies have revealed alternative roles for p53 in 
immunoregulation and autoimmunity (5). Relatively to the thymic epithelium, the 
observations that the p53 homologue p63 controls the turnover of TEC progenitors 
(6) imply a possible functional relationship within the p53 family. The analysis of the 
role of p53 in TEC physiology has been precluded due to its broad expression 
pattern and the complex phenotype of germline p53-null mice, which ultimately 
develop thymic lymphomas (7). Despite such limitations, several studies link p53 to 
TEC homeostasis. While germline deletion in wild-type p53-induced phosphatase 1 
(Wip1), a p53-target gene, impairs the maturation of mTECs and thymic 
regeneration (8), the systemic administration of p53 inhibitors moderately improves 
TEC recovery and thymopoiesis following BMT (9). As genetically engineered 
mouse models and pharmacological studies often hide lineage-specific functions of 
broadly acting genes, the cell-autonomous relevance of p53 in the dynamic 
differentiation of TECs in vivo remains unexplored. Our findings underscore the 
requirement for p53 in TECs to support their role in T-cell development and 
selection. 
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Results  
 
Inactivation of Trp53 in TECs reduces the mTEC compartment. 
 
To investigate the function of p53 in the thymic epithelium, we conditionally 
deleted the p53 gene (Trp53) in TECs by crossing mice with loxP-flanked alleles of 
Trp53 (Trp53fl/fl) (10) to mice expressing Cre recombinase under the control of the 
Foxn1 promoter (Foxn1Cre), which directs the expression of Cre recombinase to 
virtually all TECs during embryonic and postnatal life (11). Foxn1Cre:Trp53fl/fl 
(p53cKO) mice were born without obvious abnormalities and did not develop 
spontaneous tumours in the thymus or skin, which also contains Foxn1+ 
keratinocytes (11). Cre-mediated deletion of Trp53fl allele was detected in TECs but 
neither in thymocytes from p53cKO mice nor in TECs from Trp53fl/fl littermate 
controls (Ctr) (Figure 1A and supplemental Figure 1A-B). Although not statistically 
different, Trp53 levels were moderately increased in mTECs compared to cTECs 
from control thymus (Figure 1B), indicating that p53 is expressed under 
physiological conditions. The same transcript was nearly absent in cTECs and 
mTECs from p53cKO mice (Figure 1B), but remained similarly expressed in 
thymocytes from Ctr and p53cKO mice (supplemental Figure 1C). 
We started by comparing the thymic epithelium composition in control and 
p53cKO mice throughout life. Although with altered proportions relative to controls, 
cTEC numbers were normal during fetal, postnatal and pre-puberty periods, 
becoming moderately diminished in 10-week-old p53cKO mice (Figure 1C-D). In 
contrast, while seemingly similar to control mice at E16.5, the frequency and 
numbers of mTECs were continually reduced in mutant mice from the postnatal 
period onwards (Figure 1C-D). Concordantly, the global medullary compartment 
and the number of UEA+ mTECs were reduced in adult p53cKO thymus, without 
affecting the compartmentalization into cortex and medulla (supplemental Figure 
1D). We assessed possible Cre-mediated cellular toxicity, and found no major 
changes in thymic and cTEC/mTEC cellularities of Foxn1Cre:Trp53+/+ mice compared 
with Trp53+/+ mice (supplemental Figure 1E). Age-matched Trp53fl/fl littermates 
were used as controls in subsequent experiments.  
The impact of Trp53 deletion in mTECs led us to examine their differentiation 
program. First, we subdivided mTECs into CD80lo, which include immature cells and 
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a minor subset of post-Aire terminally differentiated cells in the adult thymus, and 
mature CD80hi, which contains Aire-expressing cells (1, 12). The development of  
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CD80hi and Aire+ mTECs was delayed in the embryonic p53cKO thymus, but 
normalized to the proportions of the control thymus during pre-puberty (Figure 1E). 
Despite the restoration of complete mTEC differentiation, the number of CD80hi and 
Aire+ mTECs was diminished in p53cKO thymus throughout life, while the CD80lo 
subset became affected only in adult mice (Figure 1F). Second, analysis of mTEC 
turnover revealed an increase in the rate of p53cKO mTECs in active cycling 
(S/G2/M) (supplemental Figure 1F). Moreover, we monitored the extent of DNA 
double-strand breaks (13) and apoptosis, and respectively found that the 
percentages of phosphorylated γ-H2AX and annexin V+ were slightly increased in 
p53cKO mTECs, particularly within CD80lo cells (supplemental Figure 1G-H). 
These findings suggest that increased apoptosis rather than defective proliferation 
might contribute to the reduced number of mTECs in p53cKO mice. Lastly, analysis 
of the expression of a panel of TRAs showed that Aire-independent genes were 
downregulated in p53cKO mTECs, whereas Aire-dependent genes presented a 
variable pattern in both mTEC subtypes (Figure 1G). Our data suggest that p53 is 
superfluous for cTEC/mTEC specification, but instead controls mTEC homeostasis. 
 
p53 regulates RANK expression in TECs. 
 
The similarity between the mTEC-phenotype of p53cKO mice and that of mice 
with defects in RANK, CD40 and LTβR (14) led us to evaluate whether p53 fine-
tunes the expression of these TNFRSF members. Additionally, we analysed the 
expression of osteprotegerin (OPG), a decoy receptor of RANK ligand (14). While 
the levels of Tnfrsf5 (CD40) Tnfrsf3 (LTβR) and Tnfrsf11b (OPG) were normal, the 
expression of Tnfrsf11a (RANK) was reduced in p53cKO mTECs (Figure 2A). To 
examine the functional relationship between p53 and RANK, we used well-defined in 
vitro models of mTEC differentiation, in which E15.5 dGuo-FTOCs were depleted of 
hematopoietic cells and then stimulated through RANK (15). Strikingly, the 
frequency and numbers of mature CD80+ and Aire+ mTECs in RANK-stimulated 
p53cKO dGuo-FTOCs were reduced relatively to controls (Figure 2B). Contrarily, 
CD40-mediated mTEC maturation and CD40 expression on p53cKO mTECs were 
unaffected (supplemental Figure 2A-B). Hence, loss of p53 appeared to 
specifically dampen in vitro mTEC differentiation induced by RANK.  
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Given that RANK activation induces its own expression (16), we evaluated 
whether p53 positively controls this self-amplification loop. Concordantly, RANK-
mediated stimulation augmented the expression of Tnfrsf11a in TECs from control 
dGuo-FTOC. Noticeably, this increase was attenuated in TECs from both RANK-
activated p53cKO dGuo-FTOC and RANK-activated control dGuo-FTOC co-treated 
with the p53 inhibitor pifithrin-α (Figure 2C), indicating that p53 controls the 
expression of Tnfrsf11a. In silico analysis identified six putative p53 response 
elements (RE) (17) within the 4kb region upstream of the transcription start site 
(TSS) of Tnfrsf11a (Figure 2D). We cloned 1kb genomic DNA fragments containing 
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these potential p53 RE (named A-D) into a luciferase reporter plasmid and assessed 
their p53-mediated transactivation in p53-deficient MEFs, which were co-transfected 
with a p53-expressing vector. As positive control we used a Cdkn1a (p21)-derived 
fragment containing a bona-fide p53 RE (17). Notably, p53 increased luciferase 
expression driven by Tnfrsf11a-derived fragments A, C and D, but not B (Figure 
2D). These results imply that p53 has the potential to control the activity of Tnfrsf11a 
promoter. To study whether p53 was reciprocally induced under mTEC 
differentiating conditions, control dGuo-FTOCs were activated with RANK, CD40 
and LTβR agonists. Contrarily to LTβR stimulation, individual RANK- and CD40-
engagement induced Trp53 expression in TECs, an effect that was further 
augmented by combined activation (Figure 2E). These results indicate that both 
RANK and CD40 signalling induce p53, which in turn promotes RANK expression 
and RANK-driven mTEC differentiation.  
 
p53 specifically regulates a broad network of the mTEC transcriptome. 
 
Given that p53 governs multiple transcriptional programs in distinct cells (18–20), 
we examined its genome-wide influence in TECs. To do so, we performed RNA 
sequencing (RNA-Seq) analysis and compared the transcriptome of cTECs and 
mTECs isolated from 2-week-old control and p53cKO mice. We selected this age to 
permit the maturation of mTEC, the emergence of p53cKO phenotype and the 
sufficient abundance of cTEC/mTEC subsets for analysis. The number of genes 
expressed in the control and p53cKO mTECs was higher than in their cTEC 
counterparts, resulting in the expected cTEC/mTEC segregation (Figure 3A and 
supplemental Figure 3A-B). Trp53 levels were increased in control mTECs and 
markedly reduced in p53cKO-derived TEC subsets. The expression of cTEC- and 
mTEC-associated genes separated the two lineages independently of their 
genotype (supplemental Figure 3 C-D), validating the accuracy of sorted samples. 
Strikingly, while randomly associated within cTEC subsets, the biological replicates 
of control and p53cKO mTECs defined two distinct clusters (Figure 3A). 
Accordingly, the number of differentially expressed genes between p53cKO and 
control mTECs was substantially larger than in cTECs (Figure 3B and 
supplemental Tables 1-2). The identification of 1418 upregulated and 1945 
downregulated genes in p53cKO mTECs implies that p53 negatively and positively 
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regulates gene expression in mTECs (Figure 3C). Concordant with previous 
observations, Tnfrsf11a expression was reduced in p53cKO mTECs analysed by 
RNA-seq and qRT-PCR (supplemental Figure 3E). Yet, RANK was not identified 
among the list of differentially expressed genes most possibly due to the stringent 
statistical analysis of RNA-seq, differences in gene normalization and intrathymic 
sample variation.  
 
Using a publicly available annotated list of TRA genes (21), we next cross-
examined their representation within differentially expressed genes of p53cKO 
mTECs. Notably, nearly half of the downregulated genes in p53cKO mTECs 
comprised purported TRAs, with a similar incidence of Aire-dependent and Aire-
independent targets (Figure 3D). The proportion of TRAs within upregulated genes 
of p53cKO mTECs was lower, including mostly Aire-independent targets (Figure 
3D). These data suggest that p53 regulates promiscuous gene expression in 
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mTECs. Additionally, GO enrichment analysis in differentially expressed genes did 
not reveal any particular term in cTECs, but was associated to diverse functional 
categories in p53cKO mTECs. Specifically, upregulated genes indicated an increase 
in DNA replication, mitosis, ribosome biogenesis, RNA- and protein complex-
binding, ATPase activity and constituents of nuclear pore. Conversely, 
downregulated genes suggested an attenuation in transmembrane transport, actin 
filament-based process, neuropeptide signalling pathway, carbohydrate- and ion-
binding and RNAPII transcription factor-, enzyme inhibitor-, hormone- and growth 
factor activity (Figure 3E and supplemental Tables 3-6). Concordantly to the 
mTEC-restricted phenotype of p53cKO mice, these results suggest that p53 controls 
a multifaceted transcriptional program in mTECs. 
 
Adult p53cKO mice display an impaired regular and regenerative 
thymopoiesis. 
 
We then analysed how the described changes in TEC microenvironments 
impacted in the thymic activity of p53cKO mice. The frequency and abundance of 
major thymocyte subsets, including early thymic precursors (ETP), double-negative 
(DN) subsets, double-positive (DP) and single positive (SP) CD4 and CD8 cells, 
were comparable in control and mutant mice during fetal and pre-puberty life 
(Figure 4A-C). Notably, a global deficit in thymopoiesis appeared in 10-week-old 
p53cKO mice (Figure 4A), without altering the global T-cell differentiation program. 
Namely, the progression through DN1-DN4 stages and the rate of positive selection, 
as measured by the frequency of CD3+CD69+ thymocytes, were largely similar 
between the control and p53cKO thymus (Figure 4B). However, we found a 
reduction in the proportion of DN1s and ETPs in p53cKO thymus (Figure 4B). 
Correspondingly, the numbers of all major thymic subsets steadily declined in 
p53cKO mice, being this trend apparent in 6-week-old mice (Figure 4C). These 
perturbations extended to the peripheral T-cell compartment of adult p53cKO mice, 
with a reduction in splenic CD4 and CD8 T cell counts (Figure 4D). The 
dysfunctional nature of the adult mutant thymus led us to further analyse their 
regenerative capacity following ionizing radiation. Although numerically different at 
baseline, mTECs were markedly depleted in both groups five days after sublethal  
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total-body irradiation (supplemental Figure 4A). This reduction was attenuated in 
p53cKO mTECs supplemental Figure 4A), suggesting that ablation of p53 
conferred a slight protection to radiation-induced apoptosis. While the recovery of 
cTECs was similar in both groups, the restoration of mTEC cellularity, including 
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CD80+ and Aire+ subsets, was markedly impaired in p53cKO mice (supplemental 
Figure 4A-C). Additionally, the recovery of thymopoiesis was also significantly 
compromised in p53cKO mice (Figure 4E), affecting de novo generation of all major 
thymic subsets (Figure 4F) and the reconstitution of the peripheral T cells (Figure 
4G). Our findings indicate that adult p53cKO mice fail to maintain normal and 
regenerative thymopoiesis. 
 
mTEC-dependent thymopoiesis is compromised in p53cKO mice. 
 
As the loss of mTECs preceded the deterioration of thymopoiesis during 
adulthood, we examined whether the stages of T-cell development functionally 
linked to mTECs (1) were prematurely affected in p53cKO thymus. To survey 
cortical and medullary clonal deletion, we respectively assessed the frequency of 
DP and SP4 thymocytes that co-expressed PD-1 and Helios (22), and found no 
major differences between control and p53cKO thymus (Figure 5A). Moreover, we 
crossed p53cKO mice with Marilyn-Rag2-/- TCR transgenic mice, in which 
thymocytes express I-Ab-restricted HY-specific TCR (15). Thymocyte development in 
the p53cKO background reproduced that observed in controls, with a similar number 
of positively and negatively selected thymocytes in female and male mice, 
respectively (Figure 5B). In line with the absence of SP4 accumulation at steady 
state (Figure 4B), these results indicated that negative selection seemed intact in 
p53cKO mice. Strikingly, analysis of regulatory T cell differentiation and post-
selection SP maturation showed a respective decrease in the proportions and 
numbers of CD25+Foxp3+ regulatory T cells and mature CD24loCD62Lhi SP4 
thymocytes in mutant thymus (Figure 5 C-D). These findings implicate a 
requirement for p53 in TECs to maintain continual mTEC-dependent thymopoiesis. 
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Signs of disturbed peripheral tolerance unfold in p53cKO mice.  
 
The alterations in mTECs led us to seek for signs of peripheral autoimmune 
manifestations in mutant mice. We did not detect the presence of autoantibodies 
against multiple organs (stomach, testis, liver, salivary and lacrimal glands) in the 
serum of aged p53cKO mice compared to controls (data not shown). Yet, larger and 
more prevalent lymphocytic infiltrations were found in the salivary and lacrimal 
glands of aged p53cKO mice (Figure 6A-B, supplemental Figure 5A). Despite the 
reduction in the numbers of thymic regulatory T cells, their frequency in the spleen 
of adult p53cKO mice was normal (supplemental Figure 5B). However, as total 
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peripheral CD4 T cell counts were reduced (Figure 4D), both conventional and 
regulatory T cells were diminished in mutant mice (supplemental Figure 5B). 
Moreover, p53cKO-derived peripheral regulatory T cells suppressed polyclonal T 
cell activation in vitro (supplemental Figure 5C), showing a broad intact function 
and potentially explaining the mild autoimmune manifestations. These findings 
suggest that the perturbed mTEC niche of p53cKO mice might predispose to defects 
in tolerance.  
 
The development of autoimmunity coupled to defects in mTECs is normally 
contained in the C56BL/6 background, but is potentiated by lymphopenia, as 
observed in the case of Aire and XCL1 deficiencies (23, 24). To examine the 
functional link between scarce mTEC niches and disturbed T-cell tolerance in 
p53cKO mice, we adoptively transferred thymocytes derived from control and 
mutant adult thymus into Rag2-/- mice, and monitored recipient mice for clinical signs 
of disease. Recipient mice that received p53cKO-derived thymocytes exhibited 
accelerated weight loss, developed diarrhea and presented lymphocytic infiltration 
and tissue damage in the colon (Figure 6C). The presence of T cells in the spleen 
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of both groups indicated an effective cell transfer (supplemental Figure 5D). 
Similarly to the analysis at steady state, small lymphocyte infiltrates were also more 
frequent in the salivary glands of the same group (Figure 6D). Our results indicate 
that the p53 mutant thymus renders developing T cells more susceptible to failure in 
establishing peripheral self-tolerance in aged and lymphopenia settings. 
 
Discussion 
 
Our study positions p53 as a prime determinant of mTEC integrity in vivo, 
mapping a functional link between p53 and RANK in mTECs. This was manifested 
by a reduced RANK-driven mTEC induction in p53cKO thymus in vitro, an 
observation that curiously mirrored the delayed appearance of embryonic p53cKO 
mature mTECs in vivo. We found that mTECs express higher levels of p53 than 
cTECs and p53 was reciprocally induced following RANK and CD40 stimulation. 
These results are consistent with previous studies coupling p53 induction to the 
NFкB pathway (25), which is in turn engaged by mTEC-inducing TNFRSF signalling 
(14). Yet, the reduction in mTECs of p53cKO mice was not as severe as that 
reported in RANK-deficient mice (14). The differentiation of mTECs depends on the 
coordinated action of RANK, CD40 and LTβR signalling (1). It is conceivable that 
compensatory signals via CD40 and LTbR contribute to the mTEC maturation 
program of p53cKO mice. Hence, p53 seems to fine-tune, rather than determine, 
RANK signalling in mTECs, cooperating in a functional feed-forward loop to sustain 
the medullary epithelial compartment.  
Our results suggest that p53 functions as a molecular hub in mTECs, regulating 
a wide transcriptional program that extends beyond balancing RANK expression. 
Typically, p53 is maintained at low levels under steady-state conditions, being 
activated in response to various stress signals (17). Nonetheless, p53 has also basal 
transcriptional functions in unstressed cells (19). Apart from RANK and CD40, it is 
possible that additional extrinsic and intrinsic cues generated within the thymus 
trigger a p53-driven response in mTECs. Although the mechanisms that induce p53 
in mTECs remain elusive, our observations argue that its activity is not dormant. 
Genome-wide chromatin-binding approaches revealed extensive and distinct cell-
specific p53-driven transcription programs (18–20), indicating that p53-mediated 
gene expression is context-dependent. We found that p53 controls a broad set of 
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genes linked to core processes in mTEC biology, which are not related to other well-
known mechanisms controlling mTEC maintenance. The increased apoptosis 
susceptibility of p53-deficient mTECs might be a corollary of these broad alterations, 
possibly explaining the reduced mTEC compartment of p53cKO mice. Yet, the 
presumed asynchrony of apoptosis at a population level and the rapid clearance of 
dying cells may confound measurements of cell death in vivo. Moreover, it remains 
to be determined whether differentially expressed genes are directly regulated by 
p53 or indirectly influenced through the perturbation of downstream genes of the 
p53-induced pathway. Further studies should elucidate the individual contribution of 
these gene products or processes to the maintenance of mTEC homeostasis and 
their homo- and heterotypic cellular interactions within the thymus. It is also 
important to consider that the hyperactive transcriptional state of mTECs might 
facilitate the accessibility of p53 to its target genes. The large prevalence of TRAs 
among the differentially expressed genes of p53cKO mTECs suggests that p53 
influences promiscuous gene expression. Still, the expression of Aire (21) and Fezf2 
(4) was normal in p53cKO mTECs. Since mTECs express clusters of TRAs at a 
single-cell level (3, 26), the reduction in TRAs might alternatively reflect an 
underrepresentation of certain mTEC subsets in mutant thymus.  
The disruption in the mTEC niche appeared to spread to the cTEC compartment 
in the adult p53cKO mice, evolving to a global failure in regular and regenerative 
thymopoiesis. The deficit in thymic activity extended to a decrease in splenic T cells, 
reinforcing the notion that peripheral T-cell homeostasis in mice also depends on 
regular thymic output (27). Thus, the sustainability of the mTEC niche seems to be a 
deterministic factor in regulating thymic function. How the changes in mTECs are 
reflected in the cortex is intriguing. The phenotype and transcriptional profile of 
cTECs, as well as the early T-cell development and positive selection, were 
apparently normal in p53cKO mice. Yet, we cannot formally exclude that p53 directly 
regulates cTEC homeostasis later in life. Alternatively, changes in mTECs might 
perturb the cortico-medullary junction and cortex, thereby limiting the number of BM-
derived thymic progenitors and the magnitude of pre-medullary stages of T cell 
differentiation. Accordingly, the numbers of ETPs, DN and DP thymocytes were 
diminished in aged p53cKO mice, providing a possible explanation for thymic 
hypoplasia. These findings could implicate the existence of a complex functional and 
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structural interplay between TEC and non-epithelial cell subsets (e.g. endothelia and 
mesenchyme) in balancing thymopoiesis.  
The contracted mTEC compartment of p53cKO mice was physiologically linked 
to abnormalities in mTEC-dependent regulatory T cell differentiation and SP 
maturation, providing a possible molecular explanation for the signs of deregulated 
immunological tolerance in mutant mice. Albeit negative selection seemed normal at 
a polyclonal level, we cannot exclude the possibility that rare auto-reactive 
thymocytes escape from the p53cKO thymus. In line with previous studies (28), we 
reason that the underrepresentation of regulatory T cells and mature SP4 
represents a footprint of a decrease in the availability of mTEC niches. 
Concordantly, mild signs of autoimmune manifestations unfolded in aged p53cKO 
mice and in immunodeficient mice receiving p53cKO-derived thymocytes. Although 
we did not provide a direct link between the disturbed tolerance and the deficiency in 
regulatory T cell numbers and/or their specificities and/or the specificities of 
conventional T cells, our findings suggest that the insufficient mTEC niche of 
p53cKO mice predisposes to defects in immune tolerance under lymphopenia. Also, 
the signs of abnormal immunological tolerance in p53cKO mice were less strong 
compared to other mTEC-deficient conditions (14). We reason that the remaining 
mTEC niche of mutant thymus together with the genetic background and extra-
thymic compensatory mechanisms, allow the establishment of peripheral tolerance 
during the first weeks of age, a period that is sufficient to prevent the development of 
autoimmunity (29). Future studies should identify the distinct contribution of altered 
thymic and peripheral T-cell subsets to the disturbed tolerance induction of mutant 
mice.  
Beyond positioning p53 as a novel guardian of thymus function, our findings are 
also of clinical relevance and reinforce the notion of a modulatory role for p53 in 
immune homeostasis and autoimmunity (5). Moreover, the use of p53 inhibitors, 
such as Pifithrin-α, has been approved in clinical trials to attenuate the side effects 
of chemotherapy (9). Given the described adverse impact of disrupting p53 in TECs 
and in T-cells (5), the therapeutic use of p53 inhibitors must be implemented with 
care in order to safeguard the balance between immune reconstitution and tolerance 
induction. 
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Methods 
 
Mice and Procedures. Homozygous p53fl/fl mice purchased from The Jackson 
Laboratory (10) and bred to Foxn1Cre mice obtained from Dr. Thomas Boehm (11). 
Foxn1Cre:Trp53fl/fl mice were also backcrossed with Marylin-Rag2-/- mice. All mice 
were in a C57BL/6 background and housed under specific pathogen-free conditions. 
For fetal studies, the day of the vaginal plug detection was designated as embryonic 
day (E) 0.5. To study thymic recovery, mice received sublethal total-body irradiation 
(450 rads) with a Cs137 radiation source (Gammacell 1000, Nordion). For transfer 
experiments, 2.5 × 107 thymocytes isolated either from control or p53cKO mice were 
intravenously transferred into Rag2-/- mice. All animal experiments were performed 
in accordance with European guidelines for animals used for scientific purposes 
(Directive 2010/63/EU). 
 
PCR genotyping. PCR analysis to detect the excision of exons 2-8 of the Trp53 
gene was done as described (10). Briefly, primers spanning the loxP sites in intron 1 
(F: 5′-cacaaaaacaggttaaacccag-3′ and R: 5′-agcacataggaggcagagac-3′) and intron 
10 (F: 5′-aaggggtatgagggacaagg-3′ and R: 5′-gaagacagaaaaggggaggg-3′) were 
used to detect intact p53fl allele. The excision was accessed using the primers 1 F 
and 10 R. 
 
TEC and hematopoietic cell isolation. Thymic stromal cells were isolated by 
enzymatic digestion and TECs were further enriched using a MACS-based CD45+ 
cell depletion kit (Miltenyi Biotec). Hematopoietic cells from thymus and spleen were 
prepared as previously described (15). 
 
Flow cytometry. Cells were pre-treated with FC block (anti-CD16/CD32 
antibodies TruStain fcX; Biologend). Cell suspensions were stained as described 
(15) with FITC-conjugated anti-CD8α (53-6.7) and anti-CD44 (IM7); PE-conjugated 
anti-CD4 (GK1.5), anti-CD62L (MEL-14), anti-TCRβ (H57-597), anti-CD40 (3/23), 
anti-CD80 (16-10A1) and anti-Ly51 (6C3); PerCP-Cy5.5-conjugated anti-CD45.2 
(104); PerCP-eFluor710 anti-CD4 (GK1.5); PE-Cy7-conjugated anti-CD25 (PC.61.5) 
and anti-CD69 (H1.2F3); APC/eFluor660-conjugated anti-CD8 (53-6.7), anti-CD3 
(17A2), anti-CD80 (16-10A1) and anti-EpCAM (G8.8); anti-CD279 (29F.1A12); APC-
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eFluor780-conjugated anti-I-A/I-E (M5/114-15-2) and anti-cKit (2B8); eFluor450-
conjugated anti-EpCAM (G8.8) and anti-CD24 (M1/69) (eBioscience). The binding of 
biotinylated Ulex europaeus agglutinin-1 (UEA-1) (Vector Laboratories, Burlingame, 
CA, USA) or anti-Ly51 (6C3) was revealed by PE-Cy7-conjugated streptavidin 
(eBioscience). For intracellular staining, cells were prepared according to the 
supplier’s protocol (Foxp3 staining kit, eBioscience) and stained with FITC-
conjugated anti-Helios (22F6), anti-Ki67 (SolA15) (eBioscience), anti-γ-H2AX pS139 
(REA502) (MACS Miltenyi Biotec), APC/eFluor660-conjugated anti-Foxp3 (FJK-165) 
and anti-Aire (5H12) antibodies (eBioscience). For thymic progenitor population 
analysis APC/eFluor660-conjugated antibodies against CD4 (GK1.5), CD8 (53-6.7), 
CD11b (M1/70), CD11c (N418), CD19 (eBio1D3), Gr1 (RB6-8CS), Ter119 (TER-
119), CD3 (17A2), NK1.1 (PK136) and γδTCR (eBioGL3) (eBioscience) were used 
as lineage markers. For detection of apoptosis, FITC-conjugated Annexin V 
apoptosis detection kit was used in accordance to the supplier’s protocol 
(Biolegend). Flow cytometry was performed on a FACSCanto II and LSRFortessa, 
with data analysed on FlowJo software (BD). Cell sorting was performed using the 
FACSAria I (BD Biosciences), with purities >96%. 
 
Histology, Histopathology and Immunofluorescence. Paraffin-embedded 
tissue sections from thymus, lacrimal and salivary glands and colon were stained 
with haematoxylin and eosin. Images were acquired either on a light microscope 
(Olympus CX31 with DP-25 camera) or IN Cell Analyzer 2000 (GE Healthcare). 
Area analysis was performed using Fiji software. Histopathology was scored in a 
blinded and randomized fashion by three independent observers for the presence of 
lymphocytic infiltrates, using the following criteria: 0 - no infiltrate; 0.5 – mild trace of 
infiltrates; 1 – minor infiltrates; 2 – moderate infiltrates; 3 – severe infiltrates; 4 – 
tissue destruction. For immunofluorescence analysis, thymic lobes were prepared 
as described (15). Briefly, fixed thymi sections were stained with biotinylated UEA-1 
and streptavidin Alexa 555 as secondary Abs (Invitrogen). Images were obtained on 
a Leica TCS SP5 II confocal microscope (Leica Microsystems, Germany) and 
analysed with Fiji Software.  
 
Gene expression. mRNA (RNAeasy MicroKit, Qiagen) isolation and cDNA 
synthesis (Superscript First-Strand Synthesis System, Invitrogen) were done as 
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described (15). Real-time PCR (iCycler iQ5) was performed using TaqMan 
Universal PCR Master Mix and probes for 18s, Il7, Psmb11, Dll4, Aire, Ccl19, Ccl21, 
Foxn1, Trp63, Tnfrsf11a, Tnfrsf11b, Tnfrsf5, Tnfrsf3, Trp53, Rbp3, Spt1, Ins2, Mup4, 
Tyrp1, Crp, Fabp9, Col2, Csnb and Gad1. Triplicated samples were analyzed and 
the delta-delta Ct method was used to calculate relative levels of targets mRNA 
compared with 18s. 
 
Fetal Thymic Organ Culture. FTOCs were established with E15.5 embryos, as 
described (15). 2-deoxyguanosine (dGuo)-treated FTOC were culture either alone or 
with 5µg/ml of recombinant CD40L (CD40L), 1µg/ml anti-RANK agonist antibody 
(αRANK) (R&D Systems), 10µg/ml of anti-LTβR (AC.H6, kindly provided by Dr. Jeff 
Browning, Boston University) and/or 50µg/ml Pifithrin-α (Sigma-Aldrich) for either 1 
or 4 days and TECs analyzed by flow cytometry. 
 
Luciferase assay. MatInspector and/or rVista software tolls were used for 
searching of potential p53-binding sites of the consensus p53-binding site (RRRC-
A/T-A/T-GYYY motifs, in which R is a purine and Y is a pyrimidine) upstream of the 
Tnfrsf11a transcription start site. MEFs were isolated from E14.5 p53 KO embryos 
according to standard procedures. Promoter fragments of Tnfrsf11a or Cdkn1a were 
PCR-amplified (Thermo Scientific) from genomic DNA of wild-type (WT) mice and 
cloned into the pGL3-Promoter (Promega) plasmid. MEFs were transfected with 
target firefly plasmid along with an expression vector encoding p53, kindly provided 
by Dr. Manuel Serrano (Spain), or the correspondent empty vector. Renilla 
luciferase plasmid (Promega) were cotransfected in all conditions for transfection 
efficiency control. Transfection was performed with JetPrime (Polyplus transfection) 
according to manufacturer’s protocol. Luciferease activity was measured 36 hors 
later using Dual-Luciferase Reporter Assay System (Promega) and Luciferase 
activity was normalized for Renilla luciferase activity. 
 
RNA-seq analysis of TEC subsets. Total RNA was extracted from three 
biological replicates of cTECs and mTECs, each containing 100.000 pooled FACS-
sorted cells per subset from four to six 2-week-old p53cKO and control littermates. 
Library preparation and high-throughput sequencing were performed at Gene Core 
facility (EMBL, Germany). Twelve sequencing libraries (three for cTEC Ctr, three 
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cTEC p53cKO, three for mTEC Ctr and three for mTEC p53cKO) were prepared 
using NEB Next RNA ultra protocol (#E7530 NEB). Obtained libraries were 
quantified fluorimetrically, pooled in equimolar amounts in two lanes (cTEC samples 
in one lane and mTEC samples in other lane) and sequenced on the Illumina 
NextSeq sequencer (NextSeqHi-75) by a mode enabling determination of uni-
directional 75 bases and indices, following manufacturer’s instructions (Illumina). 
372 and 424 millions of reads were produced for cTEC and mTEC lanes. 
Sequencing reads were submitted to ENA (http://www.ebi.ac.uk/ena) and are 
accessible under the accession number PRJEB15124. RNA-seq reads were 
mapped to the mouse genome (mm10) using STAR (version 2.4.2a) with mm10 
GTF annotation. An average of 63 (51-71), 61.3 (58-63), 71.5 (65-76) and 69.8 (67-
71) million reads were mapped per control cTEC, p53cKO cTEC, control mTEC and 
p53cKO mTEC samples, respectively. The number of reads per gene was counted 
using HTSeq-count (30). DESeq2 package was used to normalize and compare the 
different groups of cells (31). We selected differentially expressed genes based on 
the p-adjusted p-value lower than 0.1. Reads per kb of exon model per million 
mapped reads (RPKM) values were computed from normalized read counts. We 
identify enriched GO terms (biological processes and molecular functions) in the 
differentially expressed genes using model-based gene set analysis (MGSA) (32). 
The analysis was performed with 20 independent runs of the Markov chain of 1.109 
steps each. For each parameter, we used a regularly spaced grid with 11 points. 
The search intervals for the parameters p, alpha, and beta were set to [0.001, 0.1], 
[0, 0.2], and [0.5, 0.9] respectively for the search on biological process terms, and 
[0.001, 0.1], [0, 0.15], and [0.5, 0.9] for the search on molecular function terms. 
Functional categories with a marginal posterior probability estimate higher than 0.65 
were retained for further analysis. The hierarchical clustering, represented as a 
dendrogram, of TEC populations were performed using the hclust function in R on 
euclidean distances between the variance of the rlog-transformed read counts for 
each genes across samples 
 
In vitro regulatory T cell Suppression Assays. For in vitro suppression assay, 
5x104 control conventional T cells (CD4+CD25-) were labelled with 1 µM CFSE after 
cell sorting and cultured in duplicates for 3 days in round bottom 96-well plates 
together with different ratios of either control or p53cKO-derived regulatory T cells 
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(CD4+CD25+) and in the presence of 1 ug/ml anti-CD3 (Clone: 145-2C11; BD 
Pharmingen) and γ-irradiated spleenocytes (200 rads; 1x105/well). Suppressive 
ability of regulatory T cells was assessed based on the CFSE dilution of 
conventional T cells. The precursor frequency of dividing cells (percentage of cells in 
the initial population that undergone one or more divisions after culture) was 
calculated as follows: [∑n≥1(Pn/2n)]/[∑n≥0(Pn/2n)], where n is the division number that 
cells have gone through and Pn is the number of cells in division n (33). 
 
Statistical Analysis. Analysis was performed using Prism 6.0g software 
(GraphPad Software). The two-tailed Mann-Whitney test was used for statistical 
differences between groups. For multiple comparisons, a two-way ANOVA was 
used. p < 0.05 was considered significant. 
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Abstract 
 
Despite the well-documented effect of castration in thymic regeneration, the 
singular contribution of the bone marrow (BM) versus the thymus to this process 
remains unclear. The chief role of Interleukin-7 (IL-7) in pre- and intra-thymic stages 
of T lymphopoiesis led us to investigate the impact of disrupting this cytokine during 
thymic rebound induced by androgen blockade. We found that castration promoted 
thymopoiesis in young and aged WT mice. In contrast, only young germline IL-7 
deficient (Il7-/-) mice consistently augmented thymopoiesis after castration. The 
increase in T cell production was accompanied by the expansion of the sparse 
medullary thymic epithelial cell (mTEC) and the peripheral T cell compartment in 
young Il7-/- mice. In contrast to young Il7-/- and WT mice, the poor thymic response 
of aged Il7-/- mice after castration was associated with a defect in the expansion of 
BM hematopoietic progenitors. These findings suggest that BM-derived T cell 
precursors contribute to thymic rebound driven by androgen blockade. To assess 
the role of IL-7 within the thymus, we generated mice with conditional deletion of IL-
7 (Il7cKO) in thymic epithelial cells. As expected, Il7cKO mice presented a profound 
defect in T cell development while maintaining an intact BM hematopoietic 
compartment across life. Unlike Il7-/- mice, castration promoted the expansion of BM 
precursors and enhanced thymic activity in Il7cKO mice independently of age. Our 
findings suggest that the mobilization of BM precursors acts as a prime catalyst of 
castration-driven thymopoiesis.  
 
Introduction 
 
The thymus is a crucial organ in adaptive immune responses as the generative 
site of functionally diverse and self-tolerant T cells. Importantly, the activity of the 
thymus decreases with age, leading to a reduced and more restricted pool of newly 
generated T cells. While of marginal consequence in healthy individuals, thymic 
involution may predispose to infections, autoimmunity, and possibly cancer, in the 
elderly or patients undergoing allogeneic hematopoietic stem cell transplantation 
(HSCT) (1). Within the thymus, thymic epithelial cells (TECs) provide chief inductive 
microenvironments for T cell development and selection (2). As the number of TECs 
and thymocytes decline throughout life (3), it is thought that thymic involution stems 
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in part from deficits that affect both populations. Still, upstream alterations in the 
bone marrow (BM) influence the number of thymic seeding precursors, and this can 
also affect thymic function (4). 
Androgens are well-recognized regulators of thymopoiesis. This notion is 
supported by the observations that sex steroid ablation (SSA) augments thymic 
cellularity, restores TEC architecture and enhances T cell output in distinct 
conditions of thymic hypoplasia (5–8). Hence, manipulation of sex steroids levels 
represents an attractive therapy to correct thymic degeneration during aging or upon 
HSCT. Several reports indicate that SSA has direct effects in the thymic stromal 
cells. In particular, castration augments the proliferation and number of TECs (3, 9) 
and enhances the expression of Notch ligand Dll4 and CCL25 (10, 11), suggesting 
an improvement in TEC functioning. On the other hand, other studies revealed an 
equal beneficial impact of androgen blockade in the bone marrow (BM), such as 
reverting deficits in the numbers of lymphoid progenitors and B cells induced by 
radiation and aging (12–14) and regenerating the BM stromal microenvironment of 
aged mice (15). Therefore, thymic rebound driven by castration might also depend 
on upstream effects at the level of the BM. However, the lack of experimental 
models to uncouple the activity of these two key hematopoietic niches (BM and 
thymus) maintains this possibility unanswered.  
Interleukin 7 (IL-7) is a critical growth factor in thymopoiesis (16). The deficiency 
in IL-7 markedly inhibits T cell development, resulting in a severe combined 
immunodeficiency (SCID) both in humans, mice and jawed fish (17, 18). These 
results indicate a high functional conservation of the IL-7 signalling pathway in 
thymopoiesis. Within the thymus, IL-7 is predominantly produced by TECs (19, 20), 
wherein it regulates several aspects of T cell development, including survival and 
proliferation of early T cell precursors, αβ/γδ lineage commitment and CD4/CD8 
lineage determination during positive selection (21, 22). Previous studies suggest 
that intrathymic IL-7 expression is not altered following castration (7, 9). Still, 
surgical castration of aged mice with germline deletion of IL-7 (Il7-/-) suggests a 
requirement for this cytokine in thymic rebound induced by androgen blockade (13). 
One possibility is that intrathymic IL-7 drives castration-driven augment in 
thymopoiesis. However, the role of IL-7 in pre-thymic stages of T cell development 
may confound the interpretation of results obtained with mice with germline deletion 
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of Il7 (23). In particular, the number of common lymphoid progenitors and B cell 
precursors are profoundly reduced in the BM of Il7-/- mice, a defect that is further 
enhanced with age (16, 24). As such, the defective thymic rebound of Il7-/- mice 
following castration might result from the deterioration in the number of BM-derived 
thymic seeding progenitors.  
Using distinct loss-of-function genetic approaches, we examined the temporal 
and spatial requirements for IL-7 in thymic rebound induced by surgical castration. 
We found that castration enhances thymopoiesis in young but not aged germline Il7-
/- mice. The loss of thymic response induced by androgen blockade correlated with a 
defective expansion of hematopoietic progenitors in the BM of aged Il7-/-mice. 
Conversely, conditional deletion of IL-7 in TECs normalized the castration-driven BM 
and thymic reactivation across life. Our results indicate that the increase in 
thymopoiesis upon androgen blockade is functionally linked to the BM compartment. 
 
Results  
 
Androgen blockade augments thymopoiesis in both young and aged 
mice. 
 
We began by evaluating the impact of androgen blockade in the activity of the 
thymus of young and aged WT mice (Figure 1A) (3). We found that castration of 
young (4-week-old) mice induced an increase in thymic cellularity 2 weeks post-
surgery, which was of the same extent as the one observed in their aged 
counterparts (≥ 8 months) (Figure 1A) (6, 29). Androgen blockade did not alter the 
T-cell developmental program. Instead, it led to an expansion of all main thymocyte 
subsets (ETPs, DN2-DN4, DP, SP4 and SP8 cells) in both young and aged mice 
(Supplemental Figure 1A and B). Still, the cellularity of the thymus of mice 
castrated during puberty dropped 10 weeks post-surgery (Figure 1A), suggesting 
that age-related thymic involution is uncoupled of the effect of sex steroids (30). 
Using previously described IL-7 reporter mice (19, 31), we next examined the 
influence of castration on the expression of thymic IL-7. In these mice, IL-7YFP 
(Yellow Fluorescent Protein) cells identify a subtype of cTECs that expresses high 
levels of Il7. While abundant during embryonic and early postnatal life, IL-7YFP cells 
represent a minor subset in both young and aged thymus (19, 31) (Figure 1B, 
Chapter III | The bone marrow contributes to thymic rebound upon SSA 
Page | 92  
control IL-7 reporter mice (Ctr); non-reporter aged-matched mice are shown in 
Supplemental Figure 1C). We found that the frequency and number of IL-7YFP cells 
remained unaltered 2 weeks post-castration in young and aged mice (Figure 1B, 
upper panel, and C). These findings suggested that thymic rebound driven by 
castration seemed to proceed independently of changes in the intrathymic 
expression of IL-7. Further analysis of the composition of TEC subsets showed that 
the number of total cTECs (Ly51+) remained unaltered 2 weeks following castration 
(Figure 1B, middle panel, and C). Complementary analysis using CCRL1GFP 
(Green Fluorescent Protein) reporter mice, in which high levels of GFP expression 
identifies cTECs (26), corroborated this observation (Supplemental Figure 1D). In 
contrast, the frequency and numbers of mature CD80+ mTECs, including Aire+ cells, 
augmented in both young and aged thymus 2 weeks after castration (Figure 1B, 
middle and lower panels, and C).  
 
To determine whether the enlarged mTEC compartment resulted from direct 
effects of androgen depletion on TECs, we performed similar experiments in Rag2-/- 
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mice, which present sparse mTEC areas due to the absence of thymocyte-derived 
signals (32). Although castration induced a small increase in thymic cellularity of 
Rag2-/- mice, mTECs remained underdeveloped under this condition (Figure 1D 
and E). These findings indicate that the augmented mTEC compartment following 
castration represents a footprint of an increased TEC-thymocyte crosstalk. 
Furthermore, our results suggest that enhanced thymopoiesis driven by castration 
can be stimulated prior to the onset of age-associated thymic involution. 
 
Androgen blockade promotes thymic renewal in young IL-7-deficient 
mice.  
 
Next, we examined the temporal requirement of IL-7 during castration-induced 
thymic rebound. To do so, we castrated young and aged germline IL-7-deficient (Il7-
/-) mice, which displayed a profound thymic atrophy(16), and analyzed them 2 and 
10 weeks post-surgery. Similar to previous findings (13), most of aged Il7-/- mice did 
not augment thymopoiesis 2 weeks upon castration (Figure 2A and Supplemental 
Figure 2A). Contrarily, we found an expansion in the thymic cellularity of all  
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castrated young Il7-/- mice (Figure 2A). Still, androgen blockade did not restore 
thymic cellularity in Il7-/- mice to the level of WT mice and failed to correct the 
lymphopoietic defects that result from the lack IL-7 signalling, such as the 
developmental arrest at DN2-DN3 stage and the augmented SP4/SP8 ratio (22) 
(Figure 2B, compare to Supplemental Figure 1A). Instead, castration induced a 
global increase in the number of ETPs, immature and mature thymocytes subsets in 
Il7-/- mice (Figure 2C). The increase in thymocyte cellularity of Il7-/- mice castrated 
during puberty was maintained 10 weeks post-surgery (Figure 2A), indicating a 
durable benefit of castration in thymopoiesis. Yet, akin to WT mice, castrated Il7-/- 
mice displayed an age-dependent thymic involution (Figure 2A). Additionally, we 
analyzed the impact of androgen blockade in the TEC microenvironment and 
peripheral T cell composition of young Il7-/- mice. At steady state, the differentiation 
and number of mature mTECs, including Aire+ subset, were profoundly reduced in 
Il7-/- thymus, presumably due to the lack of thymocyte-derived signals (Figure 3A).  
 
Strikingly, castration increased the frequency and cellularity of mature mTECs 
(CD80+ and Aire+ mTECs) in Il7-/- thymi (Figure 3A). Similarly to WT mice, the 
numbers of immature mTECs and cTECs remained unaltered 2 weeks post-
castration (Figure 3A). Analysis of the lymphopenic T cell pool of Il7-/- mice (33) 
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showed that castration enhanced the frequency and number of peripheral CD4 and 
CD8 T cells, with a particular increase in the naïve T cell subset (Figure 3B). None 
of these alterations were found in castrated aged Il7-/- mice (Supplemental Figure 
2A and B), which lacked a consistent thymic response. Thus, the described 
intrathymic and peripheral improvements in castrated young Il7-/- mice seemed to 
derive directly from enhanced thymopoiesis. 
 
Androgen blockade fails to expand BM hematopoietic precursors in 
aged IL-7-deficient mice.  
 
The observation that young, but not aged, Il7-/- thymi rebound after castration 
suggested the existence of a temporal window in which this process could be 
stimulated independently of IL-7. Given that thymopoiesis requires a continual input 
of BM-derived progenitors (34) and castration promotes the expansion of common 
lymphoid progenitors (CLPs) and B cells in the BM (12), we examined whether the 
loss of castration-induced thymic rebound in aged Il7-/- mice was functionally linked 
to a defective BM response. We determined the influence of castration in the 
number of HSCs and CLPs, which were defined as previously described (35) 
(Supplemental Figure 3A). In agreement with previous reports [14], the numbers of 
LSK, CLPs and B cells increased in both young and aged WT mice 2 weeks after 
castration (Figure 4A and B). As expected, CLPs and B cell cellularities were 
markedly reduced in the BM of Il7-/- mice, being the numbers of CLPs further 
diminished with aged (Figure 4B) (24). Similarly to the thymus, the response of BM 
hematopoietic progenitors in Il7-/- mice was age-dependent. Particularly, we found a 
specific expansion of LSK and CLPs in castrated young Il7-/- mice (Figure 4B). Still, 
castration did not correct B lymphopoiesis in Il7-/- mice, indicating that androgen 
blockade did not bypass the requirement of IL-7 for B cell development in the adult 
BM (Figure 4B). These findings indicate the existence of a temporal-restricted 
window in which BM hematopoietic progenitors of Il7-/- mice respond to castration. 
Interestingly, the augmented numbers of LSK in castrated young Il7-/- mice 
correlated with the increased thymic cellularity at the individual mouse level, similar 
to young and aged WT counterparts. Albeit CLPs numbers expanded moderately in 
young Il7-/- mice after castration (Figure 4B), the correlation between their 
expansion and the increased thymic cellularity was not statistically significant 
Chapter III | The bone marrow contributes to thymic rebound upon SSA 
Page | 96  
(Figure 4C). These results suggest that the engagement of BM progenitors may be 
a requisite for castration-driven thymic rebound. 
 
Androgen blockade induces thymic rebound in aged mice with 
conditional deletion of IL-7 in the thymus. 
 
We reasoned that the loss of castration-driven thymic rebound in aged Il7-/- mice 
could be linked to a defective expansion of BM hematopoietic precursors. However, 
the use of mice with a germline deficiency in Il7 fails to uncouple the spatial 
requirements of this cytokine in the BM and thymus. To study whether thymic IL-7 
was a chief mediator of thymic renewal after castration, we generated and analyzed 
mice with conditional inactivation of Il7 in TECs. We developed mice with loxP-
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flanked alleles of Il7 (Il7fl/fl) and crossed them to mice expressing the Cre-
recombinase under the transcriptional control of the Foxn1 promoter (Foxn1Cre) (27), 
referred hereafter as Il7cKO (Supplemental Figure 4A). Young and old Il7cKO 
mice revealed a normal hematopoietic composition in the BM relatively to their 
aged-matched littermate controls (Il7fl/fl), containing similar numbers of total cells, 
LSK, CLPs and B cell subsets (Figure 5A, Il7fl/fl vs Il7cKO). In contrast, and 
consistently with a previous report (20), thymic cellularity was markedly decreased 
in young and aged Il7cKO mice, resulting in a reduction in the numbers of DN, DP, 
SP4 and SP8 subsets (Figure 5B and C; Supplemental Figure 4B Il7fl/fl vs 
Il7cKO). Similar to germline Il7-/- mice, Il7cKO mice displayed thymic developmental 
defects linked to the lack of IL-7 signalling, including the partial block in DN2-DN3 
transition and altered SP4/SP8 ratio (Figure 5C; Supplemental Figure 4B Il7fl/fl vs 
Il7cKO). These results reinforce the notion that TECs are the physiological source 
of IL-7 within the thymus. Hence, we used Il7cKO mice as a model system to 
interrogate whether the maintenance of the BM homeostasis overcame the 
requirement for intrathymic IL-7 in castration-driven thymopoiesis. As expected, the 
numbers of LSK, CLPs and B cells expanded in both young and aged Il7cKO mice 2 
weeks post-castration (Figure 5A, Ctr Il7cKO vs CTX Il7cKO). Notably, castration 
induced the rebound of the thymus in young Il7cKO and restored this effect in their 
aged counterparts (Figure 5B; Ctr Il7cKO vs CTX Il7cKO). Androgen blockade 
promoted the expansion of all major thymic subsets in both age groups of Il7cKO 
mice, but failed to correct the developmental blocks linked to the absence of IL-7, 
similar to young Il7-/- mice (Figure 5C, Supplemental Figure 4B; Ctr Il7cKO vs 
CTX Il7cKO). The correlation between the augmented numbers of LSK and CLPs in 
the BM and the increased in thymic cellularity was normalized in both young and 
aged Il7cKO castrated mice (Supplemental Figure 4C). We further analyzed 
whether the enhanced thymopoiesis after castration was manifested in the 
peripheral T cell pool of Il7cKO mice. Under steady state conditions, Il7cKO mice 
presented a peripheral T cell lymphopenia relatively to wild-type controls, with a 
reduction in the percentage and number of naïve CD4 and CD8 T cells (Figure 5D, 
Il7fl/fl vs Il7cKO). Strikingly, castration improved the peripheral T cell compartment 
of Il7cKO mice, with an increase in the frequency and number of naïve and total 
CD4 and CD8 T cells (Figure 5D, Ctr Il7cKO vs CTX Il7cKO). These results 
indicated that the maintenance of functional BM hematopoietic progenitors along life 
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bypasses the requirements for TEC-derived IL-7 during thymic rebound induced by 
androgen blockade. Together, our data provide evidence that the capacity of 
castration to stimulate thymic rebound also depends on the engagement of BM-
derived hematopoietic precursors. 
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Discussion 
 
Although it is well known that castration augments thymopoiesis under 
circumstances of thymic atrophy (6, 7), the mechanism underlying this regenerative 
process remains poorly understood. Our study provides evidence that the 
engagement of BM-derived precursors is a prime regulator of thymic renewal 
induced by castration. In mice, thymic activity reaches its maximum during puberty 
(3). Our initial observations that castration boosts thymopoiesis in young mice 
indicate that the function of the thymus can be enhanced independently of its 
atrophic status. Age-related thymic involution is accompanied by a loss in TEC 
cellularity (36), being these perturbations more pronounced in mature mTECs, 
including in Aire+ cells. Given their important role in tolerance induction (32), the 
drop in Aire+ cells with age might contribute to the predisposition to autoimmunity in 
the elderly (37). Our results showed that castration specifically expands mTECs in 
cohorts of animals that showed enhanced thymopoiesis, namely in young and aged 
immunocompetent mice and young Il7-/- mice. In contrast, the growth of the mTEC 
niche was not detected in thymi that failed to rebound after castration, as in the case 
of Rag2-/- or aged Il7-/- mice. These findings suggest that androgen blockade 
expands mTECs in a non-autonomous manner. In this regard, the establishment of 
the mTEC microenvironment involves the participation of TNFRSF RANK, LTβR and 
CD40 that are expressed in mTECs and their precursors (32). Given that castration 
augmented thymocyte cellularity, we infer that the growth of mTECs results from the 
increase in the bioavailability of TNFRSF ligands provided by distinct thymocyte 
subsets. Our results also suggest that the reduced mTEC compartment of aged or 
immunodeficient mice can be regenerated, providing that it is properly stimulated. 
Although the cellularity of cTECs was not affected after castration, one cannot 
exclude that androgen blockade does not influence their functionality. It has been 
reported that castration increases the expression of thymopoietic factors in cTECs, 
which promote the attraction, commitment and selection of thymocytes (38). These 
results implicate the existence of a complex intrathymic impact of androgen 
depletion in thymopoiesis.  
TECs are the intrathymic physiological source of IL-7 (16, 20). Although thymic 
IL-7 levels drop after testosterone administration (10), our observations indicate that 
castration does not reciprocally augment its expression in TECs. Given that IL-7 
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reporter mice identify a particular subset of cTECs expressing high levels of IL-7 
(28), we cannot exclude that androgen blockade regulates IL-7 expression in other 
thymic subsets expressing lower levels of this cytokine, such as non-IL-7 reporting 
cTECs and mTECs (39). In addition, oestrogen deficiency augments thymopoiesis in 
female mice through an increase in the levels of thymic IL-7 (40). These findings 
point to the existence of a sexual dimorphism concerning the action of sex steroids 
in regulation of IL-7 that needs to be further investigated. Intriguingly, we found that 
castration promotes thymic rebound in young (but not aged) germline Il7-/- mice, 
indicating the existence of a temporal window in which this regenerative process can 
be elicited independently of IL-7. The boost in thymopoiesis was intrathymically 
accompanied by an augment in mTEC cellularity and a moderate increase in naïve 
T cell counts. Still, castration neither restored thymic cellularity to normal levels nor 
corrected the specific defects that result from the absence of IL-7 signalling. In line 
with a previous study, most of the thymus of aged germline Il7-/- mice did not 
respond after castration (13). One hypothesis could be that cumulative intrathymic 
defects arising from the lack of IL-7 lead to this unresponsive state. Yet, the fact that 
the thymus of aged Il7cKO mice rebounded after castration argues against this 
possibility, and suggests that TEC-derived IL-7 is dispensable for this process. 
Previous findings show that androgen blockade influence the BM compartment, 
reverting age-related defects in the numbers of LSK, CLP and B cells (12). Thus, 
upstream effects in the BM niche might also contribute to the enhanced 
thymopoiesis upon castration, through the provision of an increased number of 
thymic seeding progenitors. Concordantly, we found a striking correlation between 
the expansion of hematopoietic progenitors (LSK) in the BM and the thymic rebound 
after castration in young/aged WT and Il7cKO mice as well as in young Il7-/- 
counterparts. Additionally, the castration-induced increase in the number of ETPs in 
these groups suggests an enhanced thymic colonization by BM-derived progenitors. 
Given that the number of DP and SP cells is proportional to the number of DN cells 
in the thymus (41, 42), the provision of a higher number of thymic seeding 
progenitors might contribute to an increase in the overall number of subsequent DN, 
DP, and SP subsets. Contrarily, castration failed to expand the hematopoietic 
progenitors in the BM of aged Il7-/- mice, which directly correlated to their poor 
thymic response. Despite the profound thymic hypoplasia, Il7cKO mice displayed a 
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normal BM hematopoietic composition, which restored the association between BM 
and thymus responses after castration. Our results do not exclude that castration 
might also directly influence the thymic microenvironment of Il7cKO or Il7-/- mice, for 
example enhancing the expression of thymopoietic factors Notch ligand Dll4 and 
CCL25 (10, 11). Still, upstream defects in the BM of aged Il7-/- mice might also 
actively contribute to a failure in thymic rebound, potentially explaining the 
discrepancy in castration-driven thymopoiesis between young and aged groups. 
Whether androgen blockade directly stimulates BM progenitors and/or acts indirectly 
on supportive BM stromal cells remains to be further investigated. HSCs and CLPs 
reside within the BM microenvironment, which secrete factors that promote their 
maintenance and differentiation (4). Il7 transcripts are found in multiple cell types 
within the BM, including osteoblasts, endothelial and mesenchymal progenitor cells 
(43). Despite evidence showing that Il7 transcripts are moderately increased in the 
BM after castration (15), it remains unclear what is/are the physiological source(s) of 
this cytokine within the BM microenvironment. Moreover, while IL-7 contributes to 
the maintenance of CLPs, LSKs do not express IL-7 receptor (44) and there is no 
evidence that IL-7 directly regulates their homeostasis. Thus, how androgen 
blockade drives the response of LSK and CLPs in the absence of IL-7 remains an 
open question. Previous results showed that castration promotes changes in the BM 
stromal niche (15). One possibility is that androgen blockade induces compensatory 
microenvironmental signals that act on HSCs and CLPs. Albeit the nature of these 
alternative stimulatory signals remains to be identified, our findings suggest that this 
compensatory mechanism ceases in aged Il7-/- mice. It is possible that IL-7 might 
directly influence the function of BM stromal cells. This scenario is in our view 
unlikely, as IL-7 receptor has been primarily found in hematopoietic cells and there 
is no experimental evidence that stromal cells respond to IL-7 (18). Alternatively, the 
severe and continual B lymphopenia provoked by the absence of IL-7 might alter the 
regular lympho-stromal interactions in aged Il7-/- mice, indirectly deteriorating the 
functional capacity of the BM stromal niches to produce the stimulatory signal(s), 
which in turn drive the engagement of hematopoietic progenitors after castration. 
Further in-depth studies are required to comprehend the molecular cues that 
promote androgen blockade-mediated response of LSK/CLPs in the BM. 
Taken together, our results indicate that the mobilization of BM precursors acts 
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as a prime catalyst of castration-driven thymopoiesis, providing a functional link 
between the response in the BM and thymus. These findings are also of clinical 
relevance as paediatric patients with defective IL-7-mediated signalling lack T 
lymphocytes but have a normal number of B lymphocytes. These patients are 
diagnosed during infancy and undergo corrective HSCT, which takes place following 
the identification of MHC-compatible BM donors (45). As such, our findings show the 
potential usage of androgen blockade as a readily therapeutic approach to boost 
thymic function in male paediatric patients with congenital immunodeficiencies, not 
only post but also pre-HSCT. 
 
Methods 
 
Mice. Il7-/-, Rag2-/-, CCRL1 and IL-7 reporter mice [B6.Cg-Tg (Il7-EYFP)5Pas] 
have been described previously (16, 19, 25, 26) and are all maintained on a C57Bl/6 
background. IL7 floxed mice (Il7fl/fl) were developed by a gene-targeting strategy that 
utilized the Flp-FRT and Cre-loxP recombinase systems. Briefly, embryonic stem 
(ES) cell clones containing a targeted Il7 allele (Il7tm1a(EUCOMM)Wtsi) were obtained 
from the European Conditional Mouse Mutagenesis Program 
(EUCOMM)/International Knockout Mouse Consortium (IKMC). In the targeted 
allele, the loxP-flanked neomycin phosphotransferase (NeoR) gene was inserted 
upstream the exon 3 and a third loxP site was also placed downstream the exon 4. 
ES cell clones were injected into C57Bl/6 blastocysts to generate mice bearing the 
EUCOMM IL7 allele. The NeoR cassette was deleted in vivo by Flp-mediated 
excision using Act-flippase (FLP) mice to create Il7 floxed mice, which were then 
crossed with Foxn1-Cre mice (27). Mice were housed under specific pathogen-free 
conditions and studies were conducted in accordance with the European guidelines 
for animal experimentation.  
 
Surgical castration. Mice were anesthetized by inhalation of a gaseous mixture 
of 3% isofluorane and oxygen, using an anaesthetic machine and maintained via a 
nose cone. Mice were pre-treated with an intraperitoneal injection of the analgesic 
buprenorphine at a dose of 0.05 mg/kg of body weight. A small incision was made in 
the scrotum to expose the testis, which were subsequently clamped and removed. 
The wound was closed with absorbable sutures. For surgical control, mice were 
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subjected to the entire surgical procedure, except removal of the testis 
(sham/control castration). 
Isolation of hematopoietic cells and flow cytometry analysis. Single cell 
suspensions from thymus and spleen were obtained by mechanical disruption of the 
respective tissues. Bone marrow cell suspensions were prepared by flushing femurs 
with cold FACS buffer (PBS supplemented with 2% heat-inactivated FCS) with a 26-
gauge needle. For the spleen and bone marrow, red blood cells were lysed using 
erythrocyte lysis solution (155 mM ammonium chloride; and 10 mM potassium 
bicarbonate). Three to ten million cells were stained in FACS buffer with a mixture of 
directly labelled specific antibodies: FITC-conjugated anti-Sca1 (D7) and anti-CD44 
(IM7); PE-conjugated anti-CD4 (GK1.5), anti-CD62L (MEL-14), anti-CD19 (eBio-
1D3), anti-CD127 (A7R34); PerCP-Cy5.5-conjugated anti-CD45.2 (104); PerCP-
eFluor710 anti-CD4 (GK1.5); PE-Cy7-conjugated anti-CD25 (PC.61.5); 
APC/eFluor660-conjugated anti-CD8 (53-6.7); APC-eFluor780-conjugated anti-cKit 
(2B8); eFluor450-conjugated anti-CD24 (M1/69) (eBioscience). For thymic and bone 
marrow progenitor population analysis APC/eFluor660-conjugated antibodies 
against CD4 (GK1.5), CD8 (53-6.7), CD11b (M1/70), CD11c (N418), CD19 
(eBio1D3), Gr1 (RB6-8CS), Ter119 (TER-119), CD3 (17A2), NK1.1 (PK136) and 
γδTCR (eBioGL3) (eBioscience) were used as lineage markers. Analysis was 
performed using FACS Canto II and a LSR Fortessa (BD Bioscience) and FlowJo 
software. 
 
Isolation and flow cytometry analysis of TECs. TECs were isolated as 
described (28). Before staining, cells were pre-treated with FC block (anti-
CD16/CD32 antibodies TruStain fcX; Biologend). Cell suspensions were stained 
with PE-conjugated anti-CD80 (16-10A1) and anti-Ly51 (6C3); PerCP-Cy5.5-
conjugated anti-CD45.2 (104); APC/eFluor660-conjugated anti-CD80 (16-10A1) and 
anti-EpCAM (G8.8); APC-eFluor780-conjugated anti-I-A/I-E (M5/114-15-2); 
eFluor450-conjugated anti-EpCAM (G8.8) (eBioscience). The binding of biotinylated 
anti-Ly51 (6C3) was revealed by PE-Cy7-conjugated streptavidin (eBioscience). For 
intracellular staining, cells were prepared according to the supplier’s protocol (Foxp3 
staining kit, eBioscience) and stained with APC/eFluor660-conjugated anti-Aire 
(5H12) antibodies (eBioscience). Analysis was performed using FACS Canto II and 
a LSR Fortessa (BD Bioscience) and FlowJo software. 
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Statistical Analysis. Statistical analysis of the results was performed using the 
GraphPad Prism Software. The two-tailed Mann-Whitney test was used for analysis 
between groups. For multiple comparisons, a two-way ANOVA was used. A 95% 
confidence interval was applied in the calculations and samples with p values under 
0.05 were considered significant (marked with *). For correlations, the spearman 
nonparametric correlation test was used. 
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Within the thymus, specialized subtypes of thymic epithelial cells provide unique 
microenvironments that support the development and selection of functionally 
diverse and self-tolerant T lymphocytes (1). The establishment of the cortical and 
medullary epithelial niches is a highly dynamic process that is initiated during the 
fetal period and maintained throughout life by the continuous replenishment of 
mature TECs (2). Yet, the number of differentiated TECs begins to slowly decay 
during adulthood as consequence of aged-related thymic involution (3). 
Furthermore, TECs also undergo age-independent punctual aggressions as result of 
cellular stress or stromal damage caused by infections, hormonal alterations, or 
cytoablative regimens such as chemotherapy or irradiation (4). Whereas these 
abovementioned changes might qualitatively differ from the ones occurring as a 
consequence of aging, the perturbations on the thymic microenvironment in both 
circumstances potentially reduce the production of newly generated T cells and/or 
contribute to the escape of autoreactive T cells during negative selection. Thus, 
understanding the molecular mechanisms harnessing the homeostasis of TECs has 
come to the foreground of the research field in the past few years. This knowledge 
will have important implications in comprehending how the current thymic 
rejuvenatory strategies operate (e.g.: sex steroid ablation) as well as in aiding the 
development of new approaches to re-establish thymic function in the context of 
acquired and/or congenital immunodeficiencies and autoimmune syndromes. In my 
thesis, we provide information concerning the maintenance (Chapter II) and 
regeneration (Chapter III) of TECs that helps to improve our current knowledge on 
how thymic function is regulated under different physiological conditions. 
 
Adding another piece to the puzzle: uncovering a novel regulator 
of the mTEC “engine” 
 
The transcription factor p53, initially described in 1979 (5–7), is classified as one 
of the key sentinels of the genome integrity due to its ability to prevent oncogenic 
transformation in cells with DNA damage or other cellular insults (8). Yet, beyond its 
undisputable importance as a tumour suppressor, an increasing number of recent 
studies have highlighted alternative roles for p53 as a regulator of metabolism, 
immunity, and among other aspects of cellular differentiation and development (9–
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11). Our interest in p53 stemmed from previous studies conducted in our laboratory, 
aimed at understanding the mechanisms that control the dynamic of IL-7-expressing 
TECs under circumstances of stress-induced thymic atrophy. Taking advantage of 
an IL-7 reporter mice, in which yellow fluorescent protein (YFP) identifies a subtype 
of cTECs that expresses high levels of IL-7 (12, 13), we found that thymic damage 
induced by γ-irradiation, but not by glucocorticoids, led to the re-emergence of IL-
7YFP TECs in adult mice (unpublished data). As γ-irradiation is a bona-fide DNA 
damage-inducing stimulus that engages the p53-mediated pathway (14), we 
decided to investigate whether this transcription factor could potentially be involved 
in the reestablishment of the IL-7-expressing cortical epithelium following injury. This 
premise led to the generation of a mouse model with a conditional deletion of p53 in 
TECs (p53cKO mice). While the re-induction of IL-7YFP TECs was p53-independent 
(unpublished data), a closer analysis of cTEC/mTEC composition of p53cKO mice 
paved the way for the findings described in Chapter II of this thesis, herein we 
identified p53 as a novel regulator of mTEC homeostasis. 
 The role of p53 in the thymus has been widely studied in the context of T cell 
development, where this transcription factor plays a crucial role in controlling 
thymocyte transition from the DN into DP stage and preventing malignant 
transformation (15–17). On the other hand, whereas p53 mutations have been 
reported in thymic epithelial tumours (18, 19), little is known about its potential role 
in the thymic stroma, particularly in the control of TEC physiology. The generation of 
p53cKO mice allowed us to demonstrate that p53 is fundamental to preserve thymic 
function and immune tolerance during life, through the regulation of the integrity of 
the mTEC niche. Interestingly, consistent with the specific impact of p53 inactivation 
on the medullary compartment, our analysis revealed that mTECs express higher 
levels of Trp53 transcripts than cTECs. These observations raised the question on 
whether the differential induction of p53 in TECs might be linked with distinct levels 
of cellular stress that both epithelial subtypes have to cope with. The outcome of 
p53-mediated responses depends on many variables, which includes the nature of 
the stress signal and the microenvironment in which the cell lives in (20). For 
instance, sustained levels of stress result in a robust induction of p53, leading to the 
activation of apoptotic cell death pathways and elimination of the irreparable 
damaged cells. Contrariwise, under non-stressed conditions, healthy cells can 
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transiently induce low levels of p53 activity, which elicits protective responses that 
support cell survival and development. Our results suggest that p53 induction on 
mTECs seems to occur via RANK- and CD40-activation of the NF-kB signalling 
pathway. Yet, we cannot exclude the potential influence of other mediators and/or 
stress signals in governing p53 levels in TECs. Previous reports demonstrated that 
the transcriptional regulation of Aire-dependent TRAs involves the induction of DNA 
double-stranded breaks through the coordinated action of topoisomerases-1 and -2 
(21, 22). Furthermore, while the detection of the Aire protein has been confined to a 
fraction of mature mTECs, a recent study suggested that Aire expression is an 
inherent property of the majority of mTECs across their differentiation program (23). 
Hence, though p53 was not previously identified as a putative Aire-associated 
protein (21, 24), one can postulate that cellular stress resultant from Aire-mediated 
DNA double-stranded breaks during TRA expression might also indirectly account 
for p53 induction in mTECs. In the future, it would be interesting to study whether 
and/or to what degree Aire might influence p53 activity on mTECs, by analysing 
p53cKO mice in an Aire-/- background. 
p53 belongs to a family of transcription factors that includes two other related 
homologues, p63 and p73 (25–27). Regardless their remarkable sequence similarity 
and conservation of the functional domains, current information suggests that the 
members of the p53 family control a network of overlapping as well as divergent 
cellular processes (28). In relation to the thymic epithelium, while little is known 
about a possible role for p73, a number of studies have emphasized the importance 
of p63 in controlling the proliferative potential of TEC progenitors (29). Remarkably, 
our findings suggest a division of labour between p63 and p53 in the establishment 
of the thymic microenvironment. We demonstrated that TEC-intrinsic deficiency in 
p53 causes a specific reduction in the size of the mTEC niche, probably as result of 
an impaired expression and responsiveness of RANK in mTECs. Yet, our 
observations do not utterly exclude a possible participation of p53 in the 
maintenance of TEC progenitors, particularly at the level of lineage-restricted mTEC 
precursors. In this regard, we found that p53cKO mice exhibit a progressive 
disruption of the immature mTEC compartment later life. Although the reason behind 
the reduction in immature cells remains unclear, one can speculate that such 
alterations might occur as consequent perturbations in the survival and/or 
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differentiation of mTEC-committed progenitors. In recent years, several studies 
revealed the existence of a heterogeneous pool of mTEC progenitor cells with 
unique phenotypic characteristics (2). Noticeably, some of the aforementioned 
subpopulations of mTEC progenitors have been identified on the basis of their 
RANK expression. Nonetheless, apart of being used as a surrogate marker (30), 
RANK-mediated activation of the NFкB pathway in progenitor cells was also shown 
to be critical for their stepwise differentiation into mature Aire+ mTECs (31). As the 
results depicted on this thesis establish a novel functional association between p53 
and RANK, future studies are necessary to investigate if the absence of p53 impacts 
the maintenance of RANK-expressing mTEC progenitors. Additionally, another 
interesting question that remains open concerns the effect of p53 on the expression 
of RANK across distinct stages of mTEC development. Previous studies revealed 
that RANK-derived signals elicit the upregulation of its own receptor on mTECs (31, 
32). Using a FTOC system, we gathered evidence that supports the involvement of 
p53 in an auto-amplification mechanism that regulates RANK expression, as p53 
inactivation on TECs impaired RANK upregulation following in vitro stimulation with 
agonist anti-RANK antibody. Nevertheless, given that our experiments were 
performed on the bulk population of TECs, one cannot exclude that p53 might also 
contribute to sustain the basal expression of RANK in mTECs. Therefore, detailed 
co-expression analysis of RANK and p53 within distinct medullary subpopulations 
would be of valuable information to better comprehend the potential existence of a 
stage-specific action of p53 during mTEC differentiation (Figure 1A).  
Consistent with observations that p53 governs wide transcriptional programs in 
different cell types (33–35), our genome wide study revealed that a broad set of 
genes linked to core biological processes, such as Foxn1, CD86, Il15 and Irf7 
(among many others), were compromised in p53cKO mTECs. Therefore, the 
function of p53 in mTEC homeostasis appears to extend beyond influencing RANK 
expression. Gene ontology (GO) analysis predicted the dysregulation of diverse 
pathways in p53-deficient mTECs that differ from the well-known mechanisms that 
control their maintenance. As knowledge about the molecular determinants of mTEC 
homeostasis is still limited, we speculate that the genome wide data produced in this 
thesis may provide an interesting framework to further identify new putative 
regulators of the medullary epithelial niche. In the last years, several different 
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studies uncovered how post-translational modifications differentially affect the 
transcriptional function of p53. In particular, the tight balance among acetylation, 
methylation and phosphorylation is crucial to control the cellular outcome of p53 
activity, as it may have discriminatory impacts on some target genes comparatively 
to others (20, 36). For instance, on the one hand, acetylation of the lysine 317 
residue in the linker region of the p53 protein was shown to decrease its ability to 
activate proapoptotic target genes following DNA damage without, however, 
influencing p21 transcription and cell-cycle arrest (37). On the other hand, recent 
data also revealed that acetylation of the lysine 320 of p53 is crucial for neurite 
outgrowth and axonal regeneration in mice by specifically governing the expression 
of two p53 transcriptional target, Coronin 1b and Rab13 (38). Interestingly, whereas 
acetylation functions as a dominant mechanism for activation, lysine methylation 
appears to restrains p53 transcriptional activity either by preventing p53 binding to 
coactivators or inhibiting other posttranslational modifications to take place on the 
same lysine residues (36). Our current research did not examine the status of the 
p53 protein on mTECs or the potential outcomes of post-translational p53 
modifications on the transcriptome of TECs. Actually, such studies would be as 
challenging as interesting in light of our findings that p53 regulates the regenerative 
capacity of the thymic microenvironment upon ionizing radiation. One can imagine 
that γ-irradiation-derived stress on TECs prompts specific post-translational 
modifications on p53, which in turn, would shift the transcriptional network of these 
cells towards the activation of survival and regenerative pathways. In this regard, 
comparison of the transcriptional profile of p53-deficient mTECs among distinct 
physiological conditions would provide valuable information about hypothetical p53-
mediated pathways involved in TEC recovery following radiation-induced damage. 
Uncovering the underlying mechanisms involved in TEC regeneration is one of the 
current goals of researchers in the thymus field, as it will provide new means to 
design strategies for therapeutical intervention in order to treat, repair or revert the 
deterioration of the immune system in different pathophysiological conditions. 
Interestingly, during the bioinformatic analysis of the sequencing data, we further 
noticed that the majority of the functional categories disclosed by the GO enrichment 
analysis in p53cKO mTECs incorporated purported TRAs. Taking in consideration 
the unique capacity of mTECs to virtually express all the protein-coding genes of the 
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body (39), one can assume that the presence of TRA within these pathways occurs 
as result of the promiscuous gene expression program. However, it cannot be ruled 
out that some TRAs may possess a pertinent biological activity in mTECs. As an 
example is RANK, which plays a pivotal role in mTEC differentiation and has been 
recently classified as a TRA (40). Given that some TRAs are only expressed by a 
minor fraction of mTECs (1-3%) at a certain point (41, 42), one can envision that a 
putative TRA that is functional relevant in mTEC biology should be more broadly 
expressed across the entire medullary epithelium. Future studies are warranted to 
decipher the possible influence of genes classified as TRAs in the maintenance of 
the mTEC niche. 
It is well documented the importance of RANK, CD40 and LTβR in fostering the 
maturation of the medullary epithelium (43). Nevertheless, emerging studies have 
been disclosing the novel role of numerous transcription factors in selectively 
regulating the maintenance and function of mTECs. Among these are members of 
the interferon regulatory factors (IRF) and signal transducer and activator of 
transcription (STAT) protein family (Figure 1A). The IRF group of proteins, which 
includes nine members in mammals, plays a critical function in the regulation of 
many aspects of innate and adaptive immune responses (44). Two recent reports 
described the participation of IRF4 and IRF7 in controlling distinct aspects of mTEC 
physiology (45, 46). Haljasorg et al. generated TEC-specific IRF4 knockout 
(IRF4cKO) mice and found that disruption of Irf4 leads to an increase in the 
frequency of mature mTECs and alters the expression of important chemokine and 
costimulatory molecules in these cells (45). Regardless of these alterations, the size 
of the medullary niche remained unaffected in IRF4cKO mice. These data raise the 
possibility that IRF4 controls a new checkpoint of mTEC differentiation. Interestingly, 
akin to p53cKO mice (47), inactivation of IRF4 provokes a reduction in thymic 
regulatory T cell numbers and peripheral manifestations of autoimmunity (45). In 
another study, Otero et al. demonstrated that loss of IRF7 has a detrimental impact 
on the medullary niche, characterized by a severe reduction in the overall number of 
mTECs and diminished levels of Aire transcripts (46). A more in-depth analysis 
revealed that IRF7 controls the production of IFN-β, which in turn promotes mTEC 
development (46). Contrarily to the study using IRF4cKO mice, it remains 
undetermined the physiological consequences of TEC-specific IRF7 loss in terms of 
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T cell development and tolerance induction. Curiously, while we demonstrated that 
p53 is induced by RANK and CD40 stimulation (47), both reports suggest the 
involvement of RANK-derived signals in regulating the expression of IRF4 and IRF7 
(45, 46). Yet, it remains to be further investigated whether these pathways can be 
activated by additional signals. Thus, p53-, IRF4- and IRF7-driven pathways seem 
to branch downstream of TNFRSF-induced activation of the NF-кB signalling 
pathway and coordinate multiple aspects of mTEC homeostasis (Figure 1B). 
More recently, two complementary studies demonstrated that alternative 
signalling pathways also participate in the maintenance of the medullary 
microenvironments in the adult thymus. Satoh et al. and Lomada et al. have shown 
that conditional inactivation of Stat3 in TECs prevents the expansion of thymic 
medullary areas during postnatal life (48, 49). Despite exhibiting a reduction in the 
mTEC compartment similar to that in p53cKO mice, the number of thymic regulatory 
T cells is unaltered in mice with STAT3-deficient TECs, indicating that STAT3 and 
p53 might control complementary programs in mTECs. STAT3 is activated by 
various cytokines and growth factors in vivo. Satoh et al. provide further evidence 
that STAT3 signalling in TECs might be induced by the epithelial growth factor 
receptor (EGFR), although the intrathymic physiological source of its ligand remains 
unclear (48). Cosway et al. have recently shown that targeted deletion of LTβR in 
TECs disturbs the architecture of mTECs without an overt effect on their 
functionality (50). Unlike the profound defects caused by the lack of RelB-signalling 
(51), conditional deficiency of LTβR does not affect thymic regulatory T cells and 
induces a milder phenotype reminiscent of STAT3 deficiency. These new studies 
highlight that the establishment, maintenance, and architecture of the thymus 
medulla are determined by the integration of multiple signals, although it remains 
unclear whether proper mTEC structure is required for its functionality. Further 
studies should aim to unravel the genetic program driven by the recently identified 
transcription factors in mTECs and their possible relationship in maintaining a 
functional mTEC compartment (Figure 1B). 
Intriguingly, the specific role of these transcription factors in mTEC biology was 
demonstrated in experimental models in which their genes were targeted in both 
cTECs and mTECs. On the one hand, the enriched expression and/or activation of 
these proteins in mTECs might determine their specific influence. On the other 
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hand, we hypothesized that the unique transcriptional and epigenetic states of 
mTECs (52) can facilitate the access of these TF to their targets. According to this 
conjecture, a given transcription factor drafts behind the molecular machinery 
involved in regulating pGE expression and exploit the induced changes in the 
chromatin to initiate a specific genetic program in mTECs. Still, the action of the 
newly identified transcription factor in mTEC homeostasis seems to be distinct from 
the prototypical roles of NF-кB in mTEC maturation or Aire and Fezf2 in TRA 
expression. Instead, these novel pathways appear to operate as a key rheostat to 
sustain the regular activity of the thymus medulla under physiological conditions, 
preventing the emergence of autoimmunity. Ultimately, understanding the 
mechanisms controlling the limits of the medullary microenvironment might lead to a 
better comprehension of the rules balancing immunity and tolerance induction. (Part 
of this section is adapted from Rodrigues et al, Trends Immunol. 2017) 
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Bone marrow - The “missing link” that lies beneath the 
rejuvenation of the thymus upon androgen blockade 
 
In the past two decades, sex steroid ablation (SSA) has been widely studied as 
an attractive therapeutic tool to either revert age-related thymic degeneration or to 
enhance immune recovery in bone marrow (BM) transplantation settings associated 
with cytoablative regimens (53). Nonetheless, despite its beneficial therapeutical 
effects, the pleiotropic impact of sex hormones in different cell types (54) has 
revealed a hurdle that hampers our understanding about the cellular and molecular 
regulators of SSA-mediated thymic regeneration. Previous studies revealed that 
modulation of thymic function by androgen-mediated signalling occurs as result of 
direct effects on the stromal microenvironment, in particular TECs (55, 56), rather 
than on thymocytes. In this regard, genome-wide transcriptomic analysis revealed 
that androgens negatively impact on the expression of numerous TEC-specific 
genes that are central in T cell development (e.g.: Dll4 and Ccl25) (57). Hence, one 
can speculate that androgen withdrawal stimulates thymic regeneration by 
correcting the transcriptional signature of TECs, which eventually enhances their 
ability to support thymopoiesis. Yet, in addition to its intrathymic effects, several 
reports also described similar beneficial effects of SSA in the bone marrow (BM) 
(58, 59), particularly at reverting deficits in the hematopoietic compartment. Given 
the intricate relationship between these two key hematopoietic sites (BM and 
thymus), one can alternatively propose that thymic renewal upon androgen blockade 
might rely on upstream effects at the level of the BM, through the increased 
provision of thymic seeding progenitors. 
Assessing the existence of a functional relationship between the response in the 
BM and thymus to androgen blockade represents a great challenge, mainly due to 
the lack of experimental models to uncouple the activity of these organs. Interleukin-
7 (IL-7) is a fundamental cytokine in many facets of the immune system (60). In the 
thymus, IL-7 regulates several stages of T cell development and its mainly produced 
by TECs (12, 61–63). Also, IL-7 expression is detected in multiple cell types within 
the BM (64), where it plays a critical role in common lymphoid progenitor (CLP) 
maintenance and B lymphopoiesis (65). The deficiency in IL-7 results in severe 
combined immunodeficiency (SCID), a syndrome characterized by a markedly 
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inhibition of T and B lymphopoiesis in mice (66). Owing the multifaceted impact of 
IL-7 at distinct anatomical hematopoietic niches, we postulated that the specific 
disruption of this cytokine might offer an opportunity to examine the interplay 
between the BM and the thymus following SSA. In this thesis, using distinct loss-of-
function genetic approaches to inactivate IL-7, we provide new evidence that 
positions the expansion of BM-derived precursors as the chief catalyst of thymic 
renewal induced by androgen blockade (Chapter III).  
Past evidence considered IL-7 as a prime candidate involved in thymic rebound 
induced by androgen withdrawal. This notion originates from observations that aged 
IL-7 germline KO mice were unresponsive to androgen withdrawal (67). Conversely, 
our current data reveal that SSA is able to enhance the activity of young (but not 
aged) IL7KO thymus and demonstrate that the loss of SSA-driven thymic rebound in 
aged IL-7 KO mice correlated with a defective expansion of the hematopoietic stem 
cell compartment (HSC and CLPs). Moreover, the generation of a TEC-specific IL-7 
knockout (Il7cKO) model allowed us to further conclude that: 1) thymic IL-7 is not 
required for thymic renewal during androgen blockade and 2) increase in 
thymopoiesis upon SSA is functionally linked to the BM compartment (Figure 2). 
Nonetheless, it is currently unclear how androgen blockade influences the 
maintenance and expansion of the hematopoietic precursors. The discrepancy in 
SSA-driven thymopoiesis seen amongst young and aged IL7KO mice suggests the 
existence of a temporal window in which this regenerative process can be elicited 
independently of IL-7. Yet, how the hematopoietic niche responds to androgen 
withdrawal in the absence of IL-7 is intriguing given that, contrarily to CLPs (65), 
HSCs do not express IL-7 receptor and there is no evidence that directly place IL-7 
as a regulator of their homeostasis (68). Hence, one possibility is that SSA induced 
compensatory microenvironmental signals that act on HSC and/or CLP, replacing 
the requirement of IL-7 in young mice. Alternatively, defects in the BM stromal niche 
and on its functional capacity to produce stimulatory signal(s) might accumulate with 
age in the absence of IL-7, which turns hematopoietic progenitors unresponsive to 
SSA. As previous data revealed that Il7 transcript levels are increased in the BM of 
age mice following SSA (59), future studies exploiting the temporal and conditional 
deletion of IL-7 in different BM stromal cells would help us to better comprehend the 
physiological role of this cytokine during androgen withdrawal. 
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IL-7 belongs to a unique family of cytokines termed common cytokine receptor γ-
chain (γc), which also includes IL-2, IL-4, IL-9, IL-15 and IL-21 (69). The γc family of 
cytokines were shown to have vital roles in the homeostasis of multiple cell lineages 
of the innate and adaptive immune system (70). Each cytokine has its own specific 
receptor, sharing the γc subunit is a unique feature among the different family 
members. Some years ago, while the project described in Chapter III was still at a 
premature stage, we decided to use Il2rgKO mice as a complementary approach to 
examine the contribution of IL-7 receptor-derived signals for the intrathymic effects 
of SSA. Remarkably, akin to aged IL7KO mice, we found that thymic renewal 
following androgen blockade was abrogated in young Il2rgKO mice (Appendix, 
Figure 1A). As a consequence, the growth of the mTEC microenvironment was 
blocked in Il2rgKO thymus during SSA (Appendix, Figure 1B), reinforcing the 
notion that androgen blockade impacts on the medullary epithelium through a non-
cell autonomous mechanism that entails thymocyte-derived signals. Additionally, the 
lack of thymic rebound in castrated Il2rgKO mice directly correlated with a defective 
expansion of BM-derived hematopoietic compartment (Appendix, Figure 1C and 
D). Hence, these findings propose that androgen withdrawal influences the BM-
Thymus axis by stimulating the expansion of the BM hematopoietic compartment in 
a γc-dependent manner. Future studies are warranted to ascertain the putative 
identity of the γc cytokine(s) that drives the regenerative effects of SSA. 
Interestingly, our analysis revealed that the BM of young Il2rgKO mice holds an 
enlarged LSK compartment when compared to age-matched wild-type and/or IL7KO 
counterparts (Chapter III, Figure 5B vs Appendix, Figure 1C). This observation is 
intriguing, as an increase in HSC cellularity is detected during the ageing process as 
consequence of cumulative cell-intrinsic and -extrinsic alterations. Although we still 
lack important information about the possible influence of γc cytokines in the 
homeostasis of HSCs, our results demonstrate that absence of γc-derived signals 
perturbs the size of the hematopoietic stem cell niche. In this regard, we cannot rule 
out that young Il2rgKO mice are unresponsive to androgen blockade simply due to 
the existence of profound defects on HSCs caused by the lack of the γc subunit, 
which render them unable to react to any SSA-derived stimulatory signal. In this 
regard, recent observations uncovered the broad influence of androgen-signalling in 
the transcriptional profile of HSCs and BM stromal cells (59). Nonetheless, the 
complex interplay between these two cellular compartments makes difficult to 
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assess on whether the SSA-mediated expansion of HSCs happens due to initial 
intrinsic changes on these cells and/or is driven by the ameliorated functional 
capacity of the BM microenvironment to produce stimulatory signals for their 
rebound. The development of new mouse models bearing a specific and temporal 
controlled deletion of the γc subunit in HSCs would provide a unique framework to 
clarify these queries. Simultaneously, such studies would aid in identifying the target 
cues that drive the response of LSK/CLPs to androgen withdrawal. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Several other therapeutical strategies are known to revert the physiological 
consequences of thymic involution. For instance, beneficial effects on the thymic 
stromal compartment were observed after administration of FGF7 (also known as 
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keratinocyte growth factor), insulin-like growth factor 1 (IGF1) and Ghrelin to aged 
mice (71–73). However, as aged-related thymic degeneration seems to be a 
multifactorial process (4), rejuvenation of the involuted thymus to the levels found in 
young animals has been difficult to attain, particularly if using therapeutical 
approaches whose effects are mainly restricted to the thymus. During aging, the 
HSC niche undergoes several phenotypical and functional changes, including 
skewing towards the myeloid lineages, lower reconstitution potential and numerical 
accumulation of long-term HSCs (74). While cell-intrinsic mechanisms are known to 
contribute to the appearance of these defects, microenvironmental alterations of the 
BM stroma may also contribute to the functional deterioration of HSC with age (75, 
76). Since thymic function relies on the continual supply of BM-derived progenitors 
(77), one can foresee that age-related alterations in the distinct BM niches might be 
a major impediment to achieve a sustained thymic regeneration. Therefore, the 
development of novel therapeutical strategies that promote the concurrent 
restoration of both the thymic microenvironment and the BM compartment 
(hematopoietic and stroma) stands as a more logical and efficient coordinated 
option towards the achievement of a long-term stable immune regeneration. Future 
studies should focus at identifying the molecular mediators that operate on the BM-
thymus axis during aging. 
 
Concluding remarks 
 
Despite recent advances, our knowledge about the rules that govern TEC 
development and function is still incomplete. Furthermore, there is also little 
evidence about the molecular mediators involved in the damage and regeneration of 
the thymus. Hence, the characterization of the regulatory network underlying the 
maintenance of the thymic epithelium have received considerable attention in the 
last years, as perturbations on the TEC niches are closely associated with the 
development of autoimmune syndromes or immunodeficiency. 
In this thesis, we provided new evidence that will expand our understanding on 
distinct aspects of TEC physiology. In Chapter II, we demonstrated that p53 is a 
critical regulator thymic function and immune tolerance, by mainly governing the 
homeostasis of the mTEC niche. Additionally, we found that p53 regulates a broad 
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transcriptional program in mTECs, including the expression of TRAs and genes 
associated with core processes of mTEC biology (e.g.: RANK). In Chapter III, we 
explored the temporal and spatial requirements for IL-7 in thymic regeneration 
induced by SSA. Using distinct and novel genetic approaches, which included the 
generation of Il7cKO mice, we established that 1) thymic IL-7 is dispensable for 
thymic renewal after SSA and 2) the increase in thymic activity upon castration is 
functionally linked to the BM compartment.  
In conclusion, this thesis provides new insights on the cellular and molecular 
mechanisms that govern the homeostasis of the TEC microenvironments. This 
knowledge will have important repercussions to the development of therapeutic 
strategies for the clinical management of major conditions and diseases associated 
with the need to enhance and/or correct thymic function and reconstitution. 
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Thymic epithelial cells require p53 to support their long-term function in
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Key Points
• TEC-intrinsic ablation of p53
predominantly affects
medullary TECs, altering their
RANK-driven differentiation
and transcriptome.
• Loss of p53 in TECs couples
disrupted thymopoiesis to
altered T-cell homeostasis
and tolerance.
Thymic epithelial cells (TECs) provide crucial microenvironments for T-cell development
and tolerance induction. As the regular function of the thymus declines with age, it is of
fundamental and clinical relevance to decipher new determinants that control TEC
homeostasis in vivo. Beyond its recognized tumor suppressive function, p53 controls
several immunoregulatory pathways. To study the cell-autonomous role of p53 in thymic
epithelium functioning, we developed and analyzed mice with conditional inactivation of
Trp53 in TECs (p53cKO). We report that loss of p53 primarily disrupts the integrity of
medullaryTEC (mTEC)niche, adefect that spreads to theadult corticalTECcompartment.
Mechanistically, we found that p53 controls specific and broad programs of mTEC
differentiation. Apart from restraining the expression and responsiveness of the receptor
activator of NF-kB (RANK), which is central for mTEC differentiation, deficiency of p53 in
TECs altered multiple functional modules of the mTEC transcriptome, including tissue-
restricted antigen expression. As a result, p53cKO mice presented premature defects in
mTEC-dependent regulatoryT-celldifferentiationand thymocytematuration,whichprogressed toa failure in regularand regenerative
thymopoiesis and peripheral T-cell homeostasis in the adulthood. Lastly, peripheral signs of altered immunological tolerance unfold
in mutant mice and in immunodeficient mice that received p53cKO-derived thymocytes. Our findings position p53 as a novel
molecular determinant of thymic epithelium function throughout life. (Blood. 2017;130(4):478-488)
Introduction
Within the thymus, thymic epithelial cells (TECs) orchestrate the
development of functionally diverse and self-tolerant T cells.1 Impor-
tantly, impaired TEC functions arise with aging, cytoablative regimens
and infection, which compromise T-cell responses to pathogens, and
vaccination in the elderly, and patients undergoing bone marrow
transplantation (BMT) or chemotherapy. Equally, failures in TEC-
mediated tolerance induction lead to autoimmunity.2 Hence, the
identification of novel regulators of TEC homeostasis is crucial to
comprehend the foundations of immunity and to intervene medically
in disorders linked to a dysfunctional thymus.
Cortical TECs (cTECs) and medullary TECs (mTECs) define 2
functionally distinct microenvironments, which differentiate from
bipotent TEC progenitors.1 Whereas cTECs drive T-cell lineage spec-
ification and positive selection, mTECs promote the maturation of
positively selected thymocytes, regulatory T-cell differentiation, and
elimination of autoreactive T cells.1 Important tomTEC function is their
ability to express tissue-restricted antigens (TRA),2 which depends in
part on autoimmune regulator (Aire) andFezf2.3,4 Past studies elucidated
the role ofmembers of tumor necrosis factor (TNF) receptor superfamily
(TNFRSF) receptor activator of NF-kB (RANK), lymphotoxin b
receptor (LtbR), and CD40 in the maturation of mTECs.1 Still, the
molecular determinants that control the function of these key inducers of
mTECs remain unknown. Other uncertainties concern the signaling
pathways that maintain the multilayered function of TECs in vivo.
The tumor suppressor protein p53 is a recognized regulator of cell-
cycle arrest and apoptosis. Yet recent studies have revealed alternative
roles for p53 in immunoregulation and autoimmunity.5 In relation to
the thymic epithelium, the observations that the p53 homolog p63
controls the turnover of TEC progenitors6 imply a possible functional
relationship within the p53 family. The analysis of the role of p53 in
TEC physiology has been precluded because of its broad expression
pattern and the complex phenotype of germline p53-null mice, which
ultimately develop thymic lymphomas.7 Despite such limitations,
several studies link p53 to TEC homeostasis. Although germline
deletion in wild-type p53-induced phosphatase 1, a p53-target gene,
impairs the maturation of mTECs and thymic regeneration,8 the
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systemic administration of p53 inhibitors moderately improves
TEC recovery and thymopoiesis following BMT.9 Because genetically
engineered mouse models and pharmacological studies often hide
lineage-specific functions of broadly acting genes, the cell-autonomous
relevance of p53 in the dynamic differentiation of TECs in vivo re-
mains unexplored. Our findings underscore the requirement for p53
in TECs to support their role in T-cell development and selection.
Methods
All procedures are further detailed in the supplemental Methods section,
available on the BloodWeb site.
Mice
C57BL/6 p53fl/fl, Foxn1Cre, and Marilyn-Rag2 2/2mice10-12 were housed under
specific pathogen-free conditions. Experiments were performed under the
European guidelines for animal experimentation.
Flow cytometry
TECs and hematopoietic cells were isolated and stained as described.12 Cells
were analyzed on afluorescence-activated cell sorter (FACS)Canto II and a LSR
Fortessa and sorted on a FACSAria I (BD Biosciences) (purities were .96%).
Data were analyzed on FlowJo software.
Histology
Thymic lobes were prepared for immunofluorescence analysis, as described.12
Paraffin-embedded tissue sections from indicated organs were stained with
hematoxylin and eosin (H&E). Analysis was done on a light microscope
(Olympus CX31) and IN Cell Analyzer2000 (GE Healthcare). Images were
processed using Fiji software.
Gene expression
MessengerRNA(mRNA) isolationandcomplementaryDNA(cDNA) synthesis
were done, as described.12 Real-time polymerase chain reaction (RT-PCR) was
performedusingTaqManUniversalPCRMasterMixandprobes for selectedgenes.
Fetal thymic organ culture (FTOC)
We established 2-deoxyguanosine (dGuo)-treated FTOC, as described12 and
cultured it in medium alone or with recombinant CD40L (5 mg/mL), agonist
antibodies anti-RANK (1 mg/mL) (R&D Systems) or anti-LTbR (10 mg/mL;
AC.H6), and Pifithrin-a (50 mg/mL; Sigma-Aldrich).
Luciferase assay
In silico analysis identified putative p53-binding sites in the promoter ofTnfrsf11a.
p53-DeficientMEFswere transientlycotransfectedwitha reporterfirefly luciferase
plasmid containing genomic fragments ofTnfrsf11aorCdkn1apromoters along
with a p53-expressing vector. Renilla luciferase plasmid was cotransfected as
an internal control (Dual-Luciferase Reporter Assay System, Promega).
RNA sequencing
Total RNA library preparation and high-throughput sequencing of sorted cTECs /
mTECs samples from p53cKO and control littermates were performed at
Gene Core facility (EMBL, Germany). The number of reads per gene was
counted using HTSeq-count,13 and data were analyzed with DESeq2
package.14 Gene ontology (GO) enrichment analysis was done using a
model-based gene set analysis.15
Regulatory T-cell suppression assay
Control and p53cKO-derived regulatory T cells were sorted as CD25highCD41
T cells and cocultured with carboxyfluorescein diacetate succinimidyl ester–
labeled T cells at various ratios in the presence of anti-CD3 mAb and irradiated
splenocytes. The frequency of dividing cells was determined, as described.16
Statistical analysis
The 2-tailed Mann-Whitney test was used for statistical differences between
groups, and a 2-way analysis of variance was used for multiple comparisons
(GraphPad Prism).
Results
Inactivation of Trp53 in TECs reduces the mTEC compartment
To investigate the function of p53 in the thymic epithelium, we
conditionally deleted the p53 gene (Trp53 ) in TECs by crossing mice
with loxP-flanked alleles of Trp53 (Trp53 fl/fl)10 with mice expressing
Cre recombinase under the control of the Foxn1 promoter (Foxn1Cre),
which directs the expression of Cre recombinase to virtually all TECs
during embryonic and postnatal life.11 Foxn1Cre:Trp53 fl/fl (p53cKO)
mice were born without obvious abnormalities and did not develop
spontaneous tumors in the thymus or skin, which also contains Foxn11
keratinocytes.11 The Cre-mediated deletion of Trp53 fl allele was de-
tected in TECs but not in thymocytes from p53cKOmice nor in TECs
from Trp53 fl/fl littermate controls (Ctr) (Figure 1A and supplemental
Figure 1A-B). Although not statistically different, Trp53 levels were
moderately increased in mTECs in comparison with cTECs from the
control thymus (Figure 1B), indicating that p53 is expressed under
physiological conditions. The same transcript was nearly absent in
cTECs and mTECs from p53cKO mice (Figure 1B) but remained
similarly expressed in thymocytes from Ctr and p53cKO mice
(supplemental Figure 1C).
We started by comparing the thymic epithelium composition in
control and p53cKO mice throughout life. Although with altered
proportions in relation to controls, cTEC numbers were normal during
fetal, postnatal, and prepuberty periods, becoming moderately di-
minished in 10-week-old p53cKO mice (Figure 1C-D). In contrast,
though seemingly similar to control mice at E16.5, the frequency and
numbers of mTECs were continually reduced in mutant mice from the
postnatal period onward (Figure 1C-D). Concordantly, the global
medullary compartment and the number of UEA1mTECs were
reduced in the adult p53cKO thymus, without affecting the compart-
mentalization into the cortex and medulla (supplemental Figure 1D).
We assessed possible Cre-mediated cellular toxicity and found no
major changes in thymic and cTEC/mTEC cellularities of Foxn1Cre:
Trp53 1/1 mice in comparison with Trp53 1/1 mice (supplemental
Figure 1E). Age-matched Trp53 fl/fl littermates were used as controls in
subsequent experiments.
The impact of Trp53 deletion in mTECs led us to examine their
differentiation program. First, we subdivided mTECs into CD80lo,
which include immature cells and a minor subset of post-Aire ter-
minally differentiated cells in the adult thymus, and mature CD80hi,
which contains Aire-expressing cells.1,17 The development of CD80hi
and Aire1 mTECs was delayed in the embryonic p53cKO thymus
but was normalized to the proportions of the control thymus during
prepuberty (Figure 1E). Despite the restoration of complete mTEC
differentiation, the number of CD80hi and Aire1 mTECs was di-
minished in p53cKO thymus throughout life, whereas the CD80lo
subset becameaffected only in adultmice (Figure 1F). Second, analysis
of mTEC turnover revealed an increase in the rate of p53cKOmTECs
in active cycling (S/G2/M) (supplemental Figure 1F). Moreover, we
monitored the extent of DNA double-strand breaks18 and apoptosis,
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and found that the percentages of phosphorylatedg-H2AXandannexin
V1, respectively, were slightly increased in p53cKO mTECs,
particularly within CD80lo cells (supplemental Figure 1G-H). These
findings suggest that increased apoptosis rather than defective prolif-
eration might contribute to the reduced number of mTECs in p53cKO
mice. Lastly, analysis of the expression of a panel of TRAs showed
that Aire-independent genes were downregulated in p53cKO
mTECs, whereas Aire-dependent genes presented a variable pattern
in both mTEC subtypes (Figure 1G). Our data suggest that p53 is
superfluous for cTEC/mTEC specification but instead controls
mTEC homeostasis.
p53 regulates RANK expression in TECs
The similarity between themTEC-phenotype of p53cKOmice and that
of mice with defects in RANK, CD40,and LTbR19 led us to evaluate
whether p53 fine-tunes the expression of these TNFRSF members.
Additionally, we analyzed the expression of osteoprotegerin (OPG), a
decoy receptor of RANK ligand.19 Although the levels of Tnfrsf5
(CD40), Tnfrsf3 (LTbR), and Tnfrsf11b (OPG) were normal, the
expression of Tnfrsf11a (RANK) was reduced in p53cKO mTECs
(Figure 2A). To examine the functional relationship between p53 and
RANK, we usedwell-defined in vitromodels of mTEC differentiation,
inwhich E15.5 dGuo-FTOCswere depleted of hematopoietic cells and
then stimulated through RANK.12 Strikingly, the frequency and
numbers of mature CD801 and Aire1 mTECs in RANK-stimulated
p53cKO dGuo-FTOCs were reduced in relation to controls
(Figure 2B). Contrarily, CD40-mediated mTEC maturation and
CD40 expression on p53cKOmTECs were unaffected (supplemental
Figure 2A-B). Hence, loss of p53 appeared to specifically dampen in
vitro mTEC differentiation induced by RANK. Given that RANK
activation induces its own expression,20 we evaluated whether p53
positively controls this self-amplification loop. Concordantly,
RANK-mediated stimulation augmented the expression of Tnfrsf11a
Fold difference mRNA levels (p53cKO/Ctr)
0.0
Tnfrsf11b
Tnfrsf3
Tnfrsf5
Tnfrsf11a
A B
Ctr
p = 0.02
p53cKO
0.5 1.0 1.5
# mTECAire (x10 3)
dGuo
*
*
*
*
RANK
# mTECs (x10 3)
dGuo
0
CD80Io CD80hi
Ctr
Ctr
cKO
3 6 9
0
Ctr
Ctr
cKO
1 2 3
dGuo + RANK
dGuo - Ctr
CD80
Aire
M
HC
-II
Ctr p53cKO
105
104
103
102
102 103 104 105
0
0
105
104
103
102
102 103 104 105
0
0
105
104
103
102
102 103 104 105
0
0
105
104
103
102
102 103 104 105
0
0
105
104
103
102
102 103 104 105
0
0
105
104
103
102
102 103 104 105
0
0
Tnfrsf11a
(RANK)
0
1
2
3
A.
U 
(x
10
-5
)
Tnfrsf5
(CD40)
0
6
12
18
Tnfrsf3
(LTER)
0.0
0.6
1.2
1.8
Tnfrsf11b
(OPG)
0
2
4
6
0
Ctr p53cKO
Ctr + Pifithrin-D
2Fo
ld
 c
ha
ng
e
(+
R
AN
K/
dG
uo
)
4
6
8
Tnfrsf11a
C
*
*
*
Relative luciferase activity
0 1 2 3 4 5 6
Empty
p53
7
-3649
(A)
p21
(B) (C) (D) TSS
-2392 -1888 -1112 -581-574
Tnfrsf11aD
*
*
*
*
*
*
*
*
A
B
C
D
**
*
*
*
0
CD40L
LTER
+
-
-
-
+
-
-
-
+
+
+
-
+
-
+
-
+
+
1Fo
ld
 c
ha
ng
e
(tr
ea
te
d/
dG
uo
)
2
3
Trp53
E
D
D
RANKD
RANKD
D
D
Figure 2. Ablation of Trp53 in TECs limits the expression and responsiveness of RANK. (A) The expression of Tnfrsf11a, Tnfrsf5, Tnfrsf3 , and Tnfrsf11bwas assessed
by qRT-PCR in FACS-sorted mTECs (UEA1Ly512) from 2-week-old Ctr and p53cKO mice. Values were normalized to 18s ribosomal RNA. Graphs represent data from 4
independent experiments (top). Fold difference in the relative mRNA levels between Ctr (dashed line) and p53cKO mTECs (bottom). (B) E15.5 dGuo-treated FTOCs from Ctr
and p53cKO mice were cultured for 4 days with anti-RANK (aRANK). Expression of CD80 and Aire was analyzed in mTECs (UEA1Ly512) by flow cytometry. Numbers
indicate the mean percentage of gated cells. Graphs show the cellularity of mTEC subsets per thymic lobe. Number of asterisks compare mature mTECs from Ctr with
p53cKO mice (top). Results are presented as mean 6 SEM of 10 to 12 thymic lobes per group from 5 independent experiments. (C) The expression of Tnfrsf11a was
analyzed by qRT-PCR in FACS-sorted TECs from Ctr and p53cKO E15.5 dGuo-treated FTOC stimulated over 24 hours with aRANK or aRANK plus Pifithrin-a. Values were
normalized as in panel A, and those in TECs from nonstimulated dGuo-treated FTOC were set to 1. Graphs represent data from 3 to 6 independent experiments (mean 6
SEM). (D) The region upstream of the Tnfrsf11a (RANK) TSS contains putative p53 response elements (REs) (triangles), identified on the basis of the p53 RE matrix logo
(RRRC-A/T-A/T-GYYY motifs, in which R is a purine and Y is a pyrimidine) (MatInspector, rVista, or both, software tolls). DNA fragments (A-D) from the Tnfrsf11a (RANK) and
Cdkn1a (p21) loci were cloned into the pGL3-Promoter reporter plasmid. p53 KO MEFs were transiently transfected with the indicated luciferase plasmids along with a p53
overexpressing construct (p53) or an empty construct (Empty). Luciferase reporter activity was normalized to the relative pGL3-promoter signal. Represented is the average
of 3 independent experiments (6SEM). (E) The expression of Trp53 was analyzed by qRT-PCR in FACS-sorted TECs from Ctr and p53cKO E15.5 dGuo-treated FTOC
stimulated over 24 hours with anti-RANK, recombinant CD40L, and anti-LTbR at different combinations. Values were normalized as in panel A, and those in TECs from
nonstimulated dGuo-treated FTOC were set to 1. Data are representative of 4 independent experiments (mean 6 SEM). A.U., arbitrary units; MHC, major histocompatibility
complex. *P , .05; **P , .01.
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in TECs from control dGuo-FTOC. Noticeably, this increase was
attenuated in TECs from both RANK-activated p53cKO dGuo-FTOC
and RANK-activated control dGuo-FTOC cotreated with the p53
inhibitor pifithrin-a (Figure 2C), indicating that p53 controls the
expression of Tnfrsf11a. In silico analysis identified 6 putative
p53 REs21 within the 4kb region upstream of the transcrip-
tion start site (TSS) of Tnfrsf11a (Figure 2D). We cloned 1kb
genomic DNA fragments containing these potential p53 REs
(named A-D) into a luciferase reporter plasmid and assessed their
p53-mediated transactivation in p53-deficient MEFs, which were
cotransfected with a p53-expressing vector. As a positive control,
we used a Cdkn1a (p21)-derived fragment containing a bona fide
p53 RE.21 Notably, p53 increased luciferase expression driven by
Tnfrsf11a-derived fragments A, C, and D, but not B (Figure 2D).
These results imply that p53 has the potential to control the
activity of Tnfrsf11a promoter. To study whether p53 was
reciprocally induced under mTEC differentiating conditions, we
activated control dGuo-FTOCs with RANK, CD40, and LTbR
agonists. Contrary to LTbR stimulation, individual RANK- and
CD40-engagement induced Trp53 expression in TECs, an effect
that was further augmented by combined activation (Figure 2E).
These results indicate that both RANK andCD40 signaling induce p53,
which in turn promotes RANK expression and RANK-driven mTEC
differentiation.
p53 specifically regulates a broad network of the
mTEC transcriptome
Given that p53 governs multiple transcriptional programs in distinct
cells,22-24 we examined its genome-wide influence in TECs. To do so,
we performedRNA sequencing (RNA-Seq) analysis and compared the
transcriptome of cTECs and mTECs isolated from 2-week-old control
and p53cKO mice. We selected this age to permit the maturation
of mTEC, the emergence of p53cKO phenotype, and the sufficient
abundance of cTEC/mTEC subsets for analysis. The number of genes
expressed in the control and p53cKO mTECs was higher than in their
cTEC counterparts, resulting in the expected cTEC/mTEC segrega-
tion (Figure 3A and supplemental Figure 3A-B). Trp53 levels were
increased in control mTECs andmarkedly reduced in p53cKO-derived
TEC subsets. The expression of cTEC- and mTEC-associated genes
separated the 2 lineages independently of their genotype (supplemental
Figure 3 C-D), validating the accuracy of sorted samples. Strikingly,
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though randomly associated within cTEC subsets, the biological repli-
cates of control and p53cKO mTECs defined 2 distinct clusters
(Figure 3A). Accordingly, the number of differentially expressed
genes between p53cKO and control mTECs was substantially larger
than in cTECs (Figure 3B and supplemental Tables 1-2). The
identification of 1418 upregulated genes and 1945 downregulated
genes in p53cKOmTECs implies that p53 negatively and positively
regulates gene expression in mTECs (Figure 3C). Concordant with
previous observations,Tnfrsf11a expressionwas reduced in p53cKO
mTECs analyzed byRNA-seq and quantitative RT-PCR (qRT-PCR)
(supplemental Figure 3E). Yet, RANK was not identified among
the list of differentially expressed genes most possibly due to the
stringent statistical analysis of RNA-Seq, differences in gene
normalization, and intrathymic sample variation.
Using a publicly available annotated list of TRA genes,25 we next
cross-examined their representation within differentially expressed
genes of p53cKO mTECs. Notably, nearly half of the downregulated
genes in p53cKO mTECs comprised purported TRAs, with a similar
incidence ofAire-dependent andAire-independent targets (Figure 3D).
The proportion of TRAs within upregulated genes of p53cKOmTECs
was lower, including mostly Aire-independent targets (Figure 3D).
These data suggest that p53 regulates promiscuous gene expression
in mTECs. Additionally, GO enrichment analysis in differentially
expressed genes did not reveal any particular term in cTECs but was
associated to diverse functional categories in p53cKO mTECs.
Specifically, upregulated genes indicated an increase in DNA
replication, mitosis, ribosome biogenesis, RNA and protein complex
binding, ATPase activity, and constituents of nuclear pore. Conversely,
downregulated genes suggested an attenuation in transmembrane trans-
port; actin filament-based process; neuropeptide signaling pathway;
carbohydrate and ion binding; andRNAPII transcription factor, enzyme
inhibitor, hormone-factor, and growth-factor activity (Figure 3E and
supplemental Tables 3-6). Concordant to the mTEC-restricted pheno-
type of p53cKO mice, these results suggest that p53 controls a
multifaceted transcriptional program in mTECs.
Adult p53cKO mice display an impaired regular and
regenerative thymopoiesis
We then analyzed how the described changes in TEC microenviron-
ments affected the thymic activity of p53cKOmice. The frequency and
abundance of major thymocyte subsets, including early thymic
precursors (ETP), double-negative (DN) subsets, and double-positive
(DP) and single-positive (SP) CD4 and CD8 cells, were comparable in
control andmutantmice during fetal and prepuberty life (Figure 4A-C).
Notably, a global deficit in thymopoiesis appeared in 10-week-old
p53cKO mice (Figure 4A), without altering the global T-cell differ-
entiation program. Namely, the progression through DN1-DN4 stages
and the rate of positive selection, as measured by the frequency of
CD31CD691 thymocytes, were largely similar between the control
andp53cKOthymus (Figure4B).However,we founda reduction in the
proportion of DN1s and ETPs in the p53cKO thymus (Figure 4B).
Correspondingly, the numbers of all major thymic subsets steadily
declined in p53cKOmice, this trend being apparent in 6-week-oldmice
(Figure 4C). These perturbations extended to the peripheral T-cell
compartment of adult p53cKO mice, with a reduction in splenic CD4
and CD8 T-cell counts (Figure 4D). The dysfunctional nature of the
adult mutant thymus led us to further analyze their regenerative capac-
ity following ionizing radiation. Although numerically different
at baseline, mTECs were markedly depleted in both groups 5 days
after sublethal total-body irradiation (supplemental Figure 4A).
This reduction was attenuated in p53cKO mTECs supplemental
Figure 4A), suggesting that ablation of p53 conferred a slight protec-
tion to radiation-induced apoptosis. Although the recovery of cTECs
was similar in both groups, the restoration of mTEC cellularity,
including CD801 and Aire1 subsets, was markedly impaired in
p53cKO mice (supplemental Figure 4A-C). Additionally, the recovery
of thymopoiesis was also significantly compromised in p53cKO mice
(Figure 4E), affecting de novo generation of all major thymic subsets
(Figure 4F) and the reconstitution of the peripheral T cells (Figure 4G).
Our findings indicate that adult p53cKO mice fail to maintain normal
and regenerative thymopoiesis.
mTEC-dependent thymopoiesis is compromised in
p53cKO mice
As the loss of mTECs preceded the deterioration of thymopoiesis
during adulthood, we examined whether the stages of T-cell develop-
ment that were functionally linked to mTECs1 were prematurely af-
fected in p53cKO thymus. To survey cortical and medullary clonal
deletion, we assessed the frequency of DP and SP4 thymocytes that
coexpressed PD-1 and Helios,26 respectively, and found no major
differences between control and p53cKO thymus (Figure 5A). More-
over,we crossed p53cKOmicewithMarilyn-Rag22/2TCR transgenic
mice, in which thymocytes express I-Ab-restrictedHY-specific TCR.12
Thymocyte development in the p53cKO background reproduced that
observed in controls,with a similar number of positively and negatively
selected thymocytes in female andmalemice, respectively (Figure 5B).
In linewith the absenceofSP4accumulationat steady state (Figure 4B),
these results indicated that negative selection seemed intact in p53cKO
mice. Strikingly, analysis of regulatory T-cell differentiation and
postselection SP maturation showed a respective decrease in the
proportions and numbers of CD251Foxp31 regulatory T cells and
mature CD24loCD62Lhi SP4 thymocytes inmutant thymus (Figure 5
C-D). These findings implicate a requirement for p53 in TECs to
maintain continual mTEC-dependent thymopoiesis.
Signs of disturbed peripheral tolerance unfold in p53cKO mice
The alterations inmTECs led us to seek signs of peripheral autoimmune
manifestations in mutant mice. We did not detect the presence of
autoantibodies against multiple organs (stomach, testis, liver, salivary,
and lacrimal glands) in the serum of aged p53cKO mice in compari-
son with controls (data not shown). Yet larger and more prevalent
lymphocytic infiltrations were found in the salivary and lacrimal
glands of aged p53cKO mice (Figure 6A-B, supplemental Figure 5A).
Despite the reduction in the numbers of thymic regulatory T cells,
their frequency in the spleen of adult p53cKO mice was normal
(supplemental Figure 5B). However, as total peripheral CD4 T cell
counts were reduced (Figure 4D), both conventional and regulatory
T cells were diminished in mutant mice (supplemental Figure 5B).
Moreover, p53cKO-derived peripheral regulatory T cells suppressed
polyclonal T-cell activation in vitro (supplemental Figure 5C), showing
a broad intact function and potentially explaining the mild autoimmune
manifestations. These findings suggest that the perturbed mTEC niche
of p53cKO mice might predispose to defects in tolerance. The de-
velopment of autoimmunity coupled with defects in mTECs is
normally contained in the C56BL/6 background but is potentiated
by lymphopenia, as is observed in the case of Aire and XCL1
deficiencies.27,28 To examine the functional link between scarce mTEC
niches and disturbed T-cell tolerance in p53cKO mice, we adoptively
transferred thymocytes derived from control and mutant adult thymus
into Rag2 2/2 mice and monitored recipient mice for clinical signs of
disease. Recipient mice that received p53cKO-derived thymocytes
exhibited accelerated weight loss, developed diarrhea and presented
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lymphocytic infiltration and tissue damage in the colon (Figure 6C). The
presenceofTcells in the spleenof bothgroups indicatedan effective cell
transfer (supplemental Figure 5D). Similar to the analysis at steady state,
small lymphocyte infiltrates were also more frequent in the salivary
glands of the same group (Figure 6D). Our results indicate that the
p53 mutant thymus renders developing T cells more susceptible to
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failure in establishing peripheral self-tolerance in aged and lympho-
penia settings.
Discussion
Our study positions p53 as a prime determinant of mTEC integrity in
vivo, mapping a functional link between p53 and RANK in mTECs.
This was manifested by a reduced RANK-driven mTEC induction in
the p53cKO thymus in vitro, an observation that curiouslymirrored the
delayed appearance of embryonic p53cKOmaturemTECs in vivo.We
found that mTECs express higher levels of p53 than do cTECs and that
p53was reciprocally induced following RANKandCD40 stimulation.
These results are consistent with previous studies coupling p53
induction to the NFkB pathway,29 which is in turn engaged bymTEC-
inducingTNFRSF signaling.19Yet the reduction inmTECsof p53cKO
mice was not as severe as that reported in RANK-deficient mice.19 The
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differentiation ofmTECs depends on the coordinated action of RANK,
CD40, and LTbR signaling.1 It is conceivable that compensa-
tory signals via CD40 and LTbR contribute to the mTEC maturation
program of p53cKO mice. Hence, p53 seems to fine-tune, rather than
determine, RANK signaling in mTECs, cooperating in a functional
feed-forward loop to sustain the medullary epithelial compartment.
Our results suggest that p53 functions as amolecular hub inmTECs,
regulating a wide transcriptional program that extends beyond
balancing RANK expression. Typically, p53 is maintained at low
levels under steady-state conditions, being activated in response to
various stress signals.21 Nonetheless, p53 also has basal transcriptional
functions in unstressed cells.23 Apart from RANK and CD40, it
is possible that additional extrinsic and intrinsic cues generated within
the thymus trigger a p53-driven response in mTECs. Although the
mechanisms that induce p53 in mTECs remain elusive, our
observations argue that its activity is not dormant. Genome-wide
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chromatin-binding approaches revealed extensive and distinct cell-
specific p53-driven transcription programs,22-24 indicating that p53-
mediated gene expression is context dependent. We found that p53
controls a broad set of genes linked to core processes in mTEC
biology, which are not related to other well-known mechanisms
controlling mTEC maintenance. The increased apoptosis suscepti-
bility of p53-deficient mTECs might be a corollary of these broad
alterations, possibly explaining the reduced mTEC compartment of
p53cKO mice. Yet the presumed asynchrony of apoptosis at a
population level and the rapid clearance of dying cells may confound
measurements of cell death in vivo. Moreover, it remains to be
determined whether differentially expressed genes are directly
regulated by p53 or indirectly influenced through the perturbation
of downstream genes of the p53-induced pathway. Further studies
should elucidate the individual contribution of these gene products or
processes to the maintenance of mTEC homeostasis and their homo-
and heterotypic cellular interactions within the thymus. It is also
important to consider that the hyperactive transcriptional state of
mTECs might facilitate the accessibility of p53 to its target genes.
The large prevalence of TRAs among the differentially expressed
genes of p53cKO mTECs suggests that p53 influences promiscuous
gene expression. Still, the expression of Aire25 and Fezf24 was normal
in p53cKOmTECs. Because mTECs express clusters of TRAs at a
single-cell level,3,30 the reduction in TRAs might alternatively
reflect an underrepresentation of certain mTEC subsets in mutant
thymus.
The disruption in the mTEC niche appeared to spread to the cTEC
compartment in the adult p53cKOmice, evolving to a global failure in
regular and regenerative thymopoiesis. The deficit in thymic activity
extended to a decrease in splenic T cells, reinforcing the notion that
peripheral T-cell homeostasis in mice also depends on regular thymic
output.31 Thus, the sustainability of the mTEC niche seems to be a
deterministic factor in regulating thymic function. How the changes in
mTECs are reflected in the cortex is intriguing. The phenotype and
transcriptional profile of cTECs, aswell as the earlyT-cell development
andpositive selection,were apparentlynormal in p53cKOmice.Yetwe
cannot formally exclude that p53 directly regulates cTEC homeosta-
sis later in life. Alternatively, changes in mTECs might perturb the
corticomedullary junction and cortex, thereby limiting the number of
BM-derived thymic progenitors and the magnitude of premedullary
stages ofT-cell differentiation.Accordingly, the numbers of ETPs,DN,
and DP thymocytes were diminished in aged p53cKOmice, providing
a possible explanation for thymic hypoplasia. These findings could
implicate the existence of a complex functional and structural interplay
between TEC and nonepithelial cell subsets (eg, endothelia and
mesenchyme) in balancing thymopoiesis.
The contracted mTEC compartment of p53cKO mice was phys-
iologically linked to abnormalities in mTEC-dependent regula-
tory T-cell differentiation and SP maturation, providing a possible
molecular explanation for the signs of deregulated immunological
tolerance inmutant mice. Albeit negative selection seemed normal at
a polyclonal level, we cannot exclude the possibility that rare
autoreactive thymocytes escape from the p53cKO thymus. In line
with previous studies,32 we reason that the underrepresentation of
regulatory T cells and mature SP4 represents the footprint of a
decrease in the availability of mTEC niches. Concordantly, mild
signs of autoimmune manifestations unfolded in aged p53cKOmice
and in immunodeficient mice receiving p53cKO-derived thymo-
cytes. Although we did not provide a direct link between the
disturbed tolerance and the deficiency in regulatory T- cell numbers
or their specificities and the specificities of conventional T cells, our
findings suggest that the insufficient mTEC niche of p53cKO mice
predisposes to defects in immune tolerance under lymphopenia.
Also, the signs of abnormal immunological tolerance in p53cKO
mice were weaker in comparison with other mTEC-deficient condi-
tions.19 We reason that the remaining mTEC niche of mutant thymus,
together with the genetic background and extrathymic compensatory
mechanisms, allows the establishment of peripheral tolerance during
the first weeks of age, a period that is sufficient to prevent the
development of autoimmunity.33 Future studies should identify the
distinct contribution of altered thymic and peripheral T-cell subsets to
the disturbed tolerance induction of mutant mice.
Beyondpositioning p53 as a novel guardian of thymus function, our
findings are also of clinical relevance and reinforce the notion of a
modulatory role for p53 in immune homeostasis and autoimmunity.5
Moreover, the use of p53 inhibitors, such as Pifithrin-b, has been
approved in clinical trials to attenuate the side effects of chemotherapy.9
Given the described adverse impact of disrupting p53 in TECs and in
T cells,5 the therapeutic useof p53 inhibitorsmust be implementedwith
care to safeguard the balance between immune reconstitution and
tolerance induction.
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Setting Up the
Perimeter of Tolerance:
Insights into mTEC
Physiology
Pedro M. Rodrigues,1,2
Pärt Peterson,3 and
Nuno L. Alves1,2,*
Medullary thymic epithelial cells (-
mTECs) play a central role in T cell
tolerance. However, how the
mTEC compartment is maintained
remains elusive. We review recent
discoveries on new transcription
factors involved in mTEC homeo-
stasis and discuss the possibility
that their actions might be facili-
tated by the unique biology of
mTECs.
The generation of multifunctional and
self-tolerant CD4+ [106_TD$DIFF] and CD8+ ab T cells
proceeds sequentially within dedicated
microenvironments of the thymus
formed by cortical TECs (cTECs) and
mTECs [1]. Despite deriving from com-
mon bipotent progenitors, cTECs and
mTECs specialize into functionally dis-
tinct cell types [2]. While cTECs drive T
cell lineage commitment and positive
selection, mTECs mediate the deletion
of autoreactive thymocytes or promote
their clonal deviation into regulatory T
cells [1]. The central role of mTECs in
tolerance induction depends on their
unique capacity to express virtually all
self-antigens, including tissue-restricted
antigens (TRAs). This so-called promis-
cuous gene expression (pGE) potential is
acquired during mTEC maturation in part
through the action of two transcriptional
regulators, Autoimmune regulator (Aire)
and Fezf2, that coordinate the expression
of a broad range of TRAs [3]. The devel-
opment of mTECs commences during
organogenesis and continues during
adulthood. In recent years the identifica-
tion of distinct subtypes of mTEC precur-
sors, such as Claudin3,4+stage-specific
embryonic antigen (SSEA)+, Claudin3,4+,
receptor activator of NF-kB (RANK)+[107_TD$DIFF], and
podoplanin+ cells, has emphasized the
dynamics of this process [4]. NF-kB sig-
naling is critical to mTEC differentiation
and is triggered by the engagement of
members of the TNF receptor superfamily
(TNFRSF) – RANK, CD40, and LTbR – by
their ligands expressed in developing thy-
mocytes [1]. Despite substantial advances
in our understanding of the blueprint of
mTEC differentiation, themolecular mech-
anisms that control themaintenance of the
thymic medulla in postnatal life remain
poorly defined. Interestingly, mature
mTECs turnover every 1–2weeks, indicat-
ing the need for their regular replacement
by upstream precursors. Given that
genetic or age-related defects in mTECs
are linked to the development of autoim-
munity, the study of how these cells influ-
ence thymic activity is of fundamental and
medical importance. In this Forum we
summarize recent studies that have
uncovered the role of new classes of hith-
erto overlooked transcription factors (TFs)
in the selective regulation of mTEC
homeostasis.
Our laboratories independently generated
experimental evidence using conditional
loss-of-function mouse models that adds
novel pieces to our understanding of thy-
mus medulla homeostasis and function.
Rodrigues et al. analyzed mice with a
disrupted Trp53 gene in TECs and
showed that p53 is critical for mTEC
maintenance and function [5]. TEC-intrin-
sic p53 deficiency causes a specific
reduction in the size of the mTEC com-
partment, decreasing the expression of
RANK in mTECs and conditioning their
responsiveness to RANK stimulation.
Beyond the functional link to RANK, we
found that p53 regulates a broad tran-
scriptional program in mTECs, including
the expression of TRAs and genes
associated with core processes of mTEC
biology [5]. However, it is presently
unclear how p53 maintains the mTEC
niche. Given that p53 controls a basal
transcriptional program in unstressed
cells [6], the reducedmTEC compartment
in p53 conditional knockout (KO) mice
might result from broad failures in genes
linked to essential mTEC biology. In a
complementary study, Haljasorg et al.
generated TEC-specific IFN regulatory
factor 4 (IRF4) KO mice and found that
disruption of Irf4 leads to an increase in
the frequency of mature mTECs and
alters the expression of important chemo-
kine and costimulatory molecules in these
cells [7]. This observation raises the pos-
sibility that IRF4 controls a novel check-
point in mTEC differentiation. Intriguingly,
the absence of p53 and IRF4 provokes a
common reduction in thymic regulatory T
cell numbers, leading to peripheral auto-
immunemanifestations [5,7]. Future stud-
ies should dissect to what extent p53 and
IRF4 control distinct and/or overlapping
programs in mTEC biology. Interestingly,
both reports suggest the involvement of
TNFRSF signaling in the regulation of the
expression of p53 and IRF4. While p53 is
induced by RANK and CD40 stimulation
[5], IRF4 expression is specifically con-
trolled by RANK activation [7]. The RANK-
–IRF axis was previously implicated in
mTEC differentiation with the observation
that the activation of IRF7 downstream of
RANK controls the production of IFN-b,
which in turns promotes mTEC develop-
ment [8]. Thus, p53-, IRF4-, and
IRF7-driven pathways seem to branch
downstream of TNFRSF-induced activa-
tion of the NF-kB signaling pathway and
coordinate multiple aspects of mTEC
homeostasis. However, it remains to be
further investigated whether these
pathways can be activated by alternative
signals (Figure 1).
Besides agonist signals, the TNFRSF-
mediated pathway is tempered by nega-
tive regulators that control the
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bioavailability of TNFRSF ligands, the
expression of the receptors, and the
intensity of downstream signaling. Osteo-
protegerin (OPG) is one of these regula-
tors, operating as a soluble decoy
receptor for RANK ligand. The expression
of OPG in mTECs is controlled by the TF
Spi-B, which is in turn activated by RANK
[9]. Hauri-Hohl et al. identified TGF-b as
an additional negative regulator of the
mTEC compartment. Genetic ablation
of TGF-b signaling in TECs expanded
themTEC niche and the functional capac-
ity of the thymus medulla to maintain tol-
erance induction. Mechanistically, TGF-b
signaling dampens the NF-kB pathway
elicited by RANK and CD40 engagement
[10]. These findings suggest that OPG
and TGF-b are important liaisons in the
negative feedback mechanism controlling
TNFRSF signaling during mTEC
differentiation.
Interestingly, two recent reports demon-
strated that alternative signaling path-
ways also participate in the
maintenance of the medullary microenvi-
ronment in the adult thymus. Satoh et al.
and Lomada et al. have shown that con-
ditional inactivation of Stat3 in TECs pre-
vents the expansion of thymic medullary
areas during postnatal life [11,12].
Despite exhibiting a reduction in the
mTEC compartment similar to that in
p53 conditional KO mice, the number of
thymic regulatory T cells is unaltered in
mice with STAT3-deficient TECs, indicat-
ing that STAT3 and p53 regulate comple-
mentary programs in mTECs. STAT3 is
activated by various cytokines and
growth factors in vivo. Satoh et al. provide
further evidence that STAT3 signaling in
TECs is induced by the epithelial growth
factor receptor (EGFR), although the
intrathymic physiological source of its
ligand remains unclear [11]. Cosway
et al. have recently shown that targeted
deletion of LTbR in TECs disturbs the
architecture of mTECs without an overt
effect on their functionality [13]. Unlike the
profound defects caused by the lack of
Relb signaling [14], conditional deficiency
of LTbR does not affect thymic regulatory
T cells and induces a milder phenotype
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Figure 1. Proposed Model for the Action of the Recently Identified Regulators of Medullary Thymic Epithelial Cell (mTEC) Homeostasis. (A) TEC
progenitors (TEPs) traverse through a ‘transitional TEC progenitor’ stage that expresses phenotypic andmolecular traits associated with cortical TEC (cTEC) precursors
(cTEPs) before the commitment to a cTEC or mTEC fate [2]. The NF-kB pathway regulates various stages of their differentiation, from mTEC progenitors (mTEPs) to
immature (Imm) and mature (Mat) mTECs [4]. While p53 [5] and STAT3 [11,12] appear to control the maintenance of the broad mTEC compartment, IFN regulatory
factor (IRF) 4 [7] and IRF7 [8] seem to regulate the immature–mature mTEC transition. (B) Molecular interplay between the distinct signaling pathways and transcription
factors (TFs) governing the homeostasis and differentiation of mTECs. The right side represents the well-recognized role in mTECs of members of the TNF receptor
superfamily (TNFRSF) – receptor activator of NF-kB (RANK), CD40, and LTbR – which on interaction with their respective ligands activate the canonical and
noncanonical NF-kB pathway. This pathway of mTEC differentiation is regulated at multiple levels. Osteoprotegerin (OPG) acts as a decoy receptor for RANK ligand
(RANKL), inhibiting RANK signaling [9]. Additionally, signaling through the TGF-b receptor (TGF-bR) negatively regulates the NF-kB pathway [10]. The left side
represents the role of p53-, IRF4-, IRF7-, and STAT3-mediated signaling in the coordination of mTEC differentiation and homeostasis. While p53 [5], IRF-4 [7], and IRF7
[8] appear to be activated downstream of TNFRSF signaling, STAT3 [11,12] is suggested to be engaged by signaling through the epithelial growth factor receptor
(EGFR). It remains unclear whether these pathways can be activated by other, as-yet-undefined signals (represented by ‘?’). Another uncertainty pertains to the
overlapping or distinct nature of the gene expression program driven by the recently identified TFs in mTECs. Black lines with superscript colored arrows represent
purported target genes.
2 Trends in Immunology, Month Year, Vol. xx, No. yy
TREIMM 1438 No. of Pages 3
reminiscent of STAT3 deficiency. The new
studies highlight that the establishment,
maintenance, and architecture of the thy-
mus medulla are determined by the inte-
gration of multiple signals, although it
remains unclear whether proper mTEC
structure is required for its functionality.
Further studies should aim to unravel the
genetic program driven by the recently
identified TFs in mTECs and their possible
relationship in maintaining a functional
mTEC compartment (Figure 1).
Intriguingly, the specific role of these TFs
in mTEC biology was demonstrated in
experimental models in which their genes
were targeted in both cTECs and mTECs.
On the one hand, the enriched expression
and/or activation of these proteins in
mTECs might determine their specific
influence. On the other hand, we hypoth-
esized that the unique transcriptional and
epigenetic states of mTECs [3] can facili-
tate the access of these TFs to their tar-
gets. According to this conjecture, a given
TF drafts behind the molecular machinery
involved in regulating pGE expression and
exploits the induced changes in the chro-
matin to initiate a specific genetic pro-
gram in mTECs. However, the action of
the newly identified TFs in mTEC homeo-
stasis seems to be distinct from the pro-
totypical roles of NF-kB in mTEC
maturation or Aire and Fezf2 in TRA
expression. Instead, these novel path-
ways appear to operate as a key rheostat
to sustain the regular activity of the thy-
mus medulla under physiological condi-
tions, preventing the emergence of
autoimmunity. Ultimately, understanding
the mechanisms controlling the limits of
the medullary microenvironment might
lead to a better comprehension of the
rules balancing immunity and tolerance
induction.
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